Altria (MO) 10-K 26 Feb 19 2018 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2018	Feb. 12, 2019	Jun. 30, 2018
Document And Entity Information [Abstract]
Document type	10-K
Amendment Tag	false
Document period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	FY
Trading Symbol	mo
Entity Registrant Name	ALTRIA GROUP, INC.
Entity Central Index Key	764,180
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		1,874,430,847
Entity Public Float			$ 107

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Assets
Cash and cash equivalents	$ 1,333,000,000	$ 1,253,000,000
Receivables	142,000,000	142,000,000
Inventories:
Leaf tobacco	940,000,000	941,000,000
Other raw materials	186,000,000	170,000,000
Work in process	647,000,000	560,000,000
Finished product	558,000,000	554,000,000
Inventory, net	2,331,000,000	2,225,000,000
Income taxes	167,000,000	461,000,000
Other current assets	326,000,000	263,000,000
Total current assets	4,299,000,000	4,344,000,000
Property, plant and equipment, at cost:
Land and land improvements	309,000,000	302,000,000
Buildings and building equipment	1,442,000,000	1,437,000,000
Machinery and equipment	2,981,000,000	2,975,000,000
Construction in progress	218,000,000	165,000,000
Property, plant and equipment, at cost	4,950,000,000	4,879,000,000
Less accumulated depreciation	3,012,000,000	2,965,000,000
Property, plant and equipment, net	1,938,000,000	1,914,000,000
Goodwill	5,196,000,000	5,307,000,000
Other intangible assets, net	12,279,000,000	12,400,000,000
Investment in AB InBev	17,696,000,000	17,952,000,000
Investment in JUUL	12,800,000,000	0
Other assets	1,430,000,000	1,285,000,000
Total Assets	55,638,000,000	43,202,000,000
Liabilities
Short-term borrowings	12,704,000,000	0
Current portion of long-term debt	1,144,000,000	864,000,000
Accounts payable	399,000,000	374,000,000
Accrued liabilities:
Marketing	586,000,000	695,000,000
Employment costs	189,000,000	188,000,000
Settlement charges	3,454,000,000	2,442,000,000
Other	1,214,000,000	971,000,000
Dividends payable	1,503,000,000	1,258,000,000
Total current liabilities	21,193,000,000	6,792,000,000
Long-term debt	11,898,000,000	13,030,000,000
Deferred income taxes	5,172,000,000	5,247,000,000
Accrued pension costs	544,000,000	445,000,000
Accrued postretirement health care costs	1,749,000,000	1,987,000,000
Other liabilities	254,000,000	283,000,000
Total liabilities	40,810,000,000	27,784,000,000
Contingencies
Redeemable noncontrolling interest	39,000,000	38,000,000
Stockholders' Equity
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued)	935,000,000	935,000,000
Additional paid-in capital	5,961,000,000	5,952,000,000
Earnings reinvested in the business	43,962,000,000	42,251,000,000
Accumulated other comprehensive losses	(2,547,000,000)	(1,897,000,000)
Cost of repurchased stock (931,903,722 shares at December 31, 2018 and 904,702,125 shares at December 31, 2017)	(33,524,000,000)	(31,864,000,000)
Total stockholders’ equity attributable to Altria	14,787,000,000	15,377,000,000
Noncontrolling interests	2,000,000	3,000,000
Total stockholders’ equity	14,789,000,000	15,380,000,000
Total Liabilities and Stockholders’ Equity	$ 55,638,000,000	$ 43,202,000,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Common stock, par value (usd per share)	$ 0.3333	$ 0.3333
Common stock, shares issued (in shares)	2,805,961,317	2,805,961,317
Cost of repurchased stock, shares (in shares)	931,903,722	904,702,125

Consolidated Statements of Earn

Consolidated Statements of Earnings - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net revenues	$ 6,114	$ 6,837	$ 6,305	$ 6,108	$ 6,101	$ 6,729	$ 6,663	$ 6,083	$ 25,364	$ 25,576	$ 25,744
Cost of sales									7,373	7,531	7,765
Excise taxes on products									5,737	6,082	6,407
Gross profit	2,922	3,255	3,141	2,936	2,902	3,171	3,114	2,776	12,254	11,963	11,572
Marketing, administration and research costs									2,756	2,338	2,662
Asset impairment and exit costs									383	32	149
Operating (expense) income									9,115	9,593	8,761
Interest and other debt expense, net									665	705	747
Loss on early extinguishment of debt									0	0	823
Net periodic benefit (income) cost, excluding service cost									(34)	37	(1)
Earnings from equity investment in AB InBev/SABMiller									(890)	(532)	(795)
Loss (gain) on AB InBev/SABMiller business combination	0	0	0	33	0	(37)	(408)	0	33	(445)	(13,865)
Earnings before income taxes									9,341	9,828	21,852
Provision (benefit) for income taxes									2,374	(399)	7,608
Net earnings	1,251	1,944	1,877	1,895	4,968	1,867	1,990	1,402	6,967	10,227	14,244
Net earnings attributable to noncontrolling interests									(4)	(5)	(5)
Net earnings attributable to Altria	$ 1,250	$ 1,943	$ 1,876	$ 1,894	$ 4,966	$ 1,866	$ 1,989	$ 1,401	$ 6,963	$ 10,222	$ 14,239
Per share data:
Basic earnings per share attributable to Altria (in usd per share)	$ 0.67	$ 1.03	$ 0.99	$ 1					$ 3.69	$ 5.31	$ 7.28
DIluted earnings per share attributable to Altria (in usd per share)	$ 0.66	$ 1.03	$ 0.99	$ 1					$ 3.68	$ 5.31	$ 7.28

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Earnings - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Comprehensive Income [Abstract]
Net earnings	$ 6,967	$ 10,227	$ 14,244
Other comprehensive earnings (losses), net of deferred income taxes:
Benefit plans	68	209	(38)
AB InBev/SABMiller	(309)	(54)	1,265
Currency Translation Adjustment and Other	(1)	0	1
Other comprehensive (losses) earnings, net of deferred income taxes	(242)	155	1,228
Comprehensive earnings	6,725	10,382	15,472
Comprehensive earnings attributable to noncontrolling interests	(4)	(5)	(5)
Comprehensive earnings attributable to Altria	$ 6,721	$ 10,377	$ 15,467

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Cash Provided by (Used in) Operating Activities
Net earnings	$ 6,967	$ 10,227	$ 14,244
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	227	209	204
Deferred income tax (benefit) provision	(57)	(3,126)	3,119
Earnings from equity investment in AB InBev/SABMiller	(890)	(532)	(795)
Loss (gain) on AB InBev/SABMiller business combination	33	(445)	(13,865)
Dividends from AB InBev/SABMiller	657	806	739
Asset impairment and exit costs, net of cash paid	354	(38)	106
Loss on early extinguishment of debt	0	0	823
Cash effects of changes:
Receivables	0	10	(27)
Inventories	(129)	(171)	(34)
Accounts payable	27	(55)	24
Income taxes	218	(294)	(231)
Accrued liabilities and other current assets	(21)	(85)	(113)
Accrued settlement charges	980	(1,259)	111
Pension and postretirement plans contributions	(41)	(294)	(531)
Pension provisions and postretirement, net	(13)	(11)	(73)
Other, net	79	(41)	125
Net cash provided by operating activities	8,391	4,901	3,826
Cash Provided by (Used in) Investing Activities
Capital expenditures	(238)	(199)	(189)
Acquisitions of businesses and assets	(15)	(415)	(45)
Investment in JUUL	(12,800)	0	0
Proceeds from finance assets	37	133	231
Proceeds from AB InBev/SABMiller business combination	0	0	4,773
Purchase of AB InBev ordinary shares	0	0	(1,578)
Proceeds from derivative financial instruments	35	0	510
Other, net	(7)	14	6
Net cash (used in) provided by investing activities	(12,988)	(467)	3,708
Cash Provided by (Used in) Financing Activities
Proceeds from short-term borrowings	12,800	0	0
Long-term debt issued	0	0	1,976
Long-term debt repaid	(864)	0	(933)
Repurchases of common stock	(1,673)	(2,917)	(1,030)
Dividends paid on common stock	(5,415)	(4,807)	(4,512)
Premiums and fees related to early extinguishment of debt	0	0	(809)
Other, net	(132)	(47)	(21)
Net cash used in financing activities	4,716	(7,771)	(5,329)
Cash, cash equivalents and restricted cash:
Increase (decrease)	119	(3,337)	2,205
Balance at beginning of year	1,314	4,651	2,446
Balance at end of year	1,433	1,314	4,651
Cash paid: Interest	704	696	775
Cash Paid: Income taxes	2,307	3,036	4,664
Cash, cash equivalents and restricted cash	$ 1,314	$ 4,651	$ 2,446

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Earnings Reinvested in the Business [Member]	Accumulated Other Comprehensive Losses [Member]	Cost of Repurchased Stock [Member]	Non-Controlling Interests [Member]
Beginning Balances at Dec. 31, 2015		$ 2,873	$ 935	$ 5,813	$ 27,257	$ (3,280)	$ (27,845)	$ (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	[1]	14,239			14,239
Other comprehensive earnings (losses), net of deferred income taxes		1,228				1,228
Stock award activity		53		90			(37)
Cash dividends declared		(4,590)			(4,590)
Repurchases of common stock		(1,030)					(1,030)
Other		0		(10)				10
Ending Balances at Dec. 31, 2016		12,773	935	5,893	36,906	(2,052)	(28,912)	3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	[1]	10,222			10,222
Other comprehensive earnings (losses), net of deferred income taxes		155				155
Stock award activity		24		59			(35)
Cash dividends declared		(4,877)			(4,877)
Repurchases of common stock		(2,917)					(2,917)
Ending Balances at Dec. 31, 2017		15,380	935	5,952	42,251	(1,897)	(31,864)	3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	[1]	6,963			6,963
Other comprehensive earnings (losses), net of deferred income taxes		(242)				(242)
Stock award activity		22		9			13
Cash dividends declared		(5,660)			(5,660)
Repurchases of common stock		(1,673)					(1,673)
Other		(1)						(1)
Ending Balances at Dec. 31, 2018		14,789	$ 935	$ 5,961	$ 43,962	$ (2,547)	$ (33,524)	$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification due to adoption of ASU 2018-02		$ (397)
[1]	Amounts attributable to noncontrolling interests for each of the years ended December 31, 2018, 2017 and 2016 exclude net earnings of $4 million, $5 million and $5 million, respectively, due to the redeemable noncontrolling interest related to Stag’s Leap Wine Cellars, which is reported in the mezzanine equity section on the consolidated balance sheets at December 31, 2018, 2017 and 2016. See Note 19. Contingencies.

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Stockholders' Equity [Abstract]
Net income (loss) attributable to redeemable noncontrolling interest	$ 4	$ 5	$ 5
Cash dividends declared (USD per share)	$ 3	$ 2.54	$ 2.35

Background and Basis of Present

Background and Basis of Presentation	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation ▪ Background: At December 31, 2018 , Altria Group, Inc.’s (“Altria”) wholly-owned subsidiaries included Philip Morris USA Inc. (“PM USA”), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (“Middleton”), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly-owned subsidiary of PM USA; Sherman Group Holdings, LLC and its subsidiaries (“Nat Sherman”), which are engaged in the manufacture and sale of super premium cigarettes and the sale of premium cigars; and UST LLC (“UST”), which through its wholly-owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (“USSTC”) and Ste. Michelle Wine Estates Ltd. (“Ste. Michelle”), is engaged in the manufacture and sale of smokeless tobacco products and wine. Altria’s other operating companies included Philip Morris Capital Corporation (“PMCC”), which maintains a portfolio of finance assets, substantially all of which are leveraged leases, and Nu Mark LLC (“Nu Mark”), both of which are wholly-owned subsidiaries. In December 2018, Altria announced the decision to refocus its innovative product efforts, which includes the discontinuation of production and distribution of all MarkTen and Green Smoke e-vapor products . Prior to that time, Nu Mark was engaged in the manufacture and sale of innovative tobacco products. Other Altria wholly-owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries. Altria’s access to the operating cash flows of its wholly-owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries. At December 31, 2018 , Altria’s principal wholly-owned subsidiaries were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests. At September 30, 2016, Altria had an approximate 27% ownership of SABMiller plc (“SABMiller”), which Altria accounted for under the equity method of accounting. In October 2016 , Anheuser-Busch InBev SA/NV (“Legacy AB InBev”) completed its business combination with SABMiller, and Altria received cash and shares representing a 9.6% ownership in the combined company (the “AB InBev Transaction”). The newly formed Belgian company, which retained the name Anheuser-Busch InBev SA/NV (“AB InBev”), became the holding company for the combined businesses. Subsequently, Altria purchased approximately 12 million ordinary shares of AB InBev, increasing Altria’s ownership to approximately 10.2% at December 31, 2016. At December 31, 2018, Altria had an approximate 10.1% ownership of AB InBev, which Altria accounts for under the equity method of accounting using a one-quarter lag. As a result of the one-quarter lag and the timing of the completion of the AB InBev Transaction, no earnings from Altria’s equity investment in AB InBev were recorded for the year ended December 31, 2016. Altria receives cash dividends on its interest in AB InBev if and when AB InBev pays such dividends. For further discussion, see Note 7 . Investment in AB InBev/SABMiller . On December 20, 2018, Altria purchased, through a wholly-owned subsidiary, shares of non-voting convertible common stock of JUUL Labs, Inc. (“JUUL”), representing a 35% economic interest for $12.8 billion . JUUL is engaged in the manufacture and sale of e-vapor products globally. If and when antitrust clearance is obtained, Altria’s non-voting shares will automatically convert to voting shares (“Share Conversion”). At December 31, 2018, Altria accounted for its investment in JUUL as an investment in an equity security. Upon Share Conversion, Altria expects to account for its investment in JUUL under the equity method of accounting. Altria will receive cash dividends on its interest in JUUL if and when JUUL pays such dividends. For further discussion, see Note 8 . Investment in JUUL. On December 7, 2018, Altria announced that it entered into an agreement to purchase, through a subsidiary, approximately 146.2 million newly issued common shares of Cronos Group Inc. (“Cronos”), a global cannabinoid company headquartered in Toronto, Canada. Altria expects the transaction to close in the first half of 2019. Upon completion of this transaction, Altria will own an approximate 45% equity interest in Cronos. Additionally, the agreement includes a warrant to purchase up to an additional approximately 72.2 million common shares of Cronos at a per share exercise price of Canadian dollar (“CAD”) $19.00 . The purchase price for the approximate 45% equity interest and warrant is approximately CAD $2.4 billion (approximately U.S. dollar (“USD”) $1.8 billion , based on the CAD to USD exchange rate on January 25, 2019), to be paid on the date of the closing of the transaction. Upon full exercise of the warrant, which expires four years after issuance, Altria would own approximately 55% of the outstanding common shares of Cronos. The exercise price for the warrant is approximately CAD $1.4 billion (approximately USD $1.0 billion , based on the CAD to USD exchange rate on January 25, 2019). As part of the agreement, upon completion of this transaction, Altria will have the right to nominate four directors, including one independent director, to serve on Cronos’ Board of Directors, which will be expanded from five to seven directors. Altria expects to account for its investment in Cronos under the equity method of accounting. The closing of this transaction is subject to certain customary closing conditions, including approval of Cronos shareholders and receipt of regulatory approvals. In January 2019, Altria entered into derivative financial instruments in the form of forward contracts, which mature on April 15, 2019, to hedge a portion of Altria’s exposure to foreign currency exchange rate movements in the CAD to USD, in relation to the CAD $2.4 billion aggregate purchase price for the Cronos transaction. The aggregate notional amounts of the forward contracts were approximately USD $1.1 billion (CAD $1.5 billion ). The forward contracts do not qualify for hedge accounting; therefore, changes in the fair values of the forward contracts will be recorded as gains or losses in Altria’s consolidated statements of earnings in the periods in which the changes occur. ▪ Basis of Presentation: The consolidated financial statements include Altria, as well as its wholly-owned and majority-owned subsidiaries. Investments in which Altria has the ability to exercise significant influence over the operating and financial policies of the investee are accounted for under the equity method of accounting. Equity investments in which Altria does not have the ability to exercise significant influence over the operating and financial policies of the investee are accounted for as an investment in an equity security. All intercompany transactions and balances have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of net revenues and expenses during the reporting periods. Significant estimates and assumptions include, among other things, pension and benefit plan assumptions, lives and valuation assumptions for goodwill and other intangible assets, impairment evaluations for equity investments, marketing programs, income taxes, and the allowance for losses and estimated residual values of finance leases. Actual results could differ from those estimates. On January 1, 2018, Altria adopted the following Accounting Standards Updates (“ASU”): ▪ ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) and all related ASU amendments (collectively “ASU No. 2014-09”), as discussed in Note 2 . Summary of Significant Accounting Policies and Note 3 . Revenues from Contracts with Customers ; ▪ ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10) : Recognition and Measurement of Financial Assets and Financial Liabilities and the related ASU amendment (collectively “ASU No. 2016-01”); ▪ ASU No. 2016-15, Statement of Cash Flows (Topic 230) : Classification of Certain Cash Receipts and Cash Payments (“ASU No. 2016-15”); ▪ ASU No. 2016-18, Statement of Cash Flows (Topic 230) : Restricted Cash (“ASU No. 2016-18”); and ▪ ASU No. 2017-07, Compensation-Retirement Benefits (Topic 715) : Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU No. 2017-07”), as discussed in Note 17 . Benefit Plans. Additionally, on October 1, 2018, Altria adopted ASU No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220) : Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU No. 2018-02”), as discussed in Note 15 . Income Taxes . The adoption of ASU No. 2016-01, which addresses certain aspects of the recognition, measurement, presentation and disclosure of financial instruments, did not impact Altria’s consolidated financial statements. The adoption of ASU No. 2016-15, which addresses how eight specific cash flow issues are to be presented and classified in the statement of cash flows, did not impact Altria’s consolidated statements of cash flows. In addition, Altria made an accounting policy election to continue to classify distributions received from equity method investees using the nature of distribution approach. ASU No. 2016-18, which Altria adopted retrospectively, requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents. As a result of the adoption, restricted cash of $61 million and $82 million at December 31, 2017 and 2016, respectively, was included in cash, cash equivalents and restricted cash on Altria’s consolidated statements of cash flows. Certain prior year amounts have been reclassified to conform with the current year’s presentation due primarily to Altria’s 2018 adoption of ASU No. 2016-18 and ASU No. 2017-07.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies ▪ Cash and Cash Equivalents: Cash equivalents include demand deposits with banks and all highly liquid investments with original maturities of three months or less. Cash equivalents are stated at cost plus accrued interest, which approximates fair value. ▪ Depreciation, Amortization, Impairment Testing and Asset Valuation: Property, plant and equipment are stated at historical costs and depreciated by the straight-line method over the estimated useful lives of the assets. Machinery and equipment are depreciated over periods up to 25 years, and buildings and building improvements over periods up to 50 years. Definite-lived intangible assets are amortized over their estimated useful lives up to 25 years. Altria reviews long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable. Altria performs undiscounted operating cash flow analyses to determine if an impairment exists. For purposes of recognition and measurement of an impairment for assets held for use, Altria groups assets and liabilities at the lowest level for which cash flows are separately identifiable. If Altria determines that an impairment exists, any related impairment loss is calculated based on fair value. Impairment losses on assets to be disposed of, if any, are based on the estimated proceeds to be received, less costs of disposal. Altria also reviews the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed. Altria conducts a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require Altria to perform an interim review. If the carrying value of goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired. The amount of impairment loss is measured as the difference between the carrying value and the implied fair value. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, the intangible asset is considered impaired and is reduced to fair value. Altria reviews its investment in AB InBev for impairment by comparing the fair value of its investment to its carrying value. If the carrying value of Altria’s investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and impairment is recognized in the period identified. The factors used to make this determination include the duration and magnitude of the fair value decline, AB InBev’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in AB InBev until recovery. Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators. If a qualitative assessment indicates that Altria’s investment in JUUL is impaired and the fair value of the investment is less than its carrying value, the investment is written down to its fair value. ▪ Derivative Financial Instruments: Altria enters into derivatives to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk. Altria uses various types of derivative financial instruments, including forward contracts, options and swaps. Derivative financial instruments are recorded at fair value on the consolidated balance sheets as either assets or liabilities. Derivative financial instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges at the inception of the contracts. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recorded in the consolidated statements of earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded each period in accumulated other comprehensive earnings (losses) and are reclassified to the consolidated statements of earnings in the same periods in which operating results are affected by the respective hedged item. For net investment hedges, changes in the fair value of the derivative or foreign currency transaction gains or losses on a nonderivative hedging instrument are recorded in accumulated other comprehensive earnings (losses) to offset the change in the value of the net investment being hedged. Such amounts remain in accumulated other comprehensive earnings (losses) until the complete or substantially complete liquidation of the underlying foreign operations occurs or, for investments in foreign entities accounted for under the equity method of accounting, Altria’s economic interest in the underlying foreign entity decreases. Cash flows from hedging instruments are classified in the same manner as the respective hedged item in the consolidated statements of cash flows. To qualify for hedge accounting, the hedging relationship, both at inception of the hedge and on an ongoing basis, is expected to be highly effective at offsetting changes in the fair value of the hedged risk during the period that the hedge is designated. Altria formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective, the strategy for undertaking the hedge transaction and method for assessing hedge effectiveness. Additionally, for qualified hedges of forecasted transactions, if it becomes probable that a forecasted transaction will not occur, the hedge would no longer be considered effective and all of the derivative gains and losses would be recorded in the consolidated statement of earnings in the current period. For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of earnings each period. Altria does not enter into or hold derivative financial instruments for trading or speculative purposes. ▪ Employee Benefit Plans: Altria provides a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits. Altria records annual amounts relating to these plans based on calculations specified by U.S. GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates. Altria recognizes the funded status of its defined benefit pension and other postretirement plans on the consolidated balance sheet and records as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost. The gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) are subsequently amortized into net periodic benefit cost in future years. ▪ Environmental Costs: Altria is subject to laws and regulations relating to the protection of the environment. Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated. Such accruals are adjusted as new information develops or circumstances change. Compliance with environmental laws and regulations, including the payment of any remediation and compliance costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria’s consolidated results of operations, capital expenditures, financial position or cash flows (see Note 19 . Contingencies - Environmental Regulation ). ▪ Fair Value Measurements: Altria measures certain assets and liabilities at fair value. Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Altria uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used to measure fair value are: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. ▪ Guarantees: Altria recognizes a liability for the fair value of the obligation of qualifying guarantee activities. See Note 19 . Contingencies for a further discussion of guarantees. ▪ Income Taxes: Significant judgment is required in determining income tax provisions and in evaluating tax positions. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Altria records a valuation allowance when it is more-likely-than-not that some portion or all of a deferred tax asset will not be realized. Altria recognizes a benefit for uncertain tax positions when a tax position taken or expected to be taken in a tax return is more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. Altria recognizes accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in its consolidated statements of earnings. • Inventories: The last-in, first-out (“LIFO”) method is used to determine the cost of substantially all tobacco inventories. The cost of the remaining inventories is determined using the first-in, first-out (“FIFO”) and average cost methods. Inventories that are measured using the LIFO method are stated at the lower of cost or market. Inventories that are measured using the FIFO and average cost methods are stated at the lower of cost and net realizable value. It is a generally recognized industry practice to classify leaf tobacco and wine inventories as current assets although part of such inventory, because of the duration of the curing and aging process, ordinarily would not be used within one year . ▪ Litigation Contingencies and Costs: Altria and its subsidiaries record provisions in the consolidated financial statements for pending litigation when it is determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. Litigation defense costs are expensed as incurred and included in marketing, administration and research costs in the consolidated statements of earnings. See Note 19 . Contingencies . ▪ Marketing Costs: Altria’s businesses promote their products with consumer incentives, trade promotions and consumer engagement programs. These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues. Consumer engagement program payments are made to third parties. Altria’s businesses expense these consumer engagement programs, which include event marketing, as incurred and such expenses are included in marketing, administration and research costs in Altria’s consolidated statements of earnings. For interim reporting purposes, Altria’s businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year. ▪ Revenue Recognition: On January 1, 2018, Altria adopted ASU No. 2014-09. For further discussion, see Note 3 . Revenues from Contracts with Customers . Altria’s businesses generate substantially all of their revenue from sales contracts with customers. While Altria’s businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured. These contracts create an obligation to transfer product to the customer. All performance obligations are satisfied within one year ; therefore, costs to obtain contracts are expensed as incurred and unsatisfied performance obligations are not disclosed. There is no financing component because Altria expects, at contract inception, that the period between when Altria transfers product to the customer and when the customer pays for that product will be one year or less. Altria’s businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives. Altria’s businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on cigarettes, cigars, smokeless tobacco or wine billed to customers). Altria’s businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer. Altria’s businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer. Altria’s businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in Altria’s consolidated statements of earnings. Altria’s businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on Altria’s consolidated balance sheets. Altria’s businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates. Expected payments for sales incentives are included in accrued marketing liabilities on Altria’s consolidated balance sheets. Payment terms vary depending on product type. Altria’s businesses consider payments received in advance of product shipment as deferred revenue, which is included in other accrued liabilities on Altria’s consolidated balance sheets until revenue is recognized. PM USA receives payment in advance of a customer obtaining control of the product. USSTC receives substantially all payments within one business day of the customer obtaining control of the product. Ste. Michelle receives substantially all payments from customers within 45 days of the customer obtaining control of the product. Amounts due from customers are included in receivables on Altria’s consolidated balance sheets. ▪ New Accounting Guidance Not Yet Adopted: The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria: Standards Description Effective Date for Public Entity Effect on Financial Statements ASU Nos. 2016-02; 2018-01; 2018-10; 2018-11; 2018-20 Leases (Topic 842) The guidance requires entities to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. The guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Early adoption is permitted. As a lessor, PMCC maintains a portfolio of finance assets, substantially all of which are leveraged leases, the accounting of which will be unchanged under the new guidance and is not expected to change unless there is a contract modification to an existing lease. As lessees, Altria and its subsidiaries’ various leases under existing guidance are classified as operating leases that are not recorded on Altria’s consolidated balance sheets but are recorded in Altria’s consolidated statements of earnings as expense is incurred. Altria plans to apply the new guidance retrospectively at the beginning of the period of adoption and will record substantially all leases on its consolidated balance sheets as right-of-use assets and lease liabilities. Altria does not expect its adoption of this guidance to have a material impact on Altria’s consolidated financial statements. The adoption of this guidance will result in expanded footnote disclosures. ASU Nos. 2016-13 and 2018-19 Measurement of Credit Losses on Financial Instruments (Topic 326) The guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. The adoption of this guidance is not expected to have a material impact on Altria’s consolidated financial statements. ASU No. 2018-15 Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (Subtopic 350-40) The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.

Revenues from Contracts with Cu

Revenues from Contracts with Customers	12 Months Ended
	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenues from Contracts with Customers On January 1, 2018, Altria adopted ASU No. 2014-09, which establishes principles for reporting information about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. Altria elected to apply the guidance using the modified retrospective transition method. The adoption of this guidance had no impact on the amount and timing of revenue recognized by Altria’s businesses; therefore, no adjustments were recorded to Altria’s consolidated financial statements. Altria disaggregates net revenues based on product type. For further discussion, see Note 16 . Segment Reporting . Altria’s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Altria’s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria’s consolidated balance sheets. There was no allowance for cash discounts at December 31, 2018 and 2017, and there were no differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers. Altria’s businesses that receive payments in advance of product shipment record such payments as deferred revenue. These payments are included in other accrued liabilities on Altria’s consolidated balance sheets until control of such products is obtained by the customer. Deferred revenue was $288 million and $267 million at December 31, 2018 and 2017, respectively. When cash is received in advance of product shipment, Altria’s businesses satisfy their performance obligations within three days of receiving payment. At December 31, 2018 and 2017, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue. Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were $142 million at December 31, 2018 and 2017. At December 31, 2018 and 2017, there were no expected differences between amounts recorded and subsequently received, and Altria’s businesses did not record an allowance for doubtful accounts against these receivables. Altria’s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria’s consolidated balance sheets. While all of Altria’s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, due to the limited shelf life of USSTC’s smokeless tobacco products, it is USSTC’s policy to accept authorized sales returns from its customers for products that have passed such dates. Altria’s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues. Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions. Altria’s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known. These differences, if any, have not had a material impact on Altria’s consolidated financial statements. All returned goods are destroyed upon return and not included in inventory. Consequently, Altria’s businesses do not record an asset for their right to recover goods from customers upon return. Sales incentives include variable payments related to goods sold by Altria’s businesses. Altria’s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers. The sales incentives that require significant estimates and judgments are as follows: ▪ Price promotion payments- Altria’s businesses make price promotion payments, substantially all of which are made to their retail partners to incent the promotion of certain product offerings in select geographic areas. ▪ Wholesale and retail participation payments- Altria’s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business’s trade agreements. These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates. Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions. Differences between actual and estimated payments are reflected in the period such information becomes available. These differences, if any, have not had a material impact on Altria’s consolidated financial statements.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets, net	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets, net	Goodwill and Other Intangible Assets, net Goodwill and other intangible assets, net, by segment were as follows: Goodwill Other Intangible Assets, net (in millions) December 31, 2018 December 31, 2017 December 31, 2018 December 31, 2017 Smokeable products $ 99 $ 99 $ 3,037 $ 3,054 Smokeless products 5,023 5,023 8,825 8,827 Wine 74 74 239 294 Other — 111 178 225 Total $ 5,196 $ 5,307 $ 12,279 $ 12,400 Goodwill relates to the 2017 acquisition of Nat Sherman, the 2014 acquisition of Green Smoke, Inc. and its affiliates, the 2009 acquisition of UST and the 2007 acquisition of Middleton. Other intangible assets consisted of the following: December 31, 2018 December 31, 2017 (in millions) Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Indefinite-lived intangible assets $ 11,846 $ — $ 12,125 $ — Definite-lived intangible assets 654 221 465 190 Total other intangible assets $ 12,500 $ 221 $ 12,590 $ 190 At December 31, 2018, indefinite-lived intangible assets consist substantially of trademarks from Altria’s 2009 acquisition of UST ( $9.0 billion ) and 2007 acquisition of Middleton ( $2.6 billion ). Definite-lived intangible assets, which consist primarily of customer relationships, certain cigarette trademarks and intellectual property, are amortized over periods up to 25 years. Pre-tax amortization expense for definite-lived intangible assets during the years ended December 31, 2018 , 2017 and 2016 , was $38 million , $21 million and $21 million , respectively. Annual amortization expense for each of the next five years is estimated to be approximately $30 million , assuming no additional transactions occur that require the amortization of intangible assets. The changes in goodwill and net carrying amount of intangible assets are as follows: 2018 2017 (in millions) Goodwill Other Intangible Assets, net Goodwill Other Intangible Assets, net Balance at January 1 $ 5,307 $ 12,400 $ 5,285 $ 12,036 Changes due to: Acquisitions (1) — 15 22 385 Asset impairment (2) (111 ) (98 ) — — Amortization — (38 ) — (21 ) Balance at December 31 $ 5,196 $ 12,279 $ 5,307 $ 12,400 (1) Reflects the 2018 and 2017 purchase of certain intellectual property primarily related to innovative tobacco products, and the 2017 acquisition of Nat Sherman. (2) Reflects asset impairment of goodwill and other intangible assets, net related to e-vapor products, and the Columbia Crest trademark. During 2018, Altria recorded goodwill and other intangible asset impairment charges of $111 million and $44 million , respectively, related to Altria’s decision in the fourth quarter of 2018 to refocus its innovative product efforts, which includes the discontinuation of production and distribution of all MarkTen and Green Smoke e-vapor products. In addition, during 2018 , Altria completed its quantitative annual impairment test of goodwill and indefinite-lived intangible assets. Upon completion of this testing, Altria concluded, in the wine segment, that the Columbia Crest trademark of $54 million was fully impaired as Columbia Crest has been negatively impacted by an accelerated decline in the $7 to $10 premium wine segment, increased competition and reduction in trade support. During 2017 and 2016 , Altria’s quantitative annual impairment test of goodwill and indefinite-lived intangible assets resulted in no impairment charges. In addition, there were no accumulated impairment losses related to goodwill and other intangible assets, net at December 31, 2017.

Asset Impairment, Exit and Impl

Asset Impairment, Exit and Implementation Costs	12 Months Ended
	Dec. 31, 2018
Restructuring and Related Activities [Abstract]
Asset Impairment, Exit, and Implementation Costs	Asset Impairment, Exit and Implementation Costs Pre-tax asset impairment, exit and implementation costs consisted of the following: (in millions) Asset Impairment and Exit Costs Implementation Costs Total For the year ended December 31, 2018 2017 2016 2018 (1) 2017 (1) 2016 (2) 2018 2017 2016 Smokeable products $ 82 $ 5 $ 125 $ 1 $ 17 $ 9 $ 83 $ 22 $ 134 Smokeless products 20 28 42 3 28 15 23 56 57 Wine (3) 54 — — — — — 54 — — All other 227 — 7 63 — — 290 — 7 General corporate 3 — 5 — — — 3 — 5 Total 386 33 179 67 45 24 453 78 203 Less amounts included in net periodic benefit (income) cost, excluding service cost 3 1 30 — — — 3 1 30 Total $ 383 $ 32 $ 149 $ 67 $ 45 $ 24 $ 450 $ 77 $ 173 (1) Included in cost of sales in Altria’s consolidated statements of earnings. (2) Included in cost of sales ( $17 million ) and marketing, administration and research costs ( $7 million ) in Altria’s consolidated statement of earnings. (3) Reflects impairment of the Columbia Crest trademark. See Note 4. Goodwill and Other Intangible Assets, net . Substantially all of the 2018 pre-tax asset impairment, exit and implementation costs are related to Altria’s decision to refocus its innovative product efforts, the cost reduction program discussed below and the impairment of the Columbia Crest trademark. The pre-tax asset impairment, exit and implementation costs for 2017 are related to the facilities consolidation. The pre-tax asset impairment, exit and implementation costs for 2016 are related to both the facilities consolidation and the productivity initiative. The movement in the restructuring liabilities, substantially all of which are severance liabilities, for the years ended December 31, 2018 and 2017 was as follows: (in millions) Balances at December 31, 2016 $ 79 Charges 25 Cash spent (71 ) Balances at December 31, 2017 33 Charges 154 Cash spent (32 ) Balances at December 31, 2018 $ 155 ▪ Refocus of Innovative Product Efforts: During the fourth quarter of 2018, Altria announced its decision to refocus its innovative product efforts, which includes the discontinuation of production and distribution of all MarkTen and Green Smoke e-vapor products . This decision was based upon the current and expected financial performance of these products, coupled with regulatory restrictions that burden Altria’s ability to quickly improve these products. As a result, during 2018, Altria incurred pre-tax charges of $ 272 million , consisting of asset impairment and exit costs of $ 209 million and other charges of $ 63 million . The asset impairment and exit costs primarily relate to the impairment of goodwill and other intangible assets. See Note 4. Goodwill and Other Intangible Assets, net . The other charges relate to inventory write-offs and accelerated depreciation. The majority of the charges related to these efforts will not result in cash payments. ▪ Cost Reduction Program: In December 2018, Altria announced a cost reduction program that it expects will deliver approximately $575 million in annualized cost savings by the end of 2019. This program includes, among other things, reducing third-party spending across the business and workforce reductions. As a result of the cost reduction program, Altria expects to record total pre-tax restructuring charges of approximately $210 million . Of these amounts, during 2018, Altria incurred pre-tax charges of $121 million and expects to record the remainder in 2019. The total estimated charges, substantially all of which will result in cash expenditures, relate primarily to employee separation costs of approximately $160 million and other costs of approximately $50 million . There were no cash payments related to this program in 2018. For the year ended December 31, 2018, total pre-tax asset impairment and exit costs for the cost reduction program of $121 million were recorded in the smokeable products segment ( $86 million ), smokeless products segment ( $14 million ), all other ( $18 million ) and general corporate ($ 3 million ). ▪ Facilities Consolidation: In October 2016, Altria announced the consolidation of certain of its operating companies’ manufacturing facilities to streamline operations and achieve greater efficiencies. In the first quarter of 2018, Middleton completed the transfer of its Limerick, Pennsylvania operations to the Manufacturing Center site in Richmond, Virginia (“Richmond Manufacturing Center”), and USSTC completed the transfer of its Franklin Park, Illinois operations to its Nashville, Tennessee facility and the Richmond Manufacturing Center. The pre-tax charges related to the consolidation have been completed. As a result of the consolidation, Altria recorded total pre-tax charges of $155 million . During 2018, 2017 and 2016, Altria recorded pre-tax charges of $6 million , $78 million and $71 million , respectively. The total charges related primarily to accelerated depreciation and asset impairment ( $55 million ), employee separation costs ( $40 million ) and other exit and implementation costs ( $60 million ). Cash payments related to the consolidation of $34 million were made during the year ended December 31, 2018, for total cash payments of $97 million since inception. At December 31, 2018, cash payments related to the consolidation were substantially completed. ▪ Productivity Initiative: In January 2016, Altria announced a productivity initiative designed to maintain its operating companies’ leadership and cost competitiveness through reduced spending on certain selling, general and administrative infrastructure and a leaner organizational structure. As a result of the initiative, during 2016, Altria incurred total pre-tax restructuring charges of $132 million , substantially all of which resulted in cash expenditures. The charges consisted of employee separation costs of $117 million and other associated costs of $15 million . Total pre-tax charges related to the initiative have been completed. Cash payments related to the initiative of $32 million were made during the year ended December 31, 2017, for total cash payments of $106 million since inception. At December 31, 2017, cash payments related to the initiative were substantially completed.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2018
Inventory Disclosure [Abstract]
Inventories	Inventories The cost of approximately 58% and 59% of inventories at December 31, 2018 and 2017 , respectively, was determined using the LIFO method. The stated LIFO amounts of inventories were approximately $0.7 billion lower than the current cost of inventories at December 31, 2018 and 2017 .

Investment in AB InBev_SABMille

Investment in AB InBev/SABMiller	12 Months Ended
	Dec. 31, 2018
Equity Method Investments and Joint Ventures [Abstract]
Investment in AB InBev/SABMiller	Investment in AB InBev/SABMiller At December 31, 2018, Altria had an approximate 10.1% ownership of AB InBev, consisting of approximately 185 million restricted shares of AB InBev (the “Restricted Shares”) and approximately 12 million ordinary shares of AB InBev. Altria accounts for its investment in AB InBev under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of AB InBev, including having active representation on AB InBev’s Board of Directors (“AB InBev Board”) and certain AB InBev Board Committees. Through this representation, Altria participates in AB InBev policy making processes. Altria reports its share of AB InBev’s results using a one-quarter lag because AB InBev’s results are not available in time for Altria to record them in the concurrent period. Pre-tax earnings from Altria’s equity investment in AB InBev were $890 million and $532 million for the years ended December 31, 2018 and 2017, respectively. As a result of the one-quarter lag and the timing of the completion of the AB InBev Transaction, no earnings from Altria’s equity investment in AB InBev were recorded for the year ended December 31, 2016. At September 30, 2018, AB InBev had derivative financial instruments used to hedge the share price related to 92.4 million of its share commitments. AB InBev’s share price in Euros at December 31, 2018 and September 30, 2018 was €57.70 and €75.22 , respectively. Consistent with the one-quarter lag for reporting AB InBev’s results in Altria’s financial results, Altria will record its share of AB InBev’s fourth quarter 2018 mark-to-market losses associated with these derivative financial instruments in the first quarter of 2019. Summary financial data of AB InBev is as follows: For Altria’s Year Ended (in millions) 2018 (1) 2017 (1) Net revenues $ 55,500 $ 56,004 Gross profit $ 34,986 $ 34,376 Earnings from continuing operations $ 9,020 $ 6,769 Net earnings $ 9,020 $ 6,845 Net earnings attributable to AB InBev $ 7,641 $ 5,473 At September 30, (in millions) 2018 (1) 2017 (1) Current assets $ 20,289 $ 30,920 Long-term assets $ 207,921 $ 213,696 Current liabilities $ 32,019 $ 37,765 Long-term liabilities $ 130,812 $ 134,236 Noncontrolling interests $ 7,251 $ 10,639 (1) Reflects the one-quarter lag. At December 31, 2018, Altria’s carrying amount of its equity investment in AB InBev exceeded its share of AB InBev’s net assets attributable to equity holders of AB InBev by approximately $11.8 billion . Substantially all of this difference is comprised of goodwill and other indefinite-lived intangible assets (consisting primarily of trademarks). The fair value of Altria’s equity investment in AB InBev is based on: (i) unadjusted quoted prices in active markets for AB InBev’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share. The fair value of Altria’s equity investment in AB InBev at December 31, 2018 and 2017 was $13.1 billion and $22.1 billion , respectively, compared with its carrying value of $17.7 billion and $18.0 billion , respectively. Based on Altria’s evaluation of the duration and magnitude of the fair value decline, AB InBev’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in AB InBev until recovery, Altria concluded that the decline in fair value of its investment in AB InBev below its carrying value is temporary and, therefore, no impairment was recorded. Prior to the completion of the AB InBev Transaction in October 2016, Altria held an approximate 27% ownership of SABMiller that was accounted for under the equity method of accounting. Pre-tax earnings from Altria’s equity investment in SABMiller were $795 million for the year ended December 31, 2016 . Altria’s earnings from its equity investment in SABMiller for the year ended December 31, 2016 included a pre-tax non-cash gain of $309 million , reflecting Altria’s share of SABMiller’s increase to shareholders’ equity, resulting from the completion of the SABMiller, The Coca-Cola Company and Gutsche Family Investments transaction, combining bottling operations in Africa. As a result of the timing of the completion of the AB InBev Transaction, Altria’s pre-tax earnings from its equity investment in SABMiller for the year ended December 31, 2016 included its share of approximately nine months of SABMiller’s earnings. Summary financial data of SABMiller is as follows: (in millions) For the Year Ended December 31, 2016 (1) Net revenues $ 14,543 Operating profit $ 2,099 Net earnings attributable to SABMiller $ 1,803 (1) As a result of the timing of the completion of the AB InBev Transaction, summary financial data of SABMiller for the year ended December 31, 2016 included approximately nine months of SABMiller’s results. ▪ AB InBev and SABMiller Business Combination: On October 10, 2016, Legacy AB InBev completed the AB InBev Transaction, and AB InBev became the holding company for the combined SABMiller and Legacy AB InBev businesses. Under the terms of the AB InBev Transaction, SABMiller shareholders received 45 British pounds (“GBP”) in cash for each SABMiller share held, with a partial share alternative (“PSA”), which was subject to proration, available for approximately 41% of the SABMiller shares. Altria elected the PSA. Upon completion of the AB InBev Transaction and taking into account proration, Altria received, in respect of its 430,000,000 SABMiller shares, (i) an interest that was converted into the Restricted Shares, representing a 9.6% ownership of AB InBev based on AB InBev’s shares outstanding at October 10, 2016, and (ii) approximately $4.8 billion in pre-tax cash as the cash component of the PSA. Additionally, Altria received pre-tax cash proceeds of approximately $0.5 billion from exercising the derivative financial instruments discussed below, which, together with the pre-tax cash from the AB InBev Transaction, totaled approximately $5.3 billion in pre-tax cash. Subsequently, Altria purchased approximately 12 million ordinary shares of AB InBev for a total cost of approximately $1.6 billion , thereby increasing Altria’s ownership of AB InBev to approximately 10.2% at December 31, 2016. The Restricted Shares: ▪ are unlisted and not admitted to trading on any stock exchange; ▪ are subject to a five -year lock-up (subject to limited exceptions) ending October 10, 2021; ▪ are convertible into ordinary shares of AB InBev on a one-for-one basis after the end of this five -year lock-up period; ▪ rank equally with ordinary shares of AB InBev with regards to dividends and voting rights; and ▪ have director nomination rights with respect to AB InBev. As a result of the AB InBev Transaction, for the year ended December 31, 2016, Altria recorded a pre-tax gain of approximately $13.9 billion , or $9.0 billion after-tax, which was based on the following: ▪ the Legacy AB InBev share price as of October 10, 2016; ▪ the book value of Altria’s investment in SABMiller, including Altria’s accumulated other comprehensive losses directly attributable to SABMiller, at October 10, 2016; ▪ the gains on the derivative financial instruments discussed below; and ▪ the impact of AB InBev’s divestitures of certain SABMiller assets and businesses in connection with Legacy AB InBev obtaining necessary regulatory clearances for the AB InBev Transaction (“AB InBev divestitures”) that occurred by December 31, 2016. For the years ended December 31, 2018 and 2017, Altria recorded pre-tax losses of $33 million and gains of $445 million , respectively, related to the planned completion of the remaining AB InBev divestitures in loss (gain) on AB InBev/SABMiller business combination in Altria’s consolidated statements of earnings. Altria’s net gain on the AB InBev Transaction was deferred for United States corporate income tax purposes, except to the extent of the cash consideration received. ▪ Derivative Financial Instruments: In November 2015 and August 2016, Altria entered into a derivative financial instrument, each in the form of a put option (together the “options”) to hedge Altria’s exposure to foreign currency exchange rate movements in the GBP to the USD, in relation to the pre-tax cash consideration that Altria expected to receive under the PSA pursuant to the revised and final offer announced by Legacy AB InBev on July 26, 2016. The notional amounts of the November 2015 and August 2016 options were $2,467 million ( 1,625 million GBP) and $480 million ( 378 million GBP), respectively. The options did not qualify for hedge accounting; therefore, changes in the fair values of the options were recorded as gains or losses in Altria’s consolidated statements of earnings in the periods in which the changes occurred. For the year ended December 31, 2016, Altria recorded pre-tax gains associated with the November 2015 and August 2016 options of $330 million and $19 million , respectively, for the changes in the fair values of the options in loss (gain) on AB InBev/SABMiller business combination in Altria’s consolidated statement of earnings. Exercising the options in October 2016 resulted in approximately $0.5 billion in pre-tax cash proceeds. The fair values of the options were determined using binomial option pricing models, which reflect the contractual terms of the options and other observable market-based inputs, and were classified in Level 2 of the fair value hierarchy.

Investment in JUUL

Investment in JUUL	12 Months Ended
	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Investment in JUUL	Investment in JUUL On December 20, 2018, Altria entered into a stock purchase agreement with JUUL, the U.S. leader in e-vapor, pursuant to which Altria, through a wholly-owned subsidiary, purchased shares of JUUL’s non-voting Class C-1 Common Stock for an aggregate price of $12.8 billion , which will convert automatically to shares of voting Class C Common Stock upon antitrust clearance, and a security convertible into additional shares of Class C-1 Common Stock or Class C Common Stock, as applicable, for no additional payment upon settlement or exercise of certain JUUL convertible securities (the “JUUL Transaction”). As a result of the JUUL Transaction, Altria owns 35% of the issued and outstanding capital stock of JUUL. Upon Share Conversion, Altria will possess 35% of JUUL’s outstanding voting power, except to the extent that Altria’s percentage ownership has decreased, and have the right to designate one-third of the members of the JUUL Board of Directors, subject to proportionate downward adjustment if Altria’s percentage ownership falls below 30% . Altria received a broad preemptive right to purchase JUUL shares to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its 35% interest. Furthermore, Altria agreed not to sell or transfer any of its JUUL shares for six years from December 20, 2018. Altria and JUUL entered into a services agreement pursuant to which Altria has agreed to provide JUUL with certain commercial services, as requested by JUUL, for an initial term of six years . Among other things, Altria may provide services to JUUL with respect to logistics and distribution, access to retail shelf space, youth vaping prevention, cigarette pack inserts and onserts, regulatory matters and government affairs. Altria has also agreed to grant JUUL a non-exclusive, royalty-free perpetual, irrevocable, sublicensable license to Altria’s non-trademark licensable intellectual property rights in the e-vapor field, subject to the terms and conditions set forth in an intellectual property license agreement between the parties. Altria has agreed to non-competition obligations generally requiring that it participate in the e-vapor business only through JUUL as long as Altria is supplying JUUL services, which Altria is committed to doing for at least six years . At December 31, 2018, Altria accounts for its investment in JUUL as an investment in an equity security. Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus any impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Upon Share Conversion, Altria expects to account for its investment in JUUL under the equity method of accounting. As disclosed in Note 9 . Short-term Borrowings and Borrowing Arrangements , Altria financed the JUUL Transaction through a senior unsecured term loan agreement (the “Term Loan Agreement”). Costs incurred to effect the investment in JUUL are being recognized as expenses in Altria’s consolidated statement of earnings. For the year ended December 31, 2018, Altria incurred $85 million of pre-tax acquisition-related costs, consisting primarily of advisory fees, substantially all of which were recorded in marketing, administration and research costs.

Short-Term Borrowings and Borro

Short-Term Borrowings and Borrowing Arrangements	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Short-Term Borrowings and Borrowing Arrangements	Short-Term Borrowings and Borrowing Arrangements At December 31, 2018, Altria had $12.7 billion of short-term borrowings, which is net of $96 million of debt issuance costs, resulting from the Term Loan Agreement discussed below. At December 31, 2017, Altria had no short-term borrowings. On December 20, 2018, Altria entered into the Term Loan Agreement in connection with its investments in JUUL and Cronos. The Term Loan Agreement provides for borrowings up to an aggregate principal amount of $14.6 billion and is comprised of: (i) a $12.8 billion tranche, which Altria used to finance the JUUL Transaction, and (ii) a $1.8 billion tranche, which Altria intends to use to finance its investment in Cronos. Borrowings under the Term Loan Agreement mature on December 19, 2019, and interest rates on borrowings are, and expect to be, based on the London Interbank Offered Rate (“LIBOR”) plus a percentage based on the higher of the ratings of Altria’s long-term senior unsecured debt from Moody’s Investors Service, Inc. (“Moody’s”) and Standard & Poor’s Ratings Services (“Standard & Poor’s”). The applicable percentage based on Altria’s long-term senior unsecured debt ratings at December 31, 2018 for borrowings under the Term Loan Agreement was 1.0% . In addition, the Term Loan Agreement includes a one-time duration fee of 0.125% on any advances outstanding 180 days from December 20, 2018. At December 31, 2018, Altria had aggregate borrowings under the Term Loan Agreement of $12.8 billion at an interest rate of approximately 3.5% . Altria’s estimate of the fair value of its short-term borrowings is derived from discounted future cash flows based on the contractual terms of the Term Loan Agreement and observable interest rates and is classified in Level 2 of the fair value hierarchy. The fair value of Altria’s short-term borrowings at December 31, 2018 approximated its carrying value. At December 31, 2018, accrued interest on short-term borrowings of $15 million was included in other accrued liabilities on Altria’s consolidated balance sheet. On August 1, 2018, Altria entered into a senior unsecured 5 -year revolving credit agreement, which was subsequently amended on January 25, 2019 to include certain covenants that become effective upon the completion of Altria’s pending investment in Cronos (as amended, the “Credit Agreement”). The Credit Agreement, which is used for general corporate purposes, provides for borrowings up to an aggregate principal amount of $3.0 billion . The Credit Agreement expires on August 1, 2023 and includes an option, subject to certain conditions, for Altria to extend the Credit Agreement for two additional one -year periods. The Credit Agreement replaced Altria’s prior $3.0 billion senior unsecured 5 -year revolving credit agreement, which was to expire on August 19, 2020 and was terminated effective August 1, 2018. Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria’s long-term senior unsecured debt. Interest rates on borrowings under the Credit Agreement are expected to be based on LIBOR plus a percentage based on the higher of the ratings of Altria’s long-term senior unsecured debt from Moody’s and Standard & Poor’s. The applicable percentage based on Altria’s long-term senior unsecured debt ratings at December 31, 2018 for borrowings under the Credit Agreement was 1.0% . The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral. At December 31, 2018 and 2017 , Altria had no borrowings under the Credit Agreement. The credit line available to Altria at December 31, 2018 under the Credit Agreement was $3.0 billion . The Term Loan Agreement and the Credit Agreement (collectively, the “Borrowing Agreements”) include various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“EBITDA”) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis. At December 31, 2018, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Borrowing Agreements, was 14.4 to 1.0. At December 31, 2018, Altria was in compliance with its covenants associated with the Borrowing Agreements. The terms “Consolidated EBITDA” and “Consolidated Interest Expense,” each as defined in the Borrowing Agreements, include certain adjustments. Any commercial paper issued by Altria and borrowings under the Borrowing Agreements are guaranteed by PM USA as further discussed in Note 20 . Condensed Consolidating Financial Information. At December 31, 2018, Altria had a working capital deficit that included approximately $13.9 billion of debt coming due by December 31, 2019. In addition, Altria has an additional $1.0 billion of debt coming due by January 31, 2020. Although Altria does not currently have the liquid funds necessary to repay all of the $14.9 billion of debt coming due by January 31, 2020, Altria expects to access the credit and capital markets to refinance the debt prior to maturity. Altria believes it is probable that it will implement its refinancing plan because of its profitability, its credit rating, which continues to be investment grade, and history of obtaining financing on reasonable commercial terms.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt At December 31, 2018 and 2017 , Altria’s long-term debt consisted of the following: (in millions) 2018 2017 Notes, 2.625% to 10.20%, interest payable semi-annually, due through 2046 (1) $ 13,000 $ 13,852 Debenture, 7.75%, interest payable semi-annually, due 2027 42 42 13,042 13,894 Less current portion of long-term debt 1,144 864 $ 11,898 $ 13,030 (1) Weighted-average coupon interest rate of 4.6% and 4.9% at December 31, 2018 and 2017 , respectively. At December 31, 2018 , aggregate maturities of Altria’s long-term debt were as follows: (in millions) 2019 $ 1,144 2020 1,000 2021 1,500 2022 1,900 2023 350 Thereafter 7,259 13,153 Less: debt issuance costs 60 debt discounts 51 $ 13,042 Altria’s estimate of the fair value of its debt is based on observable market information derived from a third party pricing source and is classified in Level 2 of the fair value hierarchy. The aggregate fair value of Altria’s total long-term debt at December 31, 2018 and 2017 , was $12.5 billion and $15.3 billion , respectively, as compared with its carrying value of $13.0 billion and $13.9 billion , respectively. At December 31, 2018 and 2017, accrued interest on long-term debt of $207 million and $219 million , respectively, was included in other accrued liabilities on Altria’s consolidated balance sheets. ▪ Altria Senior Notes: The notes of Altria are senior unsecured obligations and rank equally in right of payment with all of Altria’s existing and future senior unsecured indebtedness. Upon the occurrence of both (i) a change of control of Altria and (ii) the notes ceasing to be rated investment grade by each of Moody’s, Standard & Poor’s and Fitch Ratings Ltd. within a specified time period, Altria will be required to make an offer to purchase the notes at a price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the notes. During 2018, Altria repaid in full at maturity notes in the aggregate principal amount of $864 million . The obligations of Altria under the notes are guaranteed by PM USA as further discussed in Note 20 . Condensed Consolidating Financial Information . ▪ Debt Tender Offer: During 2016, Altria completed a debt tender offer to purchase for cash certain of its notes in aggregate principal amount of $0.9 billion . Details of the debt tender offer and the associated pre-tax loss on early extinguishment of debt recorded by Altria were as follows: (in millions) 2016 Notes Purchased 9.95% Notes due 2038 $ 441 10.20% Notes due 2039 492 Total $ 933 Pre-tax Loss on Early Extinguishment of Debt Premiums and fees $ 809 Write-off of unamortized debt discounts and debt issuance costs 14 Total $ 823

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Capital Stock	Capital Stock At December 31, 2018 , Altria had 12 billion shares of authorized common stock; issued, repurchased and outstanding shares of common stock were as follows: Shares Issued Shares Repurchased Shares Outstanding Balances, December 31, 2015 2,805,961,317 (845,901,836 ) 1,960,059,481 Stock award activity — (566,256 ) (566,256 ) Repurchases of common stock — (16,221,001 ) (16,221,001 ) Balances, December 31, 2016 2,805,961,317 (862,689,093 ) 1,943,272,224 Stock award activity — (408,891 ) (408,891 ) Repurchases of common stock — (41,604,141 ) (41,604,141 ) Balances, December 31, 2017 2,805,961,317 (904,702,125 ) 1,901,259,192 Stock award activity — 676,727 676,727 Repurchases of common stock — (27,878,324 ) (27,878,324 ) Balances, December 31, 2018 2,805,961,317 (931,903,722 ) 1,874,057,595 At December 31, 2018 , 40,400,278 shares of common stock were reserved for stock-based awards under Altria’s stock plans, and 10 million shares of serial preferred stock, $ 1.00 par value, were authorized. No shares of serial preferred stock have been issued. ▪ Dividends: During the first quarter of 2018, Altria’s Board of Directors (the “Board of Directors”) approved a 6.1% increase in the quarterly dividend rate to $0.70 per share of Altria common stock versus the previous rate of $0.66 per share. During the third quarter of 2018 , the Board of Directors approved an additional 14.3% increase in the quarterly dividend rate to $0.80 per share of Altria common stock, resulting in an overall quarterly dividend rate increase of 21.2% since the beginning of 2018. The current annualized dividend rate is $3.20 per share. Future dividend payments remain subject to the discretion of the Board of Directors. ▪ Share Repurchases: In July 2015, the Board of Directors authorized a $1.0 billion share repurchase program that it expanded to $3.0 billion in October 2016 and to $4.0 billion in July 2017 (as expanded, the “July 2015 share repurchase program”). During 2018 , 2017 and 2016 , Altria repurchased 0.3 million shares, 41.6 million shares, and 16.2 million shares, respectively, of its common stock (at an aggregate cost of approximately $18 million , $2,917 million and $1,030 million , respectively, and at an average price of $71.68 per share, $70.10 per share and $63.48 per share, respectively) under the July 2015 share repurchase program. In January 2018, Altria completed the July 2015 share repurchase program, under which it purchased a total of 58.7 million shares of its common stock at an average price of $68.15 per share. Following the completion of the July 2015 share repurchase program, the Board of Directors authorized a new $1.0 billion share repurchase program in January 2018 that it expanded to $2.0 billion in May 2018 (as expanded, the “January 2018 share repurchase program”). During 2018 , Altria repurchased 27.6 million shares of its common stock (at an aggregate cost of approximately $1,655 million and at an average price of $59.89 per share) under the January 2018 share repurchase program. At December 31, 2018, Altria had approximately $345 million remaining in the January 2018 share repurchase program. The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of the Board of Directors. For the years ended December 31, 2018 , 2017 and 2016 , Altria’s total share repurchase activity was as follows: 2018 2017 2016 (in millions, except per share data) Total number of shares repurchased 27.9 41.6 16.2 Aggregate cost of shares repurchased $ 1,673 $ 2,917 $ 1,030 Average price per share of shares repurchased $ 60.00 $ 70.10 $ 63.48

Stock Plans

Stock Plans	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Plans	Stock Plans Under the Altria 2015 Performance Incentive Plan (the “2015 Plan”), Altria may grant stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), deferred stock units and other stock-based awards, as well as cash-based annual and long-term incentive awards to employees of Altria or any of its subsidiaries or affiliates. Any awards granted pursuant to the 2015 Plan may be in the form of performance-based awards, including performance stock units (“PSUs”), subject to the achievement or satisfaction of performance goals and performance cycles. Up to 40 million shares of common stock may be issued under the 2015 Plan. In addition, under the 2015 Stock Compensation Plan for Non-Employee Directors (the “Directors Plan”), Altria may grant up to one million shares of common stock to members of the Board of Directors who are not employees of Altria. Shares available to be granted under the 2015 Plan and the Directors Plan at December 31, 2018 , were 37,033,741 and 880,291 , respectively. ▪ Restricted Stock and RSUs: During the vesting period, these shares include nonforfeitable rights to dividends or dividend equivalents and may not be sold, assigned, pledged or otherwise encumbered. Such shares are subject to forfeiture if certain employment conditions are not met. Altria estimates the number of awards expected to be forfeited and adjusts this estimate when subsequent information indicates that the actual number of forfeitures is likely to differ from previous estimates. Shares of restricted stock and RSUs generally vest three years after the grant date. The fair value of the shares of restricted stock and RSUs at the date of grant, net of estimated forfeitures, is amortized to expense ratably over the restriction period, which is generally three years . Altria recorded pre-tax compensation expense related to restricted stock and RSUs for the years ended December 31, 2018 , 2017 and 2016 of $39 million , $49 million and $44 million , respectively. The deferred tax benefit recorded related to this compensation expense was $9 million , $18 million and $17 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. The unamortized compensation expense related to RSUs was $62 million at December 31, 2018 and is expected to be recognized over a weighted-average period of approximately two years . Altria has not granted any restricted stock after 2014 and had no restricted stock outstanding at December 31, 2017. RSU activity was as follows for the year ended December 31, 2018 : Number of Shares Weighted-Average Grant Date Fair Value Per Share Balance at December 31, 2017 2,384,501 $ 60.40 Granted 896,962 $ 67.17 Vested (998,145 ) $ 56.44 Forfeited (153,692 ) $ 62.56 Balance at December 31, 2018 2,129,626 $ 64.94 The weighted-average grant date fair value of RSUs granted during the years ended December 31, 2018 , 2017 and 2016 was $60 million , $46 million and $56 million , respectively, or $67.17 , $71.05 and $59.38 per RSU, respectively. The total fair value of restricted stock and RSUs that vested during the years ended December 31, 2018 , 2017 and 2016 was $65 million , $95 million and $78 million , respectively. ▪ PSUs: Altria granted an aggregate of 177,338 and 187,886 of PSUs during 2018 and 2017 , respectively. Altria did not grant any PSUs during 2016. The payout of PSUs requires the achievement of certain performance measures, which were predetermined at the time of grant, over a three -year performance cycle. These performance measures consist of Altria’s adjusted diluted earnings per share compounded annual growth rate and Altria’s total shareholder return relative to a predetermined peer group. PSUs are also subject to forfeiture if certain employment conditions are not met. At December 31, 2018, Altria had 274,324 PSUs remaining, with a weighted-average grant date fair value of $65.90 per PSU. The fair value of PSUs at the date of grant, net of estimated forfeitures, is amortized to expense over the performance period. Altria recorded pre-tax compensation expense related to PSUs for the year ended December 31, 2018 and 2017 of $7 million and $6 million , respectively. The unamortized compensation expense related to PSUs was $10 million at December 31, 2018 .

Earnings per Share

Earnings per Share	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per Share Basic and diluted earnings per share (“EPS”) were calculated using the following: For the Years Ended December 31, (in millions) 2018 2017 2016 Net earnings attributable to Altria $ 6,963 $ 10,222 $ 14,239 Less: Distributed and undistributed earnings attributable to share-based awards (8 ) (14 ) (24 ) Earnings for basic and diluted EPS $ 6,955 $ 10,208 $ 14,215 Weighted-average shares for basic EPS 1,887 1,921 1,952 Plus: contingently issuable PSUs 1 — — Weighted-average shares for diluted EPS 1,888 1,921 1,952

Other Comprehensive Earnings_Lo

Other Comprehensive Earnings/Losses	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Other Comprehensive Earnings/Losses	Other Comprehensive Earnings/Losses The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria: (in millions) Benefit Plans AB InBev/SABMiller Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses Balances, December 31, 2015 $ (2,010 ) $ (1,265 ) $ (5 ) $ (3,280 ) Other comprehensive (losses) earnings before reclassifications (247 ) 787 1 541 Deferred income taxes 96 (276 ) — (180 ) Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes (151 ) 511 (1) 1 361 Amounts reclassified to net earnings 178 1,160 — 1,338 Deferred income taxes (65 ) (406 ) — (471 ) Amounts reclassified to net earnings, net of deferred income taxes 113 754 (2) — 867 Other comprehensive (losses) earnings, net of deferred income taxes (38 ) 1,265 1 1,228 Balances, December 31, 2016 (2,048 ) — (4 ) (2,052 ) Other comprehensive earnings (losses) before reclassifications 52 (91 ) — (39 ) Deferred income taxes (21 ) 32 — 11 Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes 31 (59 ) — (28 ) Amounts reclassified to net earnings 291 8 — 299 Deferred income taxes (113 ) (3 ) — (116 ) Amounts reclassified to net earnings, net of deferred income taxes 178 5 — 183 Other comprehensive earnings (losses), net of deferred income taxes 209 (54 ) (3) — 155 Balances, December 31, 2017 (1,839 ) (54 ) (4 ) (1,897 ) Adoption of ASU No. 2018-02 (4) (397 ) (11 ) — (408 ) Other comprehensive losses before reclassifications (151 ) (323 ) (1 ) (475 ) Deferred income taxes 39 64 — 103 Other comprehensive losses before reclassifications, net of deferred income taxes (112 ) (259 ) (1 ) (372 ) Amounts reclassified to net earnings 241 (64 ) — 177 Deferred income taxes (61 ) 14 — (47 ) Amounts reclassified to net earnings, net of deferred income taxes 180 — (50 ) — 130 Other comprehensive earnings (losses), net of deferred income taxes 68 (309 ) (3) (1 ) (242 ) Balances, December 31, 2018 $ (2,168 ) $ (374 ) $ (5 ) $ (2,547 ) (1) As a result of the AB InBev Transaction, Altria reversed to investment in SABMiller $414 million of its accumulated other comprehensive losses directly attributable to SABMiller; the remaining $97 million consisted primarily of currency translation adjustments. (2) As a result of the AB InBev Transaction, Altria recognized $737 million of its accumulated other comprehensive losses directly attributable to SABMiller. (3) Primarily reflects currency translation adjustments. (4) Reflects the reclassification of the stranded income tax effects of the Tax Reform Act. For further discussion, see Note 15 . Income Taxes . The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings: For the Years Ended December 31, (in millions) 2018 2017 2016 Benefit Plans: (1) Net loss $ 276 $ 325 $ 223 Prior service cost/credit (35 ) (34 ) (45 ) 241 291 178 AB InBev/SABMiller (2) (64 ) 8 1,160 Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings $ 177 $ 299 $ 1,338 ( 1) Amounts are included in net defined benefit plan costs. For further details, see Note 17 . Benefit Plans. (2) For the years ended December 31, 2018 and 2017, amounts are primarily included in earnings from equity investment in AB InBev. Substantially all of the amount for the year ended December 31, 2016 is included in gain on AB InBev/SABMiller business combination. For further information, see Note 7 . Investment in AB InBev/SABMiller.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Reform Act”). As a result of the Tax Reform Act, Altria recorded net tax benefits of approximately $3.4 billion in the fourth quarter of 2017 as discussed below. The main provisions of the Tax Reform Act that impact Altria include: (i) a reduction in the U.S. federal statutory corporate income tax rate from 35% to 21% effective January 1, 2018, and (ii) changes in the treatment of foreign-source income, commonly referred to as a modified territorial tax system. The transition to a modified territorial tax system required Altria to record a deemed repatriation tax and an associated tax basis benefit in 2017. Substantially all of the deemed repatriation tax was related to Altria’s share of AB InBev’s accumulated earnings. Dividends received from AB InBev beginning in 2017, to the extent that such dividends represent previously taxed income attributable to the deemed repatriation tax, result in an associated tax basis expense, which reverses the tax basis benefit recorded in 2017. The Tax Reform Act also includes a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries. Altria made an accounting policy election to treat taxes due under the GILTI provision as a current period expense. Earnings before income taxes and provision (benefit) for income taxes consisted of the following for the years ended December 31, 2018 , 2017 and 2016 : (in millions) 2018 2017 2016 Earnings (loss) before income taxes: United States $ 9,441 $ 9,809 $ 21,867 Outside United States (100 ) 19 (15 ) Total $ 9,341 $ 9,828 $ 21,852 Provision (benefit) for income taxes: Current: Federal $ 1,911 $ 2,346 $ 4,093 State and local 519 366 390 Outside United States 1 15 6 2,431 2,727 4,489 Deferred: Federal (18 ) (3,213 ) 3,102 State and local (42 ) 86 20 Outside United States 3 1 (3 ) (57 ) (3,126 ) 3,119 Total provision (benefit) for income taxes $ 2,374 $ (399 ) $ 7,608 Altria’s U.S. subsidiaries join in the filing of a U.S. federal consolidated income tax return. The U.S. federal income tax statute of limitations remains open for the year 2014 and forward, with years 2014 and 2015 currently under examination by the Internal Revenue Service (“IRS”) as part of an audit conducted in the ordinary course of business. With the exception of corresponding federal audit adjustments, state statutes of limitations generally remain open for the year 2014 and forward. Certain of Altria’s state tax returns are currently under examination by various states as part of routine audits conducted in the ordinary course of business. A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2018 , 2017 and 2016 was as follows: (in millions) 2018 2017 2016 Balance at beginning of year $ 66 $ 169 $ 158 Additions based on tax positions related to the current year — — 15 Additions for tax positions of prior years 22 129 29 Reductions for tax positions due to lapse of statutes of limitations — (4 ) (4 ) Reductions for tax positions of prior years (1 ) (208 ) (28 ) Settlements (2 ) (20 ) (1 ) Balance at end of year $ 85 $ 66 $ 169 Unrecognized tax benefits and Altria’s consolidated liability for tax contingencies at December 31, 2018 and 2017 were as follows: (in millions) 2018 2017 Unrecognized tax benefits $ 85 $ 66 Accrued interest and penalties 13 9 Tax credits and other indirect benefits (1 ) (1 ) Liability for tax contingencies $ 97 $ 74 The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December 31, 2018 was $59 million , along with $26 million affecting deferred taxes. The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December 31, 2017 was $43 million , along with $23 million affecting deferred taxes. Altria recognizes accrued interest and penalties associated with uncertain tax positions as part of the tax provision. For the years ended December 31, 2018 , 2017 and 2016 , Altria recognized in its consolidated statements of earnings $5 million , $(13) million and $9 million , respectively, of gross interest expense (income) associated with uncertain tax positions. Altria is subject to income taxation in many jurisdictions. Unrecognized tax benefits reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements. Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within the control of Altria. It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a decrease in unrecognized tax benefits of approximately $45 million . The effective income tax rate on pre-tax earnings differed from the U.S. federal statutory rate for the following reasons for the years ended December 31, 2018 , 2017 and 2016 : 2018 2017 2016 U.S. federal statutory rate 21.0 % 35.0 % 35.0 % Increase (decrease) resulting from: State and local income taxes, net of federal tax benefit 4.0 3.5 1.2 Re-measurement of net deferred tax liabilities — (31.2 ) — Tax basis in foreign investments 1.5 (7.8 ) — Deemed repatriation tax 0.1 4.2 — Uncertain tax positions 0.1 (0.9 ) — Investment in AB InBev/SABMiller (1.1 ) (5.9 ) (0.6 ) Domestic manufacturing deduction — (1.8 ) (0.8 ) Other (0.2 ) 0.8 — Effective tax rate 25.4 % (4.1 )% 34.8 % The tax provision in 2018 included tax expense of $188 million related to the Tax Reform Act as follows: (i) tax expense of $140 million resulting from a partial reversal of the tax basis benefit associated with the deemed repatriation tax recorded in 2017; (ii) tax expense of $34 million for a valuation allowance on foreign tax credit carryforwards that are not realizable as a result of updates to the provisional estimates recorded in 2017 and (iii) tax expense of $14 million for an adjustment to the provisional estimates for the repatriation tax recorded in 2017. Substantially all of the 2018 amounts related to the tax basis adjustment, valuation allowance on foreign tax credits and repatriation tax relate to Altria’s share of AB InBev’s accumulated earnings and associated taxes. The adjustments recorded in 2018 to the provisional estimates recorded in 2017 were based on (i) additional guidance related to, or interpretation of, the Tax Reform Act and associated tax laws and (ii) additional information received from AB InBev, including information regarding AB InBev’s accumulated earnings and associated taxes for the 2016 and 2017 tax years. The accounting for the repatriation tax is complete; therefore, no further adjustments to the provisional estimates are required. The tax benefit in 2017 included net tax benefits of $3,367 million related to the Tax Reform Act recorded in the fourth quarter of 2017 as follows: (i) a tax benefit of $3,017 million to re-measure Altria and its consolidated subsidiaries’ net deferred tax liabilities based on the new U.S. federal statutory rate and (ii) a net tax benefit of $763 million for a tax basis adjustment associated with the deemed repatriation tax, partially offset by tax expense of $413 million for the deemed repatriation tax. The 2017 amounts related to the tax basis adjustment and the deemed repatriation tax were based on provisional estimates as of January 18, 2018, substantially all of which are related to Altria’s share of AB InBev’s accumulated earnings and associated taxes. The tax benefit in 2017 also included tax benefits of $232 million for the release of a valuation allowance in the third quarter of 2017 related to deferred income tax assets for foreign tax credit carryforwards, which is included in investment in AB InBev/SABMiller in the table above; and tax benefits of $152 million related primarily to the effective settlement in the second quarter of 2017 of the IRS audit of Altria and its consolidated subsidiaries’ 2010-2013 tax years, partially offset by tax expense of $114 million in the third quarter of 2017 for tax reserves related to the calculation of certain foreign tax credits. The tax provision in 2016 included increased tax benefits associated with the cumulative SABMiller and AB InBev dividends and tax expense of $4.9 billion (approximately 35% ) for the gain on the AB InBev Transaction. The tax effects of temporary differences that gave rise to deferred income tax assets and liabilities consisted of the following at December 31, 2018 and 2017 : (in millions) 2018 2017 Deferred income tax assets: Accrued postretirement and postemployment benefits $ 500 $ 539 Settlement charges 864 614 Accrued pension costs 155 136 Net operating losses and tax credit carryforwards 57 18 Total deferred income tax assets 1,576 1,307 Deferred income tax liabilities: Property, plant and equipment (251 ) (261 ) Intangible assets (2,689 ) (2,674 ) Investment in AB InBev (3,038 ) (2,859 ) Finance assets, net (313 ) (404 ) Other (115 ) (121 ) Total deferred income tax liabilities (6,406 ) (6,319 ) Valuation allowances (71 ) — Net deferred income tax liabilities $ (4,901 ) $ (5,012 ) At December 31, 2018 , Altria had estimated gross state tax net operating losses of $658 million that, if unused, will expire in 2019 through 2038. The 2018 valuation allowance is primarily related to foreign tax credit and state net operating loss carryforwards that more-likely-than-not will not be realized. On October 1, 2018, Altria adopted ASU 2018-02 and elected to reclassify the stranded income tax effects of the Tax Reform Act on items within accumulated other comprehensive losses to earnings reinvested in the business. The adjustment relates to the change in the U.S. federal statutory corporate income tax rate. This election resulted in an increase to both accumulated other comprehensive losses and earnings reinvested in the business of $408 million on October 1, 2018.

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting The products of Altria’s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA and Nat Sherman, machine-made large cigars and pipe tobacco manufactured and sold by Middleton and premium cigars sold by Nat Sherman; smokeless tobacco products, consisting of moist smokeless tobacco and snus products manufactured and sold by USSTC; and wine produced and/or distributed by Ste. Michelle. The products and services of these subsidiaries constitute Altria’s reportable segments of smokeable products, smokeless products and wine. The financial services and the innovative tobacco products businesses are included in all other. As discussed in Note 17. Benefit Plans , on January 1, 2018, Altria adopted ASU 2017-07, which resulted in a change to prior-period operating income. As a result, certain immaterial prior-period operating companies income (loss) data has been restated. Altria’s chief operating decision maker (the “CODM”) reviews operating companies income to evaluate the performance of, and allocate resources to, the segments. Operating companies income for the segments is defined as operating income before general corporate expenses and amortization of intangibles. Interest and other debt expense, net, net periodic benefit cost/income, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM. Information about total assets by segment is not disclosed because such information is not reported to or used by the CODM. Substantially all of Altria’s long-lived assets are located in the United States. Segment goodwill and other intangible assets, net, are disclosed in Note 4 . Goodwill and Other Intangible Assets, net. The accounting policies of the segments are the same as those described in Note 2 . Summary of Significant Accounting Policies. Segment data were as follows: For the Years Ended December 31, (in millions) 2018 2017 2016 Net revenues: Smokeable products $ 22,297 $ 22,636 $ 22,851 Smokeless products 2,262 2,155 2,051 Wine 691 698 746 All other 114 87 96 Net revenues $ 25,364 $ 25,576 $ 25,744 Earnings before income taxes: Operating companies income (loss): Smokeable products $ 8,408 $ 8,426 $ 7,766 Smokeless products 1,431 1,306 1,172 Wine 50 146 164 All other (421 ) (51 ) (98 ) Amortization of intangibles (38 ) (21 ) (21 ) General corporate expenses (315 ) (213 ) (217 ) Corporate asset impairment and exit costs — — (5 ) Operating income 9,115 9,593 8,761 Interest and other debt expense, net (665 ) (705 ) (747 ) Loss on early extinguishment of debt — — (823 ) Net periodic benefit income (cost), excluding service cost 34 (37 ) 1 Earnings from equity investment in AB InBev/SABMiller 890 532 795 (Loss) gain on AB InBev/SABMiller business combination (33 ) 445 13,865 Earnings before income taxes $ 9,341 $ 9,828 $ 21,852 The smokeable products segment included net revenues of $21,506 million , $21,900 million and $22,199 million for the years ended December 31, 2018 , 2017 and 2016 , respectively, related to cigarettes and net revenues of $791 million , $736 million and $652 million for the years ended December 31, 2018 , 2017 and 2016 , respectively, related to cigars. Substantially all of Altria’s net revenues are from sales generated in the United States for the years ended December 31, 2018, 2017 and 2016. PM USA, USSTC, Middleton and Nat Sherman’s largest customer, McLane Company, Inc., accounted for approximately 27% , 26% and 25% of Altria’s consolidated net revenues for the years ended December 31, 2018 , 2017 and 2016 , respectively. In addition, Core-Mark Holding Company, Inc. accounted for approximately 14% of Altria’s consolidated net revenues for each of the years ended December 31, 2018, 2017 and 2016. Substantially all of these net revenues were reported in the smokeable products and smokeless products segments. Sales to two distributors accounted for approximately 64% of net revenues for the wine segment for the year ended December 31, 2018 . Sales to three distributors accounted for approximately 67% and 69% of net revenues for the wine segment for the years ended December 31, 2017 and 2016 , respectively. Details of Altria’s depreciation expense and capital expenditures were as follows: For the Years Ended December 31, (in millions) 2018 2017 2016 Depreciation expense: Smokeable products $ 90 $ 93 $ 93 Smokeless products 28 29 26 Wine 40 40 36 General corporate and other 31 26 28 Total depreciation expense $ 189 $ 188 $ 183 Capital expenditures: Smokeable products $ 81 $ 39 $ 55 Smokeless products 73 61 52 Wine 40 53 59 General corporate and other 44 46 23 Total capital expenditures $ 238 $ 199 $ 189 The comparability of operating companies income for the reportable segments was affected by the following: ▪ Non-Participating Manufacturer (“NPM”) Adjustment Items: For the years ended December 31, 2018 , 2017 and 2016, pre-tax (income) expense for NPM adjustment items was recorded in Altria’s consolidated statements of earnings as follows: (in millions) 2018 2017 2016 Smokeable products segment $ (145 ) $ (5 ) $ 12 Interest and other debt expense, net — 9 6 Total $ (145 ) $ 4 $ 18 NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as “NPM Adjustment Items” and are more fully described in Health Care Cost Recovery Litigation - NPM Adjustment Disputes in Note 19 . Contingencies ). The amounts shown in the table above for the smokeable products segment were recorded by PM USA as (reductions) increases to cost of sales, which (increased) decreased operating companies income in the smokeable products segment. ▪ Tobacco and Health Litigation Items: For the years ended December 31, 2018 , 2017 and 2016 , pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s consolidated statements of earnings as follows: (in millions) 2018 2017 2016 Smokeable products segment $ 103 $ 72 $ 88 Smokeless products segment 10 — — Interest and other debt expense, net 18 8 17 Total $ 131 $ 80 $ 105 The amounts shown in the table above for the smokeable and smokeless products segments were recorded in marketing, administration and research costs. For further discussion, see Note 19 . Contingencies . ▪ Smokeless Products Recall: During 2017, USSTC voluntarily recalled certain smokeless tobacco products manufactured at its Franklin Park, Illinois facility due to a product tampering incident (the “Recall”). USSTC estimated that the Recall reduced smokeless products segment operating companies income by approximately $60 million in 2017. ▪ Asset Impairment, Exit and Implementation Costs: See Note 5 . Asset Impairment, Exit and Implementation Costs for a breakdown of these costs by segment.

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans Subsidiaries of Altria sponsor noncontributory defined benefit pension plans covering certain employees of Altria and its subsidiaries. Employees hired on or after a date specific to their employee group are not eligible to participate in these noncontributory defined benefit pension plans but are instead eligible to participate in a defined contribution plan with enhanced benefits. This transition for new hires occurred from October 1, 2006 to January 1, 2008. In addition, effective January 1, 2010, certain employees of UST’s subsidiaries and Middleton who were participants in noncontributory defined benefit pension plans ceased to earn additional benefit service under those plans and became eligible to participate in a defined contribution plan with enhanced benefits. Altria and its subsidiaries also provide postretirement health care and other benefits to certain retired employees. The plan assets and benefit obligations of Altria’s pension plans and postretirement plans are measured at December 31 of each year. In December 2017, Altria made a contribution of $270 million to a trust to fund certain postretirement benefits. Prior to this contribution, Altria’s postretirement plans were not funded. The discount rates for Altria’s plans were based on a yield curve developed from a model portfolio of high-quality corporate bonds with durations that match the expected future cash flows of the pension and postretirement benefit obligations. On January 1, 2018 Altria adopted ASU No. 2017-07, which requires an employer to report the service cost component of net periodic pension cost and net periodic postretirement benefit cost in the same line item or items as other compensation costs arising from services rendered by employees during the period. The other components of net periodic pension cost and net periodic postretirement benefit cost are required to be presented in the statements of earnings separately from the service cost component and outside the subtotal of operating income. Additionally, only the service cost component is eligible for capitalization. Altria retrospectively adopted the guidance for the presentation of the service cost component and the other components of net periodic pension cost and net periodic postretirement benefit cost in its consolidated statements of earnings, and prospectively adopted the capitalization of service cost. Altria used the practical expedient provided in ASU No. 2017-07 that permits Altria to use the amounts disclosed in its benefit plans note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. For the year ended December 31, 2017 , the adoption of ASU No. 2017-07 resulted in a reclassification of net periodic benefit cost of $12 million , $24 million and $1 million from cost of sales, marketing, administration and research costs, and asset impairment and exit costs, respectively, to net periodic benefit (income) cost, excluding service cost in Altria’s consolidated statement of earnings. For the year ended December 31, 2016 , the adoption resulted in a reclassification of net periodic benefit income of $19 million and $12 million from cost of sales and marketing, administration and research costs, respectively, and a reclassification of net periodic benefit cost of $30 million from asset impairment and exit costs, to net periodic benefit (income) cost, excluding service cost in Altria’s consolidated statement of earnings. In addition, certain prior-period segment data has been reclassified to conform with the current period’s presentation. For further discussion, see Note 16. Segment Reporting . ▪ Obligations and Funded Status: The benefit obligations, plan assets and funded status of Altria’s pension and postretirement plans at December 31, 2018 and 2017 were as follows: Pension Postretirement (in millions) 2018 2017 2018 2017 Change in benefit obligation: Benefit obligation at beginning of year $ 8,510 $ 8,312 $ 2,335 $ 2,364 Service cost 81 75 18 16 Interest cost 276 288 70 76 Benefits paid (488 ) (703 ) (130 ) (139 ) Actuarial (gains) losses (660 ) 589 (298 ) 56 Termination, settlement and curtailment (18 ) (51 ) — — Other 25 — 45 (38 ) Benefit obligation at end of year 7,726 8,510 2,040 2,335 Change in plan assets: Fair value of plan assets at beginning of year 8,015 7,475 270 — Actual return on plan assets (430 ) 1,219 (14 ) — Employer contributions 41 24 — 270 Benefits paid (488 ) (703 ) (45 ) — Fair value of plan assets at end of year 7,138 8,015 211 270 Funded status at December 31 $ (588 ) $ (495 ) $ (1,829 ) $ (2,065 ) Amounts recognized on Altria’s consolidated balance sheets were as follows: Other accrued liabilities $ (44 ) $ (51 ) $ (80 ) $ (78 ) Accrued pension costs (544 ) (445 ) — — Other assets — 1 — — Accrued postretirement health care costs — — (1,749 ) (1,987 ) $ (588 ) $ (495 ) $ (1,829 ) $ (2,065 ) The table above presents the projected benefit obligation for Altria’s pension plans. The accumulated benefit obligation, which represents benefits earned to date, for the pension plans was $7.4 billion and $ 8.2 billion at December 31, 2018 and 2017 , respectively. For plans with accumulated benefit obligations in excess of plan assets at December 31, 2018 , the projected benefit obligation, accumulated benefit obligation and fair value of plan assets were $ 7,598 million , $ 7,239 million and $ 7,012 million , respectively. For plans with accumulated benefit obligations in excess of plan assets at December 31, 2017 , the projected benefit obligation, accumulated benefit obligation and fair value of plan assets were $ 413 million , $ 364 million and $ 124 million , respectively. The Patient Protection and Affordable Care Act (“PPACA”), as amended by the Health Care and Education Reconciliation Act of 2010, mandates health care reforms with staggered effective dates from 2010 to 2022, including the imposition of an excise tax on high cost health care plans effective in 2022. The additional accumulated postretirement liability resulting from the PPACA, which is not material to Altria, has been included in Altria’s accumulated postretirement benefit obligation at December 31, 2018 and 2017 . Given the complexity of the PPACA and the extended time period during which implementation is expected to occur, future adjustments to Altria’s accumulated postretirement benefit obligation may be necessary. The following assumptions were used to determine Altria’s pension and postretirement benefit obligations at December 31: Pension Postretirement 2018 2017 2018 2017 Discount rate 4.4 % 3.7 % 4.4 % 3.7 % Rate of compensation increase 4.0 4.0 — — Health care cost trend rate assumed for next year — — 6.5 7.0 Ultimate trend rate — — 5.0 5.0 Year that the rate reaches the ultimate trend rate — — 2025 2022 ▪ Components of Net Periodic Benefit Cost: Net periodic benefit cost consisted of the following for the years ended December 31, 2018 , 2017 and 2016 : Pension Postretirement (in millions) 2018 2017 2016 2018 2017 2016 Service cost $ 81 $ 75 $ 76 $ 18 $ 16 $ 17 Interest cost 276 288 281 70 76 77 Expected return on plan assets (585 ) (601 ) (553 ) (19 ) — — Amortization: Net loss 225 197 171 21 25 25 Prior service cost (credit) 4 4 5 (42 ) (38 ) (39 ) Termination, settlement and curtailment 16 86 34 — — (2 ) Net periodic benefit cost $ 17 $ 49 $ 14 $ 48 $ 79 $ 78 Termination, settlement and curtailment shown in the table above primarily relate to the settlement charge discussed below, and the cost reduction program, productivity initiative and facilities consolidation discussed in Note 5 . Asset Impairment, Exit and Implementation Costs . In the third quarter of 2017, Altria made a voluntary, limited-time offer to former employees with vested benefits in the Altria Retirement Plan who had not commenced receiving benefit payments and who met certain other conditions. Eligible participants were offered the opportunity to make a one-time election to receive their pension benefit as a single lump sum payment or as a monthly annuity. Distributions to former employees who elected to receive lump sum payments totaled approximately $277 million , substantially all of which were made in December 2017 from the Altria Retirement Plan’s assets. Payments began on January 1, 2018 to former employees who elected a monthly annuity. As a result of the lump sum distributions, Altria recorded a one-time settlement charge of $81 million in 2017. The amounts included in termination, settlement and curtailment in the table above were comprised of the following changes: Pension Post-retirement (in millions) 2018 2017 2016 2016 Benefit obligation $ — $ — $ 23 $ 11 Other comprehensive earnings/losses: Net loss 13 86 9 — Prior service cost (credit) 3 — 2 (13 ) $ 16 $ 86 $ 34 $ (2 ) The estimated net loss and prior service cost (credit) that are expected to be amortized from accumulated other comprehensive losses into net periodic benefit cost during 2019 is as follows: (in millions) Pension Postretirement Net loss $ 169 $ 12 Prior service cost (credit) 6 (32 ) The following assumptions were used to determine Altria’s net periodic benefit cost for the years ended December 31: Pension Postretirement 2018 2017 2016 2018 2017 2016 Discount rates: Service cost 3.8 % 4.3 % 4.7 % 3.8 % 4.3 % 4.5 % Interest cost 3.3 3.5 3.6 3.3 3.5 3.4 Expected rate of return on plan assets 7.8 8.0 8.0 7.8 — — Rate of compensation increase 4.0 4.0 4.0 — — — Health care cost trend rate — — — 7.0 7.0 6.5 Assumed health care cost trend rates have a significant effect on the amounts reported for the postretirement health care plans. A one-percentage-point change in assumed health care cost trend rates would have had the following effects as of December 31, 2018 : One-Percentage-Point Increase One-Percentage-Point Decrease Effect on total of postretirement service and interest cost 7.5 % (6.3 )% Effect on postretirement benefit obligation 5.6 % (4.8 )% ▪ Defined Contribution Plans: Altria sponsors deferred profit-sharing plans covering certain salaried, non-union and union employees. Contributions and costs are determined generally as a percentage of earnings, as defined by the plans. Amounts charged to expense for these defined contribution plans totaled $85 million , $83 million and $93 million in 2018 , 2017 and 2016 , respectively. ▪ Pension and Postretirement Plan Assets: Altria’s investment strategy for its pension and postretirement plan assets is based on an expectation that equity securities will outperform debt securities over the long term. Altria believes that it implements the investment strategy in a prudent and risk-controlled manner, consistent with the fiduciary requirements of the Employee Retirement Income Security Act of 1974, by investing retirement plan assets in a well-diversified mix of equities, fixed income and other securities that reflects the impact of the demographic mix of plan participants on the benefit obligation using a target asset allocation between equity securities and fixed income investments of 55% / 45% . The composition of Altria’s plan assets at December 31, 2018 was broadly characterized with the following allocation: Pension Postretirement Equity securities 48 % 48 % Corporate bonds 32 % 42 % U.S. Treasury and foreign government securities 20 % 10 % Altria’s plan asset allocations at December 31, 2018 reflect fourth quarter 2018 equity market underperformance and are monitored on an ongoing basis to adjust as necessary. Substantially all pension and all postretirement assets can be used to make monthly benefit payments. Altria’s investment objective for its pension and postretirement plan assets is accomplished by investing in U.S. and international equity index strategies that are intended to mirror indices including, but not limited to, the Standard & Poor’s 500 Index and Morgan Stanley Capital International (“MSCI”) Europe, Australasia, and the Far East (“EAFE”) Index. Altria’s pension and postretirement plans also invest in actively managed international equity securities of large, mid and small cap companies located in developed and emerging markets, as well as long duration fixed income securities that primarily include corporate bonds of companies from diversified industries. For pension plan assets, the allocation to below investment grade securities represented 14% of the fixed income holdings or 7% of the total plan assets at December 31, 2018 . The allocation to emerging markets represented 1% of equity holdings or less than 1% of total plan assets at December 31, 2018 . For postretirement plan assets, the allocation to below investment grade securities represented 13% of the fixed income holdings or 6% of the total plan assets at December 31, 2018 . There were no postretirement plan assets invested in emerging markets at December 31, 2018 . Altria’s risk management practices for its pension and postretirement plans include ongoing monitoring of asset allocation, investment performance and investment managers’ compliance with their investment guidelines, periodic rebalancing between equity and debt asset classes and annual actuarial re-measurement of plan liabilities. Altria’s expected rate of return on pension and postretirement plan assets is determined by the plan assets’ historical long-term investment performance, current asset allocation and estimates of future long-term returns by asset class. The forward-looking estimates are consistent with the overall long-term averages exhibited by returns on equity and fixed income securities. The fair values of Altria’s pension plan assets by asset category at December 31, 2018 and 2017 were as follows: 2018 2017 (in millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total U.S. and foreign government securities or their agencies: U.S. government and agencies $ — $ 868 $ — $ 868 $ — $ 588 $ — $ 588 U.S. municipal bonds — 73 — 73 — 81 — 81 Foreign government and agencies — 115 — 115 — 150 — 150 Corporate debt instruments: Above investment grade — 1,726 — 1,726 — 1,789 — 1,789 Below investment grade and no rating — 478 — 478 — 511 — 511 Common stock: International equities 237 — — 237 1,396 — — 1,396 U.S. equities 1,082 — — 1,082 831 — — 831 Cash and cash equivalents — 303 — 303 — 106 — 106 Other, net 36 36 — 72 47 42 — 89 $ 1,355 $ 3,599 $ — $ 4,954 $ 2,274 $ 3,267 $ — $ 5,541 Investments measured at NAV as a practical expedient for fair value: Collective investment funds U.S. large cap $ 1,722 $ 2,014 U.S. small cap 328 361 International developed markets 86 100 Total investments measured at NAV $ 2,136 $ 2,475 Other 48 (1 ) Fair value of plan assets, net $ 7,138 $ 8,015 Level 3 holdings and transactions were immaterial to total plan assets at December 31, 2018 and 2017 . The fair value of Altria’s postretirement plan assets at December 31, 2018 were as follows: 2018 (in millions) Level 1 Level 2 Total U.S. and foreign government securities or their agencies: U.S. government and agencies $ — $ 13 $ 13 Foreign government and agencies — 3 3 Corporate debt instruments: Above investment grade — 71 71 Below investment grade and no rating — 8 8 Other, net 2 2 4 $ 2 $ 97 $ 99 Investments measured at NAV as a practical expedient for fair value: Collective investment funds: U.S. large cap $ 77 International developed markets 26 Total investments measured at NAV $ 103 Other 9 Fair value of plan assets, net $ 211 At December 31, 2017, postretirement plan assets totaled $270 million , of which $148 million was invested in collective investment funds and $122 million was held in a non-interest bearing cash account. There were no postretirement plan investments classified in Level 1, Level 2 or Level 3 of the fair value hierarchy at December 31, 2017. There were no Level 3 postretirement plan holdings or transactions during 2018 and 2017 . For a description of the fair value hierarchy and the three levels of inputs used to measure fair value, see Note 2 . Summary of Significant Accounting Policies . Following is a description of the valuation methodologies used for investments measured at fair value. ▪ U.S. and Foreign Government Securities : U.S. and foreign government securities consist of investments in Treasury Nominal Bonds and Inflation Protected Securities and municipal securities. Government securities are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes. Matrix pricing, yield curves and indices are used when broker quotes are not available. ▪ Corporate Debt Instruments : Corporate debt instruments are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes. Matrix pricing, yield curves and indices are used when broker quotes are not available. ▪ Common Stock : Common stocks are valued based on the price of the security as listed on an open active exchange on last trade date. ▪ Collective Investment Funds : Collective investment funds consist of funds that are intended to mirror indices such as Standard & Poor’s 500 Index and MSCI EAFE Index. They are valued on the basis of the relative interest of each participating investor in the fair value of the underlying assets of each of the respective collective investment funds. The underlying assets are valued based on the net asset value (“NAV”), which is provided by the investment account manager as a practical expedient to estimate fair value. These investments are not classified by level but are disclosed to permit reconciliation to the fair value of plan assets. Cash Flows: Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under IRS regulations. Currently, Altria anticipates making employer contributions to its pension plans of up to approximately $ 50 million in 2019 based on current tax law. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension plan assets, or changes in interest rates. Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately $60 million in 2019. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on postretirement plan assets. Estimated future benefit payments at December 31, 2018 were as follows: (in millions) Pension Postretirement 2019 $ 484 $ 132 2020 464 130 2021 468 129 2022 470 129 2023 474 125 2024-2028 2,362 598 Comprehensive Earnings/Losses The amounts recorded in accumulated other comprehensive losses at December 31, 2018 consisted of the following: (in millions) Pension Post- retirement Post- employment Total Net loss $ (2,591 ) $ (327 ) $ (78 ) $ (2,996 ) Prior service (cost) credit (34 ) 108 (6 ) 68 Deferred income taxes 679 61 20 760 Amounts recorded in accumulated other comprehensive losses $ (1,946 ) $ (158 ) $ (64 ) $ (2,168 ) The amounts recorded in accumulated other comprehensive losses at December 31, 2017 consisted of the following: (in millions) Pension Post- retirement Post- employment Total Net loss $ (2,493 ) $ (612 ) $ (93 ) $ (3,198 ) Prior service (cost) credit (15 ) 195 — 180 Deferred income taxes 979 166 34 1,179 Amounts recorded in accumulated other comprehensive losses $ (1,529 ) $ (251 ) $ (59 ) $ (1,839 ) The movements in other comprehensive earnings/losses during the year ended December 31, 2018 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 225 $ 21 $ 17 $ 263 Prior service cost/credit 4 (42 ) — (38 ) Other expense: Net loss 13 — — 13 Prior service cost/credit 3 — — 3 Deferred income taxes (61 ) 4 (4 ) (61 ) $ 184 $ (17 ) $ 13 $ 180 Other movements during the year: Adoption of ASU 2018-02 (1) $ (330 ) $ (55 ) $ (12 ) $ (397 ) Net loss (336 ) 264 (2 ) (74 ) Prior service cost/credit (26 ) (45 ) (6 ) (77 ) Deferred income taxes 91 (54 ) 2 39 $ (601 ) $ 110 $ (18 ) $ (509 ) Total movements in other comprehensive earnings/losses $ (417 ) $ 93 $ (5 ) $ (329 ) (1) Reflects the reclassification of the stranded income tax effects of the Tax Reform Act. For further discussion, see Note 15 . Income Taxes . The movements in other comprehensive earnings/losses during the year ended December 31, 2017 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 197 $ 25 $ 17 $ 239 Prior service cost/credit 4 (38 ) — (34 ) Other expense: Net loss 86 — — 86 Deferred income taxes (113 ) 6 (6 ) (113 ) $ 174 $ (7 ) $ 11 $ 178 Other movements during the year: Net loss $ 81 $ (56 ) $ (11 ) $ 14 Prior service cost/credit — 38 — 38 Deferred income taxes (32 ) 7 4 (21 ) $ 49 $ (11 ) $ (7 ) $ 31 Total movements in other comprehensive earnings/losses $ 223 $ (18 ) $ 4 $ 209 The movements in other comprehensive earnings/losses during the year ended December 31, 2016 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 171 $ 25 $ 18 $ 214 Prior service cost/credit 5 (39 ) — (34 ) Other expense (income): Net loss 9 — — 9 Prior service cost/credit 2 (13 ) — (11 ) Deferred income taxes (69 ) 11 (7 ) (65 ) $ 118 $ (16 ) $ 11 $ 113 Other movements during the year: Net loss $ (232 ) $ (18 ) $ (9 ) $ (259 ) Prior service cost/credit (4 ) 16 — 12 Deferred income taxes 92 1 3 96 $ (144 ) $ (1 ) $ (6 ) $ (151 ) Total movements in other comprehensive earnings/losses $ (26 ) $ (17 ) $ 5 $ (38 )

Additional Information

Additional Information	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Additional Information	Additional Information For the Years Ended December 31, (in millions) 2018 2017 2016 Research and development expense $ 252 $ 241 $ 203 Advertising expense $ 37 $ 29 $ 27 Interest and other debt expense, net: Interest expense $ 697 $ 727 $ 754 Interest income (32 ) (31 ) (13 ) Interest related to NPM Adjustment Items — 9 6 $ 665 $ 705 $ 747 Rent expense $ 42 $ 43 $ 53 Minimum rental commitments and sublease income under non-cancelable operating leases in effect at December 31, 2018 were as follows: (in millions) Rental Commitments Sublease Income 2019 $ 41 $ 5 2020 35 5 2021 31 5 2022 24 5 2023 17 5 Thereafter 34 2 $ 182 $ 27 The activity in the allowance for discounts and allowance for returned goods for the years ended December 31, 2018 , 2017 and 2016 was as follows: (in millions) 2018 2017 2016 Discounts Returned Goods Discounts Returned Goods Discounts Returned Goods Balance at beginning of year $ — $ 40 $ — $ 49 $ — $ 68 Charged to costs and expenses 620 97 626 130 628 133 Deductions (1) (620 ) (105 ) (626 ) (139 ) (628 ) (152 ) Balance at end of year $ — $ 32 $ — $ 40 $ — $ 49 (1) Represents the recording of discounts and returns for which allowances were created. The activity in the allowance for losses on finance assets for the years ended December 31, 2018 , 2017 and 2016 was as follows: (in millions) 2018 2017 2016 Balance at beginning of year $ 23 $ 32 $ 42 Decrease to allowance (4 ) (9 ) (10 ) Balance at end of year $ 19 $ 23 $ 32

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and its subsidiaries, including PM USA and UST and its subsidiaries, as well as their respective indemnitees. Various types of claims may be raised in these proceedings, including product liability, consumer protection, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors. Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases. An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation. Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. In certain cases, plaintiffs claim that defendants’ liability is joint and several. In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts. Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries may also be required to pay interest and attorneys’ fees. Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases. This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all. As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida’s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well. Such challenges may include the applicability of state bond caps in federal court. States, including Florida, may also seek to repeal or alter bond cap statutes through legislation. Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges. Altria and its subsidiaries record provisions in the consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 19 Contingencies : (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending tobacco-related cases; and (iii) accordingly, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any. Litigation defense costs are expensed as incurred. Altria and its subsidiaries have achieved substantial success in managing litigation. Nevertheless, litigation is subject to uncertainty and significant challenges remain. It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. Each of the companies has defended, and will continue to defend, vigorously against litigation challenges. However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so. Overview of Altria and/or PM USA Tobacco-Related Litigation Types and Number of Cases: Claims related to tobacco products generally fall within the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including cases in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding; (iii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iv) class action suits alleging that the uses of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of the Racketeer Influenced and Corrupt Organizations Act (“RICO”); and (v) other tobacco-related litigation described below. Plaintiffs’ theories of recovery and the defenses raised in pending smoking and health, health care cost recovery and “Lights/Ultra Lights” cases are discussed below. The table below lists the number of certain tobacco-related cases pending in the United States against PM USA and, in some instances, Altria as of December 31, 2018, 2017 and 2016: 2018 2017 2016 Individual Smoking and Health Cases (1) 100 92 70 Smoking and Health Class Actions and Aggregated Claims Litigation (2) 2 4 5 Health Care Cost Recovery Actions (3) 1 1 1 “Lights/Ultra Lights” Class Actions 2 3 8 (1) Includes 30 cases filed in Massachusetts and 37 non- Engle cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the Engle case (these Engle progeny cases are discussed below in Smoking and Health Litigation - Engle Class Action ). Also does not include 1,490 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 ( Broin ). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, 923 of these cases were voluntarily dismissed without prejudice. (2) The 2016 and 2017 pending cases include as one case the 30 civil actions that were to be tried in six consolidated trials in West Virginia ( In re: Tobacco Litigation ). PM USA was a defendant in nine of the 30 cases. The parties resolved these cases for an immaterial amount, and in the second quarter of 2018, the court dismissed all 30 cases. (3) See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below. International Tobacco-Related Cases: As of January 29, 2019, PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant. PM USA and Altria are also named defendants in seven smoking and health class actions filed in various Canadian provinces. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (“PMI”) that provides for indemnities for certain liabilities concerning tobacco products. Tobacco-Related Cases Set for Trial: As of January 29, 2019, 10 Engle progeny cases are set for trial through March 31, 2019. In addition, there are no individual smoking and health cases against PM USA set for trial during this period. Cases against other companies in the tobacco industry may also be scheduled for trial during this period. Trial dates are subject to change. Trial Results: Since January 1999, excluding the Engle progeny cases (separately discussed below), verdicts have been returned in 65 smoking and health, “Lights/Ultra Lights” and health care cost recovery cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 43 of the 65 cases. These 43 cases were tried in Alaska ( 1 ), California ( 7 ), Connecticut ( 1 ), Florida ( 10 ), Louisiana ( 1 ), Massachusetts ( 3 ), Mississippi ( 1 ), Missouri ( 4 ), New Hampshire ( 1 ), New Jersey ( 1 ), New York ( 5 ), Ohio ( 2 ), Pennsylvania ( 1 ), Rhode Island ( 1 ), Tennessee ( 2 ) and West Virginia ( 2 ). A motion for a new trial was granted in one of the cases in Florida and in the case in Alaska. In the Alaska case ( Hunter ), the jury returned a verdict in favor of PM USA in April 2018 in the third trial of this case. In May 2018, plaintiff filed a motion for a new trial, which the court denied. Of the 22 non- Engle progeny cases in which verdicts were returned in favor of plaintiffs, 19 have reached final resolution. See Smoking and Health Litigation - Engle Progeny Trial Results below for a discussion of verdicts in state and federal Engle progeny cases involving PM USA as of January 29, 2019. Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation): After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid in the aggregate judgments and settlements (including related costs and fees) totaling approximately $578 million and interest totaling approximately $195 million as of December 31, 2018. These amounts include payments for Engle progeny judgments (and related costs and fees) totaling approximately $186 million , interest totaling approximately $33 million and payment of approximately $43 million in connection with the Federal Engle Agreement, discussed below. The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows: (in millions) 2018 2017 2016 Accrued liability for tobacco and health litigation items at beginning of year (1) $ 106 $ 47 $ 132 Pre-tax charges for: Tobacco and health litigation 113 72 88 Related interest costs 18 8 17 Payments (1) (125 ) (21 ) (190 ) Accrued liability for tobacco and health litigation items at end of year (1) $ 112 $ 106 $ 47 (1) Includes amounts related to the costs of implementing the corrective communications remedy related to the Federal Government’s Lawsuit discussed below. The accrued liability for tobacco and health litigation items, including related interest costs, was included in liabilities on Altria’s consolidated balance sheets. Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria’s consolidated statements of earnings. Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria’s consolidated statements of earnings. Security for Judgments: To obtain stays of judgments pending appeal, PM USA has posted various forms of security. As of December 31, 2018 , PM USA has posted appeal bonds totaling approximately $100 million , which have been collateralized with restricted cash that are included in assets on the consolidated balance sheet. Smoking and Health Litigation Overview: Plaintiffs’ allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of deceptive trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes. Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act. Non- Engle Progeny Litigation: Summarized below are the non- Engle progeny smoking and health cases pending during 2018 in which a verdict was returned in favor of plaintiff and against PM USA. Charts listing certain verdicts for plaintiffs in the Engle progeny cases can be found in Smoking and Health Litigation - Engle Progeny Trial Results below. Capone : In December 2018, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding $225,000 in compensatory damages. Gentile : In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA (an amount of approximately $5.3 million ). In April 2018, the trial court entered final judgment in favor of plaintiff and PM USA posted a bond in the amount of approximately $8 million . In May 2018, PM USA filed a notice of appeal to the Florida Fourth District Court of Appeal. Bullock : In December 2015, a jury in the U.S. District Court for the Central District of California returned a verdict in favor of plaintiff, awarding $900,000 in compensatory damages. On appeal, the U.S. Court of Appeals for the Ninth Circuit affirmed the judgment. In the fourth quarter of 2017, PM USA recorded a provision on its consolidated balance sheet of approximately $1 million for the judgment, interest and associated costs. In the first quarter of 2018, PM USA paid this amount, concluding this litigation. Federal Government’s Lawsuit : See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case. Engle Class Action: In July 2000, in the second phase of the Engle smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA. Following entry of judgment, PM USA appealed. In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class. Plaintiffs petitioned the Florida Supreme Court for further review. In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate. The court further declared the following Phase I findings are entitled to res judicata effect in such individual actions brought within one year of the issuance of the mandate: (i) that smoking causes various diseases; (ii) that nicotine in cigarettes is addictive; (iii) that defendants’ cigarettes were defective and unreasonably dangerous; (iv) that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v) that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi) that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii) that all defendants sold or supplied cigarettes that were defective; and (viii) that defendants were negligent. In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion. In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to res judicata effect by excluding finding (v) listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants. In January 2007, the Florida Supreme Court issued the mandate from its revised opinion. In May 2007, defendants filed a petition for writ of certiorari with the United States Supreme Court, which was denied. In February 2008, the trial court decertified the class. Engle Progeny Cases: The deadline for filing Engle progeny cases expired in January 2008. As of January 29, 2019, approximately 2,100 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 3,000 state court plaintiffs. Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates. While the Federal Engle Agreement (discussed below) resolved nearly all Engle progeny cases pending in federal court, as of January 29, 2019, approximately seven cases were pending against PM USA in federal court representing the cases excluded from that agreement. Agreement to Resolve Federal Engle Progeny Cases: In 2015, PM USA, R.J. Reynolds Tobacco Company (“R.J. Reynolds”) and Lorillard Tobacco Company (“Lorillard”) resolved approximately 415 pending federal Engle progeny cases (the “Federal Engle Agreement”). Federal cases that were in trial and those that previously reached final verdict were not included in the Federal Engle Agreement. Engle Progeny Trial Results: As of January 29, 2019, 126 federal and state Engle progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court Engle decision. Sixty-nine verdicts were returned in favor of plaintiffs and seven verdicts ( Skolnick , Calloway , McCoy , Duignan , Caprio, Oshinsky-Blacker and McCall ) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending. Skolnick was remanded for a new trial on plaintiff’s concealment and conspiracy claims; Calloway was reversed and remanded for a new trial on an appellate finding that improper arguments by plaintiff’s counsel deprived defendants of a fair trial; McCoy was reversed and remanded for a new trial on an appellate finding that the trial court erred in admitting certain materials into evidence that deprived defendants of a fair trial; Duignan was reversed and remanded for a new trial on an appellate finding that the trial judge erred in responding to a question from the jury during deliberations; Caprio was reversed post-trial after defendants agreed to voluntarily dismiss their appeal in exchange for a full retrial; Oshinsky-Blacker was reversed post-trial based on plaintiff’s counsel’s improper arguments at trial; and McCall was reversed based on an appellate finding that the trial judge erred in instructing the jury on the warning labels on cigarette packs. Forty-seven verdicts were returned in favor of PM USA, of which 39 were state cases. In addition, there have been a number of mistrials, only some of which have resulted in new trials as of January 29, 2019. Three verdicts ( D. Cohen , Collar , and Chacon ) that were returned in favor of PM USA were subsequently reversed for new trials. Juries in two cases ( Reider and Banks ) returned zero damages verdicts in favor of PM USA . Juries in two other cases ( Weingart and Hancock ) returned verdicts against PM USA awarding no damages, but the trial court in each case granted an additur . One case, Pollari , resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff. Florida’s Fourth District Court of Appeal reversed the verdict in favor of plaintiff. Plaintiff petitioned the Florida Supreme Court to review the District Court of Appeal’s decision, but subsequently dismissed their petition. The charts below list the verdicts and post-trial developments in certain Engle progeny cases in which verdicts were returned in favor of plaintiffs. The first chart lists such cases that are pending as of January 29, 2019 where PM USA has recorded a provision in its consolidated financial statements because an unfavorable outcome is probable and the amount of the loss can be reasonably estimated; the second chart lists other such cases that are pending as of January 29, 2019 but where an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated; the third chart lists other such cases that have concluded within the previous 12 months. Unless otherwise noted for a particular case, the jury’s award for compensatory damages will not be reduced by any finding of plaintiff’s comparative fault (see Engle Progeny Appellate Issues below for a discussion of the Florida Supreme Court’s decision in Schoeff ). Further, the damages noted reflect adjustments based on post-trial or appellate rulings. Currently Pending Engle Cases with Accrued Liabilities (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Compensatory Damages (All Defendants) Punitive Damages (PM USA) Appeal Status Accrual (1) Berger ( Cote ) September 2014 PM USA Federal Court - Middle District of Florida $6 million $21 million The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court. PM USA intends to challenge the punitive damages award. $6 million accrual in the fourth quarter of 2018 McKeever February 2015 PM USA Broward $6 million $12 million Fourth District Court of Appeal reduced compensatory damages; Florida Supreme Court remanded case to reinstate full compensatory damages award; PM USA’s petition for review by the U.S. Supreme Court is pending. $20 million accrual in fourth quarter of 2017 Pardue December 2016 PM USA and R.J. Reynolds Alachua $5 million $7 million First District Court of Appeal affirmed the judgment; defendants’ petition for review by the U.S. Supreme Court is pending. $10 million accrual ($9 million in second quarter of 2018 and $1 million in third quarter of 2018) Jordan August 2015 PM USA Duval $6 million $3 million First District Court of Appeal affirmed the judgment; PM USA’s petition for review by the U.S. Supreme Court is pending. $11 million accrual in second quarter of 2018 M. Brown May 2015 PM USA Duval $6 million $0 First District Court of Appeal affirmed the judgment; PM USA’s petition for review by the U.S. Supreme Court is pending. Trial court awarded plaintiff approximately $7 million in attorneys’ fees. PM USA filed a motion for rehearing. $7 million accrual in second quarter of 2018 Boatright November 2014 PM USA and Liggett Group LLC (“Liggett Group”) Polk $15 million $20 million Florida Supreme Court upheld the full amount of the trial court judgment without a reduction for plaintiff’s comparative fault and denied PM USA’s request for reconsideration; defendants’ petition for review by the U.S. Supreme Court is pending. $41 million accrual in second quarter of 2018 Searcy April 2013 PM USA and R.J. Reynolds Federal Court - Middle District of Florida <$1 million $2 million U.S. Court of Appeals for the Eleventh Circuit affirmed the judgment; defendants’ petition for review by the U.S. Supreme Court is pending. $2 million accrual in third quarter of 2018 (1) Accrual amounts include interest and associated costs if applicable. For cases with multiple defendants, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff’s favor after taking into account any portion potentially payable by the other defendant(s). Other Currently Pending Engle Cases with Verdicts Against PM USA (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Compensatory Damages (1) Punitive Damages Appeal Status Chadwell September 2018 PM USA Miami-Dade $2 million $0 Trial court denied post-trial motions. PM USA intends to appeal the trial court decision. Kaplan July 2018 PM USA and R.J. Reynolds Broward $2 million $2 million Appeals by plaintiff and defendants to Fourth District Court of Appeal pending. Landi June 2018 PM USA and R.J. Reynolds Broward $8 million $5 million Appeals by plaintiff and defendants to Fourth District Court of Appeal pending. Theis May 2018 PM USA and R.J. Reynolds Sarasota $7 million $10 million Defendants’ appeal to Second District Court of Appeal pending. Freeman March 2018 PM USA Alachua $4 million $0 Defendant’s appeal to First District Court of Appeal pending. Gloger February 2018 PM USA and R.J. Reynolds Miami-Dade $8 million $5 million Defendants’ appeal to Third District Court of Appeal pending. Bryant December 2017 PM USA Escambia <$1 million <$1 million Defendant’s appeal to First District Court of Appeal pending. R. Douglas November 2017 PM USA Duval <$1 million $0 Awaiting entry of final judgment by the trial court. Wallace October 2017 PM USA and R.J. Reynolds Brevard $12 million $16 million Appeals by plaintiff and defendants to Fifth District Court of Appeal pending. L. Martin May 2017 PM USA Miami-Dade $1 million $1 million Appeals by plaintiff and defendant to Third District Court of Appeal pending. Sommers April 2017 PM USA Miami-Dade $1 million $0 New trial ordered on punitive damages; appeals by plaintiff and defendant to Third District Court of Appeal pending. Santoro March 2017 PM USA, R.J. Reynolds and Liggett Group Broward $2 million $0 Trial court set aside punitive damages award; appeals by plaintiff and defendants to Fourth District Court of Appeal pending. J. Brown February 2017 PM USA and R.J. Reynolds Pinellas $5 million <$1 million Second District Court of Appeals issued a per curiam affirmance of the judgment; defendants’ motion for a written opinion pending. S. Martin November 2016 PM USA and R.J. Reynolds Broward $5 million $0 Fourth District Court of Appeal vacated the punitive damages and reinstated the entire compensatory damages award. Danielson November 2015 PM USA Escambia $3 million <$1 million Appeals by plaintiff and defendant to First District Court of Appeal pending. Cooper September 2015 PM USA and R.J. Reynolds Broward $5 million $0 Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages. McCoy July 2015 PM USA, Broward $2 million $3 million Fourth District Court of Appeal reversed judgment and ordered a new trial; plaintiff requested review by the Florida Supreme Court; case stayed pending decision in Pollari , discussed above. D. Brown January 2015 PM USA Federal Court - Middle District of Florida $8 million $9 million Appeal to U.S. Court of Appeals for the Eleventh Circuit stayed pending final disposition in the Searcy case, discussed below. Other Currently Pending Engle Cases with Verdicts Against PM USA (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Compensatory Damages (1) Punitive Damages Appeal Status Kerrivan October 2014 PM USA and R.J. Reynolds Federal Court - Middle District of Florida $16 million $16 million Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending. Harris July 2014 PM USA, Federal Court - Middle District of Florida $2 million $0 Post-trial motions pending. Skolnick June 2013 PM USA and R.J. Reynolds Palm Beach $0 $0 Fourth District Court of Appeal reversed compensatory damages award, ruled in favor of defendants on strict liability and negligence claims and remanded conspiracy and concealment claims for a new trial. Currently pending limited retrial. (1) PM USA’s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. Engle Cases Concluded Within Past 12 Months (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Accrual Date Payment Amount (if any) Payment Date Boulter December 2018 PM USA and Lee Fourth quarter of 2018 <$1 million January 2019 Simon September 2018 PM USA and Broward Fourth quarter of 2018 <$1 million October 2018 Perrotto November 2014 PM USA, Palm Beach Third quarter of 2018 $1 million September 2018 Gore March 2015 PM USA and Indian River First quarter of 2018 $1 million September 2018 Putney April 2010 PM USA, Broward Third quarter of 2018 $5 million September 2018 Sermons July 2016 PM USA and Duval Third quarter of 2018 <$1 million August 2018 Tognoli November 2015 PM USA Broward Fourth quarter of 2017 $1 million May 2018 Howles November 2016 PM USA and Broward First quarter of 2018 $6 million May 2018 Purdo April 2016 PM USA and Palm Beach First quarter of 2018 $10 million May 2018 Griffin June 2014 PM USA Federal Court - Middle District of Florida Second quarter of 2017 $1 million May 2018 Ledoux December 2015 PM USA and Miami-Dade Fourth quarter of 2017 $20 million May 2018 Burkhart May 2014 PM USA, Federal Court - Middle District of Florida Second quarter of 2018 $2 million May 2018 Barbose November 2015 PM USA and Pasco Fourth quarter of 2017 $12 million May 2018 Allen November 2014 PM USA and Duval First quarter of 2018 $10 million May 2018 Engle Cases Concluded Within Past 12 Months (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Accrual Date Payment Amount (if any) Payment Date Ahrens February 2016 PM USA and Pinellas Fourth quarter of 2017 $7 million May 2018 Starr-Blundell June 2013 PM USA and Duval First quarters of 2016 and 2018 <$1 million March 2018 Zamboni February 2015 PM USA and Federal Court - Middle District of Florida First quarter of 2018 <$1 million March 2018 Graham May 2013 PM USA and Federal Court - Middle District of Florida Second quarter of 2017 $1 million January 2018 Naugle November 2009 PM USA Broward Second quarter of 2017 $14 million January 2018 Lourie October 2014 PM USA, Hillsborough Second quarter of 2017 $3 million January 2018 Marchese October 2015 PM USA and Broward Fourth quarter of 2017 $1 million January 2018 ________________________________________________________________________________________________________________________________________ Engle Progeny Appellate Issues: In Douglas , an Engle progeny case against PM USA and R.J. Reynolds, in March 2012, the Florida Second District Court of Appeal issued a decision affirming the judgment of the trial court in favor of the plaintiff and upholding the use of the Engle jury findings with respect to strict liability claims but certified to the Florida Supreme Court the question of whether granting res judicata effect to the Engle jury findings violates defendants’ federal due process rights. In March 2013, the Florida Supreme Court affirmed the final judgment entered in favor of plaintiff upholding the use of the Engle jury findings with respect to strict liability and negligence claims. PM USA’s subsequent petition for writ of certiorari with the United States Supreme Court was unsuccessful. In Graham , an Engle progeny case against PM USA and R.J. Reynolds, in April 2015, the U.S. Court of Appeals for the Eleventh Circuit found in favor of defendants on the basis of federal preemption, reversing the trial court’s denial of judgment as a matter of law. Thereafter, plaintiff filed a petition for rehearing en banc , which the E

Condensed Consolidating Financi

Condensed Consolidating Financial Information	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Financial Information	Condensed Consolidating Financial Information PM USA, which is a 100% owned subsidiary of Altria, has guaranteed Altria’s obligations under its outstanding debt securities, borrowings under the Borrowing Agreements and amounts outstanding under its commercial paper program (the “Guarantees”). Pursuant to the Guarantees, PM USA fully and unconditionally guarantees, as primary obligor, the payment and performance of Altria’s obligations under the guaranteed debt instruments (the “Obligations”), subject to release under certain customary circumstances as noted below. The Guarantees provide that PM USA guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations. The liability of PM USA under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, Altria or PM USA. The obligations of PM USA under the Guarantees are limited to the maximum amount as will not result in PM USA’s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of PM USA that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees. For this purpose, “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors. PM USA will be unconditionally released and discharged from the Obligations upon the earliest to occur of: ▪ the date, if any, on which PM USA consolidates with or merges into Altria or any successor; ▪ the date, if any, on which Altria or any successor consolidates with or merges into PM USA; ▪ the payment in full of the Obligations pertaining to such Guarantees; and ▪ the rating of Altria’s long-term senior unsecured debt by Standard & Poor’s of A or higher. At December 31, 2018 , the respective principal 100% owned subsidiaries of Altria and PM USA were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests. The following sets forth the condensed consolidating balance sheets as of December 31, 2018 and 2017 , condensed consolidating statements of earnings and comprehensive earnings for the years ended December 31, 2018 , 2017 and 2016 , and condensed consolidating statements of cash flows for the years ended December 31, 2018 , 2017 and 2016 for Altria, PM USA and, collectively, Altria’s other subsidiaries that are not guarantors of Altria’s debt instruments (the “Non-Guarantor Subsidiaries”). The financial information may not necessarily be indicative of results of operations or financial position had PM USA and the Non-Guarantor Subsidiaries operated as independent entities. Altria and PM USA account for investments in their subsidiaries under the equity method of accounting. Condensed Consolidating Balance Sheets (in millions of dollars) ____________________________ at December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Assets Cash and cash equivalents $ 1,277 $ — $ 56 $ — $ 1,333 Receivables — 18 124 — 142 Inventories: Leaf tobacco — 561 379 — 940 Other raw materials — 123 63 — 186 Work in process — 2 645 — 647 Finished product — 128 430 — 558 — 814 1,517 — 2,331 Due from Altria and subsidiaries 46 3,828 1,194 (5,068 ) — Income taxes 100 94 — (27 ) 167 Other current assets 41 167 118 — 326 Total current assets 1,464 4,921 3,009 (5,095 ) 4,299 Property, plant and equipment, at cost — 2,928 2,022 — 4,950 Less accumulated depreciation — 2,111 901 — 3,012 — 817 1,121 — 1,938 Goodwill — — 5,196 — 5,196 Other intangible assets, net — 2 12,277 — 12,279 Investment in AB InBev 17,696 — — — 17,696 Investment in JUUL — — 12,800 — 12,800 Investment in consolidated subsidiaries 25,996 2,825 — (28,821 ) — Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 193 955 952 (670 ) 1,430 Total Assets $ 50,139 $ 9,520 $ 35,355 $ (39,376 ) $ 55,638 Condensed Consolidating Balance Sheets (Continued) (in millions of dollars) ____________________________ at December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Liabilities Short-term borrowings $ 12,704 $ — $ — $ — $ 12,704 Current portion of long-term debt 1,144 — — — 1,144 Accounts payable 1 91 307 — 399 Accrued liabilities: Marketing — 483 103 — 586 Employment costs 16 11 162 — 189 Settlement charges — 3,448 6 — 3,454 Other 279 513 449 (27 ) 1,214 Dividends payable 1,503 — — — 1,503 Due to Altria and subsidiaries 4,499 407 162 (5,068 ) — Total current liabilities 20,146 4,953 1,189 (5,095 ) 21,193 Long-term debt 11,898 — — — 11,898 Deferred income taxes 3,010 — 2,832 (670 ) 5,172 Accrued pension costs 187 — 357 — 544 Accrued postretirement health care costs — 1,072 677 — 1,749 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 111 47 96 — 254 Total liabilities 35,352 6,072 9,941 (10,555 ) 40,810 Contingencies Redeemable noncontrolling interest — — 39 — 39 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,961 3,310 25,047 (28,357 ) 5,961 Earnings reinvested in the business 43,962 359 2,201 (2,560 ) 43,962 Accumulated other comprehensive losses (2,547 ) (221 ) (1,884 ) 2,105 (2,547 ) Cost of repurchased stock (33,524 ) — — — (33,524 ) Total stockholders’ equity attributable to Altria 14,787 3,448 25,373 (28,821 ) 14,787 Noncontrolling interests — — 2 — 2 Total stockholders’ equity 14,787 3,448 25,375 (28,821 ) 14,789 Total Liabilities and Stockholders’ Equity $ 50,139 $ 9,520 $ 35,355 $ (39,376 ) $ 55,638 Condensed Consolidating Balance Sheets (in millions of dollars) ____________________________ at December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Assets Cash and cash equivalents $ 1,203 $ 1 $ 49 $ — $ 1,253 Receivables 1 10 131 — 142 Inventories: Leaf tobacco — 579 362 — 941 Other raw materials — 111 59 — 170 Work in process — 5 555 — 560 Finished product — 128 426 — 554 — 823 1,402 — 2,225 Due from Altria and subsidiaries 2 2,413 1,022 (3,437 ) — Income taxes — 542 17 (98 ) 461 Other current assets 11 147 105 — 263 Total current assets 1,217 3,936 2,726 (3,535 ) 4,344 Property, plant and equipment, at cost — 2,930 1,949 — 4,879 Less accumulated depreciation — 2,086 879 — 2,965 — 844 1,070 — 1,914 Goodwill — — 5,307 — 5,307 Other intangible assets, net — 2 12,398 — 12,400 Investment in AB InBev 17,952 — — — 17,952 Investment in consolidated subsidiaries 13,111 2,818 — (15,929 ) — Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 34 671 1,056 (476 ) 1,285 Total Assets $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202 Condensed Consolidating Balance Sheets (Continued) (in millions of dollars) ____________________________ at December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Liabilities Current portion of long-term debt $ 864 $ — $ — $ — $ 864 Accounts payable 2 91 281 — 374 Accrued liabilities: Marketing — 578 117 — 695 Employment costs 21 14 153 — 188 Settlement charges — 2,437 5 — 2,442 Other 389 433 247 (98 ) 971 Dividends payable 1,258 — — — 1,258 Due to Altria and subsidiaries 3,040 317 80 (3,437 ) — Total current liabilities 5,574 3,870 883 (3,535 ) 6,792 Long-term debt 13,030 — — — 13,030 Deferred income taxes 2,809 — 2,914 (476 ) 5,247 Accrued pension costs 206 — 239 — 445 Accrued postretirement health care costs — 1,214 773 — 1,987 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 108 49 126 — 283 Total liabilities 21,727 5,133 9,725 (8,801 ) 27,784 Contingencies Redeemable noncontrolling interest — — 38 — 38 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,952 3,310 12,045 (15,355 ) 5,952 Earnings reinvested in the business 42,251 96 2,243 (2,339 ) 42,251 Accumulated other comprehensive losses (1,897 ) (268 ) (1,506 ) 1,774 (1,897 ) Cost of repurchased stock (31,864 ) — — — (31,864 ) Total stockholders’ equity attributable to Altria 15,377 3,138 12,791 (15,929 ) 15,377 Noncontrolling interests — — 3 — 3 Total stockholders’ equity 15,377 3,138 12,794 (15,929 ) 15,380 Total Liabilities and Stockholders’ Equity $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202 Condensed Consolidating Statements of Earnings and Comprehensive Earnings (in millions of dollars) _____________________________ for the year ended December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 21,422 $ 3,980 $ (38 ) $ 25,364 Cost of sales — 6,153 1,258 (38 ) 7,373 Excise taxes on products — 5,517 220 — 5,737 Gross profit — 9,752 2,502 — 12,254 Marketing, administration and research costs 219 1,892 645 — 2,756 Asset impairment and exit costs — 81 302 — 383 Operating (expense) income (219 ) 7,779 1,555 — 9,115 Interest and other debt expense (income), net 511 (61 ) 215 — 665 Net periodic benefit cost (income), excluding service cost 16 (41 ) (9 ) — (34 ) Earnings from equity investment in AB InBev (890 ) — — — (890 ) Loss on AB InBev/SABMiller business combination 33 — — — 33 Earnings before income taxes and equity earnings of subsidiaries 111 7,881 1,349 — 9,341 Provision for income taxes 36 1,980 358 — 2,374 Equity earnings of subsidiaries 6,888 402 — (7,290 ) — Net earnings 6,963 6,303 991 (7,290 ) 6,967 Net earnings attributable to noncontrolling interests — — (4 ) — (4 ) Net earnings attributable to Altria $ 6,963 $ 6,303 $ 987 $ (7,290 ) $ 6,963 Net earnings $ 6,963 $ 6,303 $ 991 $ (7,290 ) $ 6,967 Other comprehensive (losses) earnings, net of deferred income taxes (242 ) 104 (54 ) (50 ) (242 ) Comprehensive earnings 6,721 6,407 937 (7,340 ) 6,725 Comprehensive earnings attributable to noncontrolling interests — — (4 ) — (4 ) Comprehensive earnings attributable to Altria $ 6,721 $ 6,407 $ 933 $ (7,340 ) $ 6,721 Condensed Consolidating Statements of Earnings and Comprehensive Earnings (in millions of dollars) _____________________________ for the year ended December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 21,826 $ 3,787 $ (37 ) $ 25,576 Cost of sales — 6,394 1,174 (37 ) 7,531 Excise taxes on products — 5,864 218 — 6,082 Gross profit — 9,568 2,395 — 11,963 Marketing, administration and research costs 161 1,713 464 — 2,338 Asset impairment and exit costs — — 32 — 32 Operating (expense) income (161 ) 7,855 1,899 — 9,593 Interest and other debt expense (income), net 510 (20 ) 215 — 705 Net periodic benefit cost, excluding service cost 12 18 7 — 37 Earnings from equity investment in AB InBev (532 ) — — — (532 ) Gain on AB InBev/SABMiller business combination (445 ) — — — (445 ) Earnings before income taxes and equity earnings of subsidiaries 294 7,857 1,677 — 9,828 (Benefit) provision for income taxes (2,624 ) 3,127 (902 ) — (399 ) Equity earnings of subsidiaries 7,304 558 — (7,862 ) — Net earnings 10,222 5,288 2,579 (7,862 ) 10,227 Net earnings attributable to noncontrolling interests — — (5 ) — (5 ) Net earnings attributable to Altria $ 10,222 $ 5,288 $ 2,574 $ (7,862 ) $ 10,222 Net earnings $ 10,222 $ 5,288 $ 2,579 $ (7,862 ) $ 10,227 Other comprehensive earnings, net of deferred income taxes 155 3 214 (217 ) 155 Comprehensive earnings 10,377 5,291 2,793 (8,079 ) 10,382 Comprehensive earnings attributable to noncontrolling interests — — (5 ) — (5 ) Comprehensive earnings attributable to Altria $ 10,377 $ 5,291 $ 2,788 $ (8,079 ) $ 10,377 Condensed Consolidating Statements of Earnings and Comprehensive Earnings (in millions of dollars) _____________________________ for the year ended December 31, 2016 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 22,146 $ 3,633 $ (35 ) $ 25,744 Cost of sales — 6,641 1,159 (35 ) 7,765 Excise taxes on products — 6,187 220 — 6,407 Gross profit — 9,318 2,254 — 11,572 Marketing, administration and research costs 160 2,009 493 — 2,662 Asset impairment and exit costs 5 77 67 — 149 Operating (expense) income (165 ) 7,232 1,694 — 8,761 Interest and other debt expense, net 519 10 218 — 747 Loss on early extinguishment of debt 823 — — — 823 Net periodic benefit cost (income), excluding service cost 5 (6 ) — — (1 ) Earnings from equity investment in SABMiller (795 ) — — — (795 ) Gain on AB InBev/SABMiller business combination (13,865 ) — — — (13,865 ) Earnings before income taxes and equity earnings of subsidiaries 13,148 7,228 1,476 — 21,852 Provision for income taxes 4,453 2,631 524 — 7,608 Equity earnings of subsidiaries 5,544 268 — (5,812 ) — Net earnings 14,239 4,865 952 (5,812 ) 14,244 Net earnings attributable to noncontrolling interests — — (5 ) — (5 ) Net earnings attributable to Altria $ 14,239 $ 4,865 $ 947 $ (5,812 ) $ 14,239 Net earnings $ 14,239 $ 4,865 $ 952 $ (5,812 ) $ 14,244 Other comprehensive earnings (losses), net of deferred income taxes 1,228 (16 ) (28 ) 44 1,228 Comprehensive earnings 15,467 4,849 924 (5,768 ) 15,472 Comprehensive earnings attributable to noncontrolling interests — — (5 ) — (5 ) Comprehensive earnings attributable to Altria $ 15,467 $ 4,849 $ 919 $ (5,768 ) $ 15,467 Condensed Consolidating Statements of Cash Flows (in millions of dollars) _____________________________ for the year ended December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 6,907 $ 7,580 $ 1,354 $ (7,450 ) $ 8,391 Cash Provided by (Used in) Investing Activities Capital expenditures — (57 ) (181 ) — (238 ) Acquisitions of businesses and assets — — (15 ) — (15 ) Investment in JUUL — — (12,800 ) — (12,800 ) Proceeds from finance assets — — 37 — 37 Proceeds from derivative financial instruments 35 — — — 35 Investment in consolidated subsidiaries (13,003 ) — — 13,003 — Other, net — — (7 ) — (7 ) Net cash provided by (used in) investing activities (12,968 ) (57 ) (12,966 ) 13,003 (12,988 ) Cash Provided by (Used in) Financing Activities Proceeds from short-term borrowings 12,800 — — — 12,800 Long-term debt repaid (864 ) — — — (864 ) Repurchases of common stock (1,673 ) — — — (1,673 ) Dividends paid on common stock (5,415 ) — — — (5,415 ) Changes in amounts due to/from Altria and subsidiaries 1,415 (1,388 ) 12,976 (13,003 ) — Cash dividends paid to parent — (6,097 ) (1,353 ) 7,450 — Other (128 ) — (4 ) — (132 ) Net cash (used in) provided by financing activities 6,135 (7,485 ) 11,619 (5,553 ) 4,716 Cash, cash equivalents and restricted cash (1) : Increase 74 38 7 — 119 Balance at beginning of year 1,203 62 49 — 1,314 Balance at end of year $ 1,277 $ 100 $ 56 $ — $ 1,433 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 19 . Contingencies . Condensed Consolidating Statements of Cash Flows (in millions of dollars) _____________________________ for the year ended December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 6,910 $ 4,028 $ 841 $ (6,878 ) $ 4,901 Cash Provided by (Used in) Investing Activities Capital expenditures — (34 ) (165 ) — (199 ) Acquisitions of businesses and assets — — (415 ) — (415 ) Proceeds from finance assets — — 133 — 133 Investment in consolidated subsidiaries (460 ) — — 460 — Other, net (5 ) 4 15 — 14 Net cash used in investing activities (465 ) (30 ) (432 ) 460 (467 ) Cash Provided by (Used in) Financing Activities Repurchases of common stock (2,917 ) — — — (2,917 ) Dividends paid on common stock (4,807 ) — — — (4,807 ) Changes in amounts due to/from Altria and subsidiaries (1,999 ) 1,410 1,049 (460 ) — Cash dividends paid to parent — (5,429 ) (1,449 ) 6,878 — Other (40 ) — (7 ) — (47 ) Net cash used in financing activities (9,763 ) (4,019 ) (407 ) 6,418 (7,771 ) Cash, cash equivalents and restricted cash (1) : (Decrease) increase (3,318 ) (21 ) 2 — (3,337 ) Balance at beginning of year 4,521 83 47 — 4,651 Balance at end of year $ 1,203 $ 62 $ 49 $ — $ 1,314 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 19 . Contingencies . Condensed Consolidating Statements of Cash Flows (in millions of dollars) _____________________________ for the year ended December 31, 2016 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 4,356 $ 5,143 $ 319 $ (5,992 ) $ 3,826 Cash Provided by (Used in) Investing Activities Capital expenditures — (45 ) (144 ) — (189 ) Acquisition of assets — — (45 ) — (45 ) Proceeds from finance assets — — 231 — 231 Proceeds from AB InBev/SABMiller business combination 4,773 — — — 4,773 Purchase of AB InBev ordinary shares (1,578 ) — — — (1,578 ) Proceeds from derivative financial instruments 510 — — — 510 Investment in consolidated subsidiaries (138 ) — — 138 — Other, net (3 ) — 9 — 6 Net cash provided by (used in) investing activities 3,564 (45 ) 51 138 3,708 Cash Provided by (Used in) Financing Activities Long-term debt issued 1,976 — — — 1,976 Long-term debt repaid (933 ) — — — (933 ) Repurchases of common stock (1,030 ) — — — (1,030 ) Dividends paid on common stock (4,512 ) — — — (4,512 ) Changes in amounts due to/from Altria and subsidiaries (392 ) (28 ) 558 (138 ) — Premiums and fees related to early extinguishment of debt (809 ) — — — (809 ) Cash dividends paid to parent — (5,064 ) (928 ) 5,992 — Other, net (12 ) — (9 ) — (21 ) Net cash used in financing activities (5,712 ) (5,092 ) (379 ) 5,854 (5,329 ) Cash, cash equivalents and restricted cash (1) : Increase (decrease) 2,208 6 (9 ) — 2,205 Balance at beginning of year 2,313 77 56 — 2,446 Balance at end of year $ 4,521 $ 83 $ 47 $ — $ 4,651 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 19 . Contingencies .

Quarterly Financial Data (Unaud

Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Data [Abstract]
Quarterly Financial Data (Unaudited)	Quarterly Financial Data (Unaudited) 2018 Quarters (in millions, except per share data) 1st 2nd 3rd 4th Net revenues $ 6,108 $ 6,305 $ 6,837 $ 6,114 Gross profit $ 2,936 $ 3,141 $ 3,255 $ 2,922 Net earnings $ 1,895 $ 1,877 $ 1,944 $ 1,251 Net earnings attributable to Altria $ 1,894 $ 1,876 $ 1,943 $ 1,250 Per share data: Basic EPS attributable to Altria $ 1.00 $ 0.99 $ 1.03 $ 0.67 Diluted EPS attributable to Altria $ 1.00 $ 0.99 $ 1.03 $ 0.66 2017 Quarters (in millions, except per share data) 1st 2nd 3rd 4th Net revenues $ 6,083 $ 6,663 $ 6,729 $ 6,101 Gross profit (1) $ 2,776 $ 3,114 $ 3,171 $ 2,902 Net earnings $ 1,402 $ 1,990 $ 1,867 $ 4,968 Net earnings attributable to Altria $ 1,401 $ 1,989 $ 1,866 $ 4,966 Per share data: Basic and diluted EPS attributable to Altria $ 0.72 $ 1.03 $ 0.97 $ 2.60 (1) Certain prior year amounts have been reclassified to conform with the current year’s presentation due to Altria’s adoption of ASU 2017-07. For further discussion, see Note 17 . Benefit Plans . During 2018 and 2017 , the following pre-tax (gains) or charges were included in net earnings attributable to Altria: 2018 Quarters (in millions) 1st 2nd 3rd 4th NPM Adjustment Items $ (68 ) $ (77 ) $ — $ — Tobacco and health litigation items, including accrued interest 28 70 21 12 Asset impairment, exit, implementation and acquisition-related costs 3 6 (3 ) 532 Loss on AB InBev/SABMiller business combination 33 — — — AB InBev special items (117 ) (72 ) 35 69 $ (121 ) $ (73 ) $ 53 $ 613 2017 Quarters (in millions) 1st 2nd 3rd 4th NPM Adjustment Items $ (1 ) $ — $ 5 $ — Tobacco and health litigation items, including accrued interest 1 17 — 62 Asset impairment, exit, implementation and acquisition-related costs 30 30 17 12 Settlement charge for lump sum pension payments — — — 81 Gain on AB InBev/SABMiller business combination — (408 ) (37 ) — AB InBev special items 73 2 34 51 $ 103 $ (359 ) $ 19 $ 206 As discussed in Note 15 . Income Taxes , Altria has recognized income tax benefits and charges in the consolidated statements of earnings during 2018 and 2017 as a result of various tax events, including the impact of the Tax Reform Act in 2018 and the fourth quarter of 2017.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Cash and Cash Equivalents	Cash equivalents include demand deposits with banks and all highly liquid investments with original maturities of three months or less. Cash equivalents are stated at cost plus accrued interest, which approximates fair value.
Depreciation and Amortization	Property, plant and equipment are stated at historical costs and depreciated by the straight-line method over the estimated useful lives of the assets. Machinery and equipment are depreciated over periods up to 25 years, and buildings and building improvements over periods up to 50 years. Definite-lived intangible assets are amortized over their estimated useful lives up to 25 years.
Impairment Testing and Asset Valuation	Altria reviews long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable. Altria performs undiscounted operating cash flow analyses to determine if an impairment exists. For purposes of recognition and measurement of an impairment for assets held for use, Altria groups assets and liabilities at the lowest level for which cash flows are separately identifiable. If Altria determines that an impairment exists, any related impairment loss is calculated based on fair value. Impairment losses on assets to be disposed of, if any, are based on the estimated proceeds to be received, less costs of disposal. Altria also reviews the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed. Altria conducts a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require Altria to perform an interim review. If the carrying value of goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired. The amount of impairment loss is measured as the difference between the carrying value and the implied fair value. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, the intangible asset is considered impaired and is reduced to fair value. Altria reviews its investment in AB InBev for impairment by comparing the fair value of its investment to its carrying value. If the carrying value of Altria’s investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and impairment is recognized in the period identified. The factors used to make this determination include the duration and magnitude of the fair value decline, AB InBev’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in AB InBev until recovery. Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators. If a qualitative assessment indicates that Altria’s investment in JUUL is impaired and the fair value of the investment is less than its carrying value, the investment is written down to its fair value.
Derivative Financial Instruments	Altria enters into derivatives to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk. Altria uses various types of derivative financial instruments, including forward contracts, options and swaps. Derivative financial instruments are recorded at fair value on the consolidated balance sheets as either assets or liabilities. Derivative financial instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges at the inception of the contracts. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recorded in the consolidated statements of earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded each period in accumulated other comprehensive earnings (losses) and are reclassified to the consolidated statements of earnings in the same periods in which operating results are affected by the respective hedged item. For net investment hedges, changes in the fair value of the derivative or foreign currency transaction gains or losses on a nonderivative hedging instrument are recorded in accumulated other comprehensive earnings (losses) to offset the change in the value of the net investment being hedged. Such amounts remain in accumulated other comprehensive earnings (losses) until the complete or substantially complete liquidation of the underlying foreign operations occurs or, for investments in foreign entities accounted for under the equity method of accounting, Altria’s economic interest in the underlying foreign entity decreases. Cash flows from hedging instruments are classified in the same manner as the respective hedged item in the consolidated statements of cash flows. To qualify for hedge accounting, the hedging relationship, both at inception of the hedge and on an ongoing basis, is expected to be highly effective at offsetting changes in the fair value of the hedged risk during the period that the hedge is designated. Altria formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective, the strategy for undertaking the hedge transaction and method for assessing hedge effectiveness. Additionally, for qualified hedges of forecasted transactions, if it becomes probable that a forecasted transaction will not occur, the hedge would no longer be considered effective and all of the derivative gains and losses would be recorded in the consolidated statement of earnings in the current period. For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of earnings each period. Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.
Employee Benefit Plans	Altria provides a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits. Altria records annual amounts relating to these plans based on calculations specified by U.S. GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates. Altria recognizes the funded status of its defined benefit pension and other postretirement plans on the consolidated balance sheet and records as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost. The gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) are subsequently amortized into net periodic benefit cost in future years.
Environmental Costs	Altria is subject to laws and regulations relating to the protection of the environment. Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated. Such accruals are adjusted as new information develops or circumstances change. Compliance with environmental laws and regulations, including the payment of any remediation and compliance costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria’s consolidated results of operations, capital expenditures, financial position or cash flows
Fair Value Measurements	Altria measures certain assets and liabilities at fair value. Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Altria uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used to measure fair value are: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Guarantees	Altria recognizes a liability for the fair value of the obligation of qualifying guarantee activities.
Income Taxes	Significant judgment is required in determining income tax provisions and in evaluating tax positions. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Altria records a valuation allowance when it is more-likely-than-not that some portion or all of a deferred tax asset will not be realized. Altria recognizes a benefit for uncertain tax positions when a tax position taken or expected to be taken in a tax return is more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. Altria recognizes accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in its consolidated statements of earnings.
Inventories	The last-in, first-out (“LIFO”) method is used to determine the cost of substantially all tobacco inventories. The cost of the remaining inventories is determined using the first-in, first-out (“FIFO”) and average cost methods. Inventories that are measured using the LIFO method are stated at the lower of cost or market. Inventories that are measured using the FIFO and average cost methods are stated at the lower of cost and net realizable value. It is a generally recognized industry practice to classify leaf tobacco and wine inventories as current assets although part of such inventory, because of the duration of the curing and aging process, ordinarily would not be used within one year .
Litigation Contingencies and Costs	Altria and its subsidiaries record provisions in the consolidated financial statements for pending litigation when it is determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. Litigation defense costs are expensed as incurred and included in marketing, administration and research costs in the consolidated statements of earnings.
Marketing Costs	Altria’s businesses promote their products with consumer incentives, trade promotions and consumer engagement programs. These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues. Consumer engagement program payments are made to third parties. Altria’s businesses expense these consumer engagement programs, which include event marketing, as incurred and such expenses are included in marketing, administration and research costs in Altria’s consolidated statements of earnings. For interim reporting purposes, Altria’s businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year.
Revenue Recognition	On January 1, 2018, Altria adopted ASU No. 2014-09. For further discussion, see Note 3 . Revenues from Contracts with Customers . Altria’s businesses generate substantially all of their revenue from sales contracts with customers. While Altria’s businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured. These contracts create an obligation to transfer product to the customer. All performance obligations are satisfied within one year ; therefore, costs to obtain contracts are expensed as incurred and unsatisfied performance obligations are not disclosed. There is no financing component because Altria expects, at contract inception, that the period between when Altria transfers product to the customer and when the customer pays for that product will be one year or less. Altria’s businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives. Altria’s businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on cigarettes, cigars, smokeless tobacco or wine billed to customers). Altria’s businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer. Altria’s businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer. Altria’s businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in Altria’s consolidated statements of earnings. Altria’s businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on Altria’s consolidated balance sheets. Altria’s businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates. Expected payments for sales incentives are included in accrued marketing liabilities on Altria’s consolidated balance sheets. Payment terms vary depending on product type. Altria’s businesses consider payments received in advance of product shipment as deferred revenue, which is included in other accrued liabilities on Altria’s consolidated balance sheets until revenue is recognized. PM USA receives payment in advance of a customer obtaining control of the product. USSTC receives substantially all payments within one business day of the customer obtaining control of the product. Ste. Michelle receives substantially all payments from customers within 45 days of the customer obtaining control of the product. Amounts due from customers are included in receivables on Altria’s consolidated balance sheets.
New Accounting Standards	The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria: Standards Description Effective Date for Public Entity Effect on Financial Statements ASU Nos. 2016-02; 2018-01; 2018-10; 2018-11; 2018-20 Leases (Topic 842) The guidance requires entities to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. The guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Early adoption is permitted. As a lessor, PMCC maintains a portfolio of finance assets, substantially all of which are leveraged leases, the accounting of which will be unchanged under the new guidance and is not expected to change unless there is a contract modification to an existing lease. As lessees, Altria and its subsidiaries’ various leases under existing guidance are classified as operating leases that are not recorded on Altria’s consolidated balance sheets but are recorded in Altria’s consolidated statements of earnings as expense is incurred. Altria plans to apply the new guidance retrospectively at the beginning of the period of adoption and will record substantially all leases on its consolidated balance sheets as right-of-use assets and lease liabilities. Altria does not expect its adoption of this guidance to have a material impact on Altria’s consolidated financial statements. The adoption of this guidance will result in expanded footnote disclosures. ASU Nos. 2016-13 and 2018-19 Measurement of Credit Losses on Financial Instruments (Topic 326) The guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. The adoption of this guidance is not expected to have a material impact on Altria’s consolidated financial statements. ASU No. 2018-15 Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (Subtopic 350-40) The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. On October 1, 2018, Altria adopted ASU 2018-02 and elected to reclassify the stranded income tax effects of the Tax Reform Act on items within accumulated other comprehensive losses to earnings reinvested in the business. On January 1, 2018 Altria adopted ASU No. 2017-07, which requires an employer to report the service cost component of net periodic pension cost and net periodic postretirement benefit cost in the same line item or items as other compensation costs arising from services rendered by employees during the period. The other components of net periodic pension cost and net periodic postretirement benefit cost are required to be presented in the statements of earnings separately from the service cost component and outside the subtotal of operating income. Additionally, only the service cost component is eligible for capitalization. Altria retrospectively adopted the guidance for the presentation of the service cost component and the other components of net periodic pension cost and net periodic postretirement benefit cost in its consolidated statements of earnings, and prospectively adopted the capitalization of service cost. Altria used the practical expedient provided in ASU No. 2017-07 that permits Altria to use the amounts disclosed in its benefit plans note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements.
Investments	Altria accounts for its investment in JUUL as an investment in an equity security. Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus any impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
Methodology of Determining Fair Value of Pension Assets	Following is a description of the valuation methodologies used for investments measured at fair value. ▪ U.S. and Foreign Government Securities : U.S. and foreign government securities consist of investments in Treasury Nominal Bonds and Inflation Protected Securities and municipal securities. Government securities are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes. Matrix pricing, yield curves and indices are used when broker quotes are not available. ▪ Corporate Debt Instruments : Corporate debt instruments are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes. Matrix pricing, yield curves and indices are used when broker quotes are not available. ▪ Common Stock : Common stocks are valued based on the price of the security as listed on an open active exchange on last trade date. ▪ Collective Investment Funds : Collective investment funds consist of funds that are intended to mirror indices such as Standard & Poor’s 500 Index and MSCI EAFE Index. They are valued on the basis of the relative interest of each participating investor in the fair value of the underlying assets of each of the respective collective investment funds. The underlying assets are valued based on the net asset value (“NAV”), which is provided by the investment account manager as a practical expedient to estimate fair value. These investments are not classified by level but are disclosed to permit reconciliation to the fair value of plan assets.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles	The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria: Standards Description Effective Date for Public Entity Effect on Financial Statements ASU Nos. 2016-02; 2018-01; 2018-10; 2018-11; 2018-20 Leases (Topic 842) The guidance requires entities to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. The guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Early adoption is permitted. As a lessor, PMCC maintains a portfolio of finance assets, substantially all of which are leveraged leases, the accounting of which will be unchanged under the new guidance and is not expected to change unless there is a contract modification to an existing lease. As lessees, Altria and its subsidiaries’ various leases under existing guidance are classified as operating leases that are not recorded on Altria’s consolidated balance sheets but are recorded in Altria’s consolidated statements of earnings as expense is incurred. Altria plans to apply the new guidance retrospectively at the beginning of the period of adoption and will record substantially all leases on its consolidated balance sheets as right-of-use assets and lease liabilities. Altria does not expect its adoption of this guidance to have a material impact on Altria’s consolidated financial statements. The adoption of this guidance will result in expanded footnote disclosures. ASU Nos. 2016-13 and 2018-19 Measurement of Credit Losses on Financial Instruments (Topic 326) The guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. The adoption of this guidance is not expected to have a material impact on Altria’s consolidated financial statements. ASU No. 2018-15 Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (Subtopic 350-40) The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets, net (Tables)	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill	The changes in goodwill and net carrying amount of intangible assets are as follows: 2018 2017 (in millions) Goodwill Other Intangible Assets, net Goodwill Other Intangible Assets, net Balance at January 1 $ 5,307 $ 12,400 $ 5,285 $ 12,036 Changes due to: Acquisitions (1) — 15 22 385 Asset impairment (2) (111 ) (98 ) — — Amortization — (38 ) — (21 ) Balance at December 31 $ 5,196 $ 12,279 $ 5,307 $ 12,400 (1) Reflects the 2018 and 2017 purchase of certain intellectual property primarily related to innovative tobacco products, and the 2017 acquisition of Nat Sherman. (2) Reflects asset impairment of goodwill and other intangible assets, net related to e-vapor products, and the Columbia Crest trademark. Goodwill and other intangible assets, net, by segment were as follows: Goodwill Other Intangible Assets, net (in millions) December 31, 2018 December 31, 2017 December 31, 2018 December 31, 2017 Smokeable products $ 99 $ 99 $ 3,037 $ 3,054 Smokeless products 5,023 5,023 8,825 8,827 Wine 74 74 239 294 Other — 111 178 225 Total $ 5,196 $ 5,307 $ 12,279 $ 12,400
Schedule of Indefinite-Lived Intangible Assets	Other intangible assets consisted of the following: December 31, 2018 December 31, 2017 (in millions) Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Indefinite-lived intangible assets $ 11,846 $ — $ 12,125 $ — Definite-lived intangible assets 654 221 465 190 Total other intangible assets $ 12,500 $ 221 $ 12,590 $ 190
Schedule of Definite-Lived Intangible Assets	Other intangible assets consisted of the following: December 31, 2018 December 31, 2017 (in millions) Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Indefinite-lived intangible assets $ 11,846 $ — $ 12,125 $ — Definite-lived intangible assets 654 221 465 190 Total other intangible assets $ 12,500 $ 221 $ 12,590 $ 190

Asset Impairment, Exit and Im_2

Asset Impairment, Exit and Implementation Costs (Tables)	12 Months Ended
	Dec. 31, 2018
Restructuring and Related Activities [Abstract]
Pre-tax Asset Impairment, Exit, and Implementation Costs	Pre-tax asset impairment, exit and implementation costs consisted of the following: (in millions) Asset Impairment and Exit Costs Implementation Costs Total For the year ended December 31, 2018 2017 2016 2018 (1) 2017 (1) 2016 (2) 2018 2017 2016 Smokeable products $ 82 $ 5 $ 125 $ 1 $ 17 $ 9 $ 83 $ 22 $ 134 Smokeless products 20 28 42 3 28 15 23 56 57 Wine (3) 54 — — — — — 54 — — All other 227 — 7 63 — — 290 — 7 General corporate 3 — 5 — — — 3 — 5 Total 386 33 179 67 45 24 453 78 203 Less amounts included in net periodic benefit (income) cost, excluding service cost 3 1 30 — — — 3 1 30 Total $ 383 $ 32 $ 149 $ 67 $ 45 $ 24 $ 450 $ 77 $ 173 (1) Included in cost of sales in Altria’s consolidated statements of earnings. (2) Included in cost of sales ( $17 million ) and marketing, administration and research costs ( $7 million ) in Altria’s consolidated statement of earnings. (3) Reflects impairment of the Columbia Crest trademark. See Note 4. Goodwill and Other Intangible Assets, net .
Schedule of Movement in Restructuring Liabilities	The movement in the restructuring liabilities, substantially all of which are severance liabilities, for the years ended December 31, 2018 and 2017 was as follows: (in millions) Balances at December 31, 2016 $ 79 Charges 25 Cash spent (71 ) Balances at December 31, 2017 33 Charges 154 Cash spent (32 ) Balances at December 31, 2018 $ 155

Investment in AB InBev_SABMil_2

Investment in AB InBev/SABMiller (Tables)	12 Months Ended
	Dec. 31, 2018
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	Summary financial data of AB InBev is as follows: For Altria’s Year Ended (in millions) 2018 (1) 2017 (1) Net revenues $ 55,500 $ 56,004 Gross profit $ 34,986 $ 34,376 Earnings from continuing operations $ 9,020 $ 6,769 Net earnings $ 9,020 $ 6,845 Net earnings attributable to AB InBev $ 7,641 $ 5,473 At September 30, (in millions) 2018 (1) 2017 (1) Current assets $ 20,289 $ 30,920 Long-term assets $ 207,921 $ 213,696 Current liabilities $ 32,019 $ 37,765 Long-term liabilities $ 130,812 $ 134,236 Noncontrolling interests $ 7,251 $ 10,639 (1) Reflects the one-quarter lag. Summary financial data of SABMiller is as follows: (in millions) For the Year Ended December 31, 2016 (1) Net revenues $ 14,543 Operating profit $ 2,099 Net earnings attributable to SABMiller $ 1,803 (1) As a result of the timing of the completion of the AB InBev Transaction, summary financial data of SABMiller for the year ended December 31, 2016 included approximately nine months of SABMiller’s results.

Long-term Debt (Tables)

Long-term Debt (Tables)	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Components of Long-Term Debt	At December 31, 2018 and 2017 , Altria’s long-term debt consisted of the following: (in millions) 2018 2017 Notes, 2.625% to 10.20%, interest payable semi-annually, due through 2046 (1) $ 13,000 $ 13,852 Debenture, 7.75%, interest payable semi-annually, due 2027 42 42 13,042 13,894 Less current portion of long-term debt 1,144 864 $ 11,898 $ 13,030 (1) Weighted-average coupon interest rate of 4.6% and 4.9% at December 31, 2018 and 2017 , respectively.
Aggregate Maturities of Long-Term Debt	At December 31, 2018 , aggregate maturities of Altria’s long-term debt were as follows: (in millions) 2019 $ 1,144 2020 1,000 2021 1,500 2022 1,900 2023 350 Thereafter 7,259 13,153 Less: debt issuance costs 60 debt discounts 51 $ 13,042
Schedule of Tender Offers and Associated Pre-tax Losses on Early Extinguishment of Debt	Details of the debt tender offer and the associated pre-tax loss on early extinguishment of debt recorded by Altria were as follows: (in millions) 2016 Notes Purchased 9.95% Notes due 2038 $ 441 10.20% Notes due 2039 492 Total $ 933 Pre-tax Loss on Early Extinguishment of Debt Premiums and fees $ 809 Write-off of unamortized debt discounts and debt issuance costs 14 Total $ 823

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Schedule Components of Issued, Repurchased and Outstanding Shares	At December 31, 2018 , Altria had 12 billion shares of authorized common stock; issued, repurchased and outstanding shares of common stock were as follows: Shares Issued Shares Repurchased Shares Outstanding Balances, December 31, 2015 2,805,961,317 (845,901,836 ) 1,960,059,481 Stock award activity — (566,256 ) (566,256 ) Repurchases of common stock — (16,221,001 ) (16,221,001 ) Balances, December 31, 2016 2,805,961,317 (862,689,093 ) 1,943,272,224 Stock award activity — (408,891 ) (408,891 ) Repurchases of common stock — (41,604,141 ) (41,604,141 ) Balances, December 31, 2017 2,805,961,317 (904,702,125 ) 1,901,259,192 Stock award activity — 676,727 676,727 Repurchases of common stock — (27,878,324 ) (27,878,324 ) Balances, December 31, 2018 2,805,961,317 (931,903,722 ) 1,874,057,595
Share Repurchases	For the years ended December 31, 2018 , 2017 and 2016 , Altria’s total share repurchase activity was as follows: 2018 2017 2016 (in millions, except per share data) Total number of shares repurchased 27.9 41.6 16.2 Aggregate cost of shares repurchased $ 1,673 $ 2,917 $ 1,030 Average price per share of shares repurchased $ 60.00 $ 70.10 $ 63.48

Stock Plans (Tables)

Stock Plans (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Activity	RSU activity was as follows for the year ended December 31, 2018 : Number of Shares Weighted-Average Grant Date Fair Value Per Share Balance at December 31, 2017 2,384,501 $ 60.40 Granted 896,962 $ 67.17 Vested (998,145 ) $ 56.44 Forfeited (153,692 ) $ 62.56 Balance at December 31, 2018 2,129,626 $ 64.94

Earnings per Share (Tables)

Earnings per Share (Tables)	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Earnings Per Share	Basic and diluted earnings per share (“EPS”) were calculated using the following: For the Years Ended December 31, (in millions) 2018 2017 2016 Net earnings attributable to Altria $ 6,963 $ 10,222 $ 14,239 Less: Distributed and undistributed earnings attributable to share-based awards (8 ) (14 ) (24 ) Earnings for basic and diluted EPS $ 6,955 $ 10,208 $ 14,215 Weighted-average shares for basic EPS 1,887 1,921 1,952 Plus: contingently issuable PSUs 1 — — Weighted-average shares for diluted EPS 1,888 1,921 1,952

Other Comprehensive Earnings__2

Other Comprehensive Earnings/losses (Tables)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria: (in millions) Benefit Plans AB InBev/SABMiller Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses Balances, December 31, 2015 $ (2,010 ) $ (1,265 ) $ (5 ) $ (3,280 ) Other comprehensive (losses) earnings before reclassifications (247 ) 787 1 541 Deferred income taxes 96 (276 ) — (180 ) Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes (151 ) 511 (1) 1 361 Amounts reclassified to net earnings 178 1,160 — 1,338 Deferred income taxes (65 ) (406 ) — (471 ) Amounts reclassified to net earnings, net of deferred income taxes 113 754 (2) — 867 Other comprehensive (losses) earnings, net of deferred income taxes (38 ) 1,265 1 1,228 Balances, December 31, 2016 (2,048 ) — (4 ) (2,052 ) Other comprehensive earnings (losses) before reclassifications 52 (91 ) — (39 ) Deferred income taxes (21 ) 32 — 11 Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes 31 (59 ) — (28 ) Amounts reclassified to net earnings 291 8 — 299 Deferred income taxes (113 ) (3 ) — (116 ) Amounts reclassified to net earnings, net of deferred income taxes 178 5 — 183 Other comprehensive earnings (losses), net of deferred income taxes 209 (54 ) (3) — 155 Balances, December 31, 2017 (1,839 ) (54 ) (4 ) (1,897 ) Adoption of ASU No. 2018-02 (4) (397 ) (11 ) — (408 ) Other comprehensive losses before reclassifications (151 ) (323 ) (1 ) (475 ) Deferred income taxes 39 64 — 103 Other comprehensive losses before reclassifications, net of deferred income taxes (112 ) (259 ) (1 ) (372 ) Amounts reclassified to net earnings 241 (64 ) — 177 Deferred income taxes (61 ) 14 — (47 ) Amounts reclassified to net earnings, net of deferred income taxes 180 — (50 ) — 130 Other comprehensive earnings (losses), net of deferred income taxes 68 (309 ) (3) (1 ) (242 ) Balances, December 31, 2018 $ (2,168 ) $ (374 ) $ (5 ) $ (2,547 ) (1) As a result of the AB InBev Transaction, Altria reversed to investment in SABMiller $414 million of its accumulated other comprehensive losses directly attributable to SABMiller; the remaining $97 million consisted primarily of currency translation adjustments. (2) As a result of the AB InBev Transaction, Altria recognized $737 million of its accumulated other comprehensive losses directly attributable to SABMiller. (3) Primarily reflects currency translation adjustments. (4) Reflects the reclassification of the stranded income tax effects of the Tax Reform Act. For further discussion, see Note 15 . Income Taxes .
Reclassification out of Accumulated Other Comprehensive Income	The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings: For the Years Ended December 31, (in millions) 2018 2017 2016 Benefit Plans: (1) Net loss $ 276 $ 325 $ 223 Prior service cost/credit (35 ) (34 ) (45 ) 241 291 178 AB InBev/SABMiller (2) (64 ) 8 1,160 Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings $ 177 $ 299 $ 1,338 ( 1) Amounts are included in net defined benefit plan costs. For further details, see Note 17 . Benefit Plans. (2) For the years ended December 31, 2018 and 2017, amounts are primarily included in earnings from equity investment in AB InBev. Substantially all of the amount for the year ended December 31, 2016 is included in gain on AB InBev/SABMiller business combination. For further information, see Note 7 . Investment in AB InBev/SABMiller.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Schedule of Earnings Before Income Taxes and Provision for Income Taxes	Earnings before income taxes and provision (benefit) for income taxes consisted of the following for the years ended December 31, 2018 , 2017 and 2016 : (in millions) 2018 2017 2016 Earnings (loss) before income taxes: United States $ 9,441 $ 9,809 $ 21,867 Outside United States (100 ) 19 (15 ) Total $ 9,341 $ 9,828 $ 21,852 Provision (benefit) for income taxes: Current: Federal $ 1,911 $ 2,346 $ 4,093 State and local 519 366 390 Outside United States 1 15 6 2,431 2,727 4,489 Deferred: Federal (18 ) (3,213 ) 3,102 State and local (42 ) 86 20 Outside United States 3 1 (3 ) (57 ) (3,126 ) 3,119 Total provision (benefit) for income taxes $ 2,374 $ (399 ) $ 7,608
Reconciliation of Beginning and Ending Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2018 , 2017 and 2016 was as follows: (in millions) 2018 2017 2016 Balance at beginning of year $ 66 $ 169 $ 158 Additions based on tax positions related to the current year — — 15 Additions for tax positions of prior years 22 129 29 Reductions for tax positions due to lapse of statutes of limitations — (4 ) (4 ) Reductions for tax positions of prior years (1 ) (208 ) (28 ) Settlements (2 ) (20 ) (1 ) Balance at end of year $ 85 $ 66 $ 169
Schedule of Unrecognized Tax Benefits and Consolidated Liability for Tax Contingencies	Unrecognized tax benefits and Altria’s consolidated liability for tax contingencies at December 31, 2018 and 2017 were as follows: (in millions) 2018 2017 Unrecognized tax benefits $ 85 $ 66 Accrued interest and penalties 13 9 Tax credits and other indirect benefits (1 ) (1 ) Liability for tax contingencies $ 97 $ 74
Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate	The effective income tax rate on pre-tax earnings differed from the U.S. federal statutory rate for the following reasons for the years ended December 31, 2018 , 2017 and 2016 : 2018 2017 2016 U.S. federal statutory rate 21.0 % 35.0 % 35.0 % Increase (decrease) resulting from: State and local income taxes, net of federal tax benefit 4.0 3.5 1.2 Re-measurement of net deferred tax liabilities — (31.2 ) — Tax basis in foreign investments 1.5 (7.8 ) — Deemed repatriation tax 0.1 4.2 — Uncertain tax positions 0.1 (0.9 ) — Investment in AB InBev/SABMiller (1.1 ) (5.9 ) (0.6 ) Domestic manufacturing deduction — (1.8 ) (0.8 ) Other (0.2 ) 0.8 — Effective tax rate 25.4 % (4.1 )% 34.8 %
Schedule of Deferred Income Tax Assets and Liabilities	The tax effects of temporary differences that gave rise to deferred income tax assets and liabilities consisted of the following at December 31, 2018 and 2017 : (in millions) 2018 2017 Deferred income tax assets: Accrued postretirement and postemployment benefits $ 500 $ 539 Settlement charges 864 614 Accrued pension costs 155 136 Net operating losses and tax credit carryforwards 57 18 Total deferred income tax assets 1,576 1,307 Deferred income tax liabilities: Property, plant and equipment (251 ) (261 ) Intangible assets (2,689 ) (2,674 ) Investment in AB InBev (3,038 ) (2,859 ) Finance assets, net (313 ) (404 ) Other (115 ) (121 ) Total deferred income tax liabilities (6,406 ) (6,319 ) Valuation allowances (71 ) — Net deferred income tax liabilities $ (4,901 ) $ (5,012 )

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Segment Data Schedule	Segment data were as follows: For the Years Ended December 31, (in millions) 2018 2017 2016 Net revenues: Smokeable products $ 22,297 $ 22,636 $ 22,851 Smokeless products 2,262 2,155 2,051 Wine 691 698 746 All other 114 87 96 Net revenues $ 25,364 $ 25,576 $ 25,744 Earnings before income taxes: Operating companies income (loss): Smokeable products $ 8,408 $ 8,426 $ 7,766 Smokeless products 1,431 1,306 1,172 Wine 50 146 164 All other (421 ) (51 ) (98 ) Amortization of intangibles (38 ) (21 ) (21 ) General corporate expenses (315 ) (213 ) (217 ) Corporate asset impairment and exit costs — — (5 ) Operating income 9,115 9,593 8,761 Interest and other debt expense, net (665 ) (705 ) (747 ) Loss on early extinguishment of debt — — (823 ) Net periodic benefit income (cost), excluding service cost 34 (37 ) 1 Earnings from equity investment in AB InBev/SABMiller 890 532 795 (Loss) gain on AB InBev/SABMiller business combination (33 ) 445 13,865 Earnings before income taxes $ 9,341 $ 9,828 $ 21,852
Schedule of Depreciation Expense and Capital Expenditures of Segments	Details of Altria’s depreciation expense and capital expenditures were as follows: For the Years Ended December 31, (in millions) 2018 2017 2016 Depreciation expense: Smokeable products $ 90 $ 93 $ 93 Smokeless products 28 29 26 Wine 40 40 36 General corporate and other 31 26 28 Total depreciation expense $ 189 $ 188 $ 183 Capital expenditures: Smokeable products $ 81 $ 39 $ 55 Smokeless products 73 61 52 Wine 40 53 59 General corporate and other 44 46 23 Total capital expenditures $ 238 $ 199 $ 189
Schedule of NPM Adjustment Items	For the years ended December 31, 2018 , 2017 and 2016, pre-tax (income) expense for NPM adjustment items was recorded in Altria’s consolidated statements of earnings as follows: (in millions) 2018 2017 2016 Smokeable products segment $ (145 ) $ (5 ) $ 12 Interest and other debt expense, net — 9 6 Total $ (145 ) $ 4 $ 18
Schedule of Pre-tax Tobacco and Health Litigation Charges	For the years ended December 31, 2018 , 2017 and 2016 , pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s consolidated statements of earnings as follows: (in millions) 2018 2017 2016 Smokeable products segment $ 103 $ 72 $ 88 Smokeless products segment 10 — — Interest and other debt expense, net 18 8 17 Total $ 131 $ 80 $ 105

Benefit Plans (Tables)

Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans	The benefit obligations, plan assets and funded status of Altria’s pension and postretirement plans at December 31, 2018 and 2017 were as follows: Pension Postretirement (in millions) 2018 2017 2018 2017 Change in benefit obligation: Benefit obligation at beginning of year $ 8,510 $ 8,312 $ 2,335 $ 2,364 Service cost 81 75 18 16 Interest cost 276 288 70 76 Benefits paid (488 ) (703 ) (130 ) (139 ) Actuarial (gains) losses (660 ) 589 (298 ) 56 Termination, settlement and curtailment (18 ) (51 ) — — Other 25 — 45 (38 ) Benefit obligation at end of year 7,726 8,510 2,040 2,335 Change in plan assets: Fair value of plan assets at beginning of year 8,015 7,475 270 — Actual return on plan assets (430 ) 1,219 (14 ) — Employer contributions 41 24 — 270 Benefits paid (488 ) (703 ) (45 ) — Fair value of plan assets at end of year 7,138 8,015 211 270 Funded status at December 31 $ (588 ) $ (495 ) $ (1,829 ) $ (2,065 ) Amounts recognized on Altria’s consolidated balance sheets were as follows: Other accrued liabilities $ (44 ) $ (51 ) $ (80 ) $ (78 ) Accrued pension costs (544 ) (445 ) — — Other assets — 1 — — Accrued postretirement health care costs — — (1,749 ) (1,987 ) $ (588 ) $ (495 ) $ (1,829 ) $ (2,065 )
Net Pension Liability Recognized in Consolidated Balance Sheets	The benefit obligations, plan assets and funded status of Altria’s pension and postretirement plans at December 31, 2018 and 2017 were as follows: Pension Postretirement (in millions) 2018 2017 2018 2017 Change in benefit obligation: Benefit obligation at beginning of year $ 8,510 $ 8,312 $ 2,335 $ 2,364 Service cost 81 75 18 16 Interest cost 276 288 70 76 Benefits paid (488 ) (703 ) (130 ) (139 ) Actuarial (gains) losses (660 ) 589 (298 ) 56 Termination, settlement and curtailment (18 ) (51 ) — — Other 25 — 45 (38 ) Benefit obligation at end of year 7,726 8,510 2,040 2,335 Change in plan assets: Fair value of plan assets at beginning of year 8,015 7,475 270 — Actual return on plan assets (430 ) 1,219 (14 ) — Employer contributions 41 24 — 270 Benefits paid (488 ) (703 ) (45 ) — Fair value of plan assets at end of year 7,138 8,015 211 270 Funded status at December 31 $ (588 ) $ (495 ) $ (1,829 ) $ (2,065 ) Amounts recognized on Altria’s consolidated balance sheets were as follows: Other accrued liabilities $ (44 ) $ (51 ) $ (80 ) $ (78 ) Accrued pension costs (544 ) (445 ) — — Other assets — 1 — — Accrued postretirement health care costs — — (1,749 ) (1,987 ) $ (588 ) $ (495 ) $ (1,829 ) $ (2,065 )
Assumptions used to Determine Benefit Obligations	The following assumptions were used to determine Altria’s pension and postretirement benefit obligations at December 31: Pension Postretirement 2018 2017 2018 2017 Discount rate 4.4 % 3.7 % 4.4 % 3.7 % Rate of compensation increase 4.0 4.0 — — Health care cost trend rate assumed for next year — — 6.5 7.0 Ultimate trend rate — — 5.0 5.0 Year that the rate reaches the ultimate trend rate — — 2025 2022
Schedule of Net Benefit Costs	Net periodic benefit cost consisted of the following for the years ended December 31, 2018 , 2017 and 2016 : Pension Postretirement (in millions) 2018 2017 2016 2018 2017 2016 Service cost $ 81 $ 75 $ 76 $ 18 $ 16 $ 17 Interest cost 276 288 281 70 76 77 Expected return on plan assets (585 ) (601 ) (553 ) (19 ) — — Amortization: Net loss 225 197 171 21 25 25 Prior service cost (credit) 4 4 5 (42 ) (38 ) (39 ) Termination, settlement and curtailment 16 86 34 — — (2 ) Net periodic benefit cost $ 17 $ 49 $ 14 $ 48 $ 79 $ 78
Schedule Of Termination Settlement And Curtailment Cost	The amounts included in termination, settlement and curtailment in the table above were comprised of the following changes: Pension Post-retirement (in millions) 2018 2017 2016 2016 Benefit obligation $ — $ — $ 23 $ 11 Other comprehensive earnings/losses: Net loss 13 86 9 — Prior service cost (credit) 3 — 2 (13 ) $ 16 $ 86 $ 34 $ (2 )
Schedule of Estimated Net Loss and Prior Service Cost (Credit) Expected to be Amortized in 2017	The estimated net loss and prior service cost (credit) that are expected to be amortized from accumulated other comprehensive losses into net periodic benefit cost during 2019 is as follows: (in millions) Pension Postretirement Net loss $ 169 $ 12 Prior service cost (credit) 6 (32 )
Schedule Of Assumptions To Determine Net Periodic Benefit Cost	The following assumptions were used to determine Altria’s net periodic benefit cost for the years ended December 31: Pension Postretirement 2018 2017 2016 2018 2017 2016 Discount rates: Service cost 3.8 % 4.3 % 4.7 % 3.8 % 4.3 % 4.5 % Interest cost 3.3 3.5 3.6 3.3 3.5 3.4 Expected rate of return on plan assets 7.8 8.0 8.0 7.8 — — Rate of compensation increase 4.0 4.0 4.0 — — — Health care cost trend rate — — — 7.0 7.0 6.5
Effects of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates	A one-percentage-point change in assumed health care cost trend rates would have had the following effects as of December 31, 2018 : One-Percentage-Point Increase One-Percentage-Point Decrease Effect on total of postretirement service and interest cost 7.5 % (6.3 )% Effect on postretirement benefit obligation 5.6 % (4.8 )%
Schedule of Fair Value of Plan Assets by Asset Category	The composition of Altria’s plan assets at December 31, 2018 was broadly characterized with the following allocation: Pension Postretirement Equity securities 48 % 48 % Corporate bonds 32 % 42 % U.S. Treasury and foreign government securities 20 % 10 % The fair values of Altria’s pension plan assets by asset category at December 31, 2018 and 2017 were as follows: 2018 2017 (in millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total U.S. and foreign government securities or their agencies: U.S. government and agencies $ — $ 868 $ — $ 868 $ — $ 588 $ — $ 588 U.S. municipal bonds — 73 — 73 — 81 — 81 Foreign government and agencies — 115 — 115 — 150 — 150 Corporate debt instruments: Above investment grade — 1,726 — 1,726 — 1,789 — 1,789 Below investment grade and no rating — 478 — 478 — 511 — 511 Common stock: International equities 237 — — 237 1,396 — — 1,396 U.S. equities 1,082 — — 1,082 831 — — 831 Cash and cash equivalents — 303 — 303 — 106 — 106 Other, net 36 36 — 72 47 42 — 89 $ 1,355 $ 3,599 $ — $ 4,954 $ 2,274 $ 3,267 $ — $ 5,541 Investments measured at NAV as a practical expedient for fair value: Collective investment funds U.S. large cap $ 1,722 $ 2,014 U.S. small cap 328 361 International developed markets 86 100 Total investments measured at NAV $ 2,136 $ 2,475 Other 48 (1 ) Fair value of plan assets, net $ 7,138 $ 8,015 Level 3 holdings and transactions were immaterial to total plan assets at December 31, 2018 and 2017 . The fair value of Altria’s postretirement plan assets at December 31, 2018 were as follows: 2018 (in millions) Level 1 Level 2 Total U.S. and foreign government securities or their agencies: U.S. government and agencies $ — $ 13 $ 13 Foreign government and agencies — 3 3 Corporate debt instruments: Above investment grade — 71 71 Below investment grade and no rating — 8 8 Other, net 2 2 4 $ 2 $ 97 $ 99 Investments measured at NAV as a practical expedient for fair value: Collective investment funds: U.S. large cap $ 77 International developed markets 26 Total investments measured at NAV $ 103 Other 9 Fair value of plan assets, net $ 211
Estimated Future Benefit Payments	Estimated future benefit payments at December 31, 2018 were as follows: (in millions) Pension Postretirement 2019 $ 484 $ 132 2020 464 130 2021 468 129 2022 470 129 2023 474 125 2024-2028 2,362 598
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	The amounts recorded in accumulated other comprehensive losses at December 31, 2018 consisted of the following: (in millions) Pension Post- retirement Post- employment Total Net loss $ (2,591 ) $ (327 ) $ (78 ) $ (2,996 ) Prior service (cost) credit (34 ) 108 (6 ) 68 Deferred income taxes 679 61 20 760 Amounts recorded in accumulated other comprehensive losses $ (1,946 ) $ (158 ) $ (64 ) $ (2,168 ) The amounts recorded in accumulated other comprehensive losses at December 31, 2017 consisted of the following: (in millions) Pension Post- retirement Post- employment Total Net loss $ (2,493 ) $ (612 ) $ (93 ) $ (3,198 ) Prior service (cost) credit (15 ) 195 — 180 Deferred income taxes 979 166 34 1,179 Amounts recorded in accumulated other comprehensive losses $ (1,529 ) $ (251 ) $ (59 ) $ (1,839 )
Movements in Other Comprehensive Earnings/Losses	The movements in other comprehensive earnings/losses during the year ended December 31, 2018 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 225 $ 21 $ 17 $ 263 Prior service cost/credit 4 (42 ) — (38 ) Other expense: Net loss 13 — — 13 Prior service cost/credit 3 — — 3 Deferred income taxes (61 ) 4 (4 ) (61 ) $ 184 $ (17 ) $ 13 $ 180 Other movements during the year: Adoption of ASU 2018-02 (1) $ (330 ) $ (55 ) $ (12 ) $ (397 ) Net loss (336 ) 264 (2 ) (74 ) Prior service cost/credit (26 ) (45 ) (6 ) (77 ) Deferred income taxes 91 (54 ) 2 39 $ (601 ) $ 110 $ (18 ) $ (509 ) Total movements in other comprehensive earnings/losses $ (417 ) $ 93 $ (5 ) $ (329 ) (1) Reflects the reclassification of the stranded income tax effects of the Tax Reform Act. For further discussion, see Note 15 . Income Taxes . The movements in other comprehensive earnings/losses during the year ended December 31, 2017 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 197 $ 25 $ 17 $ 239 Prior service cost/credit 4 (38 ) — (34 ) Other expense: Net loss 86 — — 86 Deferred income taxes (113 ) 6 (6 ) (113 ) $ 174 $ (7 ) $ 11 $ 178 Other movements during the year: Net loss $ 81 $ (56 ) $ (11 ) $ 14 Prior service cost/credit — 38 — 38 Deferred income taxes (32 ) 7 4 (21 ) $ 49 $ (11 ) $ (7 ) $ 31 Total movements in other comprehensive earnings/losses $ 223 $ (18 ) $ 4 $ 209 The movements in other comprehensive earnings/losses during the year ended December 31, 2016 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 171 $ 25 $ 18 $ 214 Prior service cost/credit 5 (39 ) — (34 ) Other expense (income): Net loss 9 — — 9 Prior service cost/credit 2 (13 ) — (11 ) Deferred income taxes (69 ) 11 (7 ) (65 ) $ 118 $ (16 ) $ 11 $ 113 Other movements during the year: Net loss $ (232 ) $ (18 ) $ (9 ) $ (259 ) Prior service cost/credit (4 ) 16 — 12 Deferred income taxes 92 1 3 96 $ (144 ) $ (1 ) $ (6 ) $ (151 ) Total movements in other comprehensive earnings/losses $ (26 ) $ (17 ) $ 5 $ (38 ) The movements in other comprehensive earnings/losses during the year ended December 31, 2018 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 225 $ 21 $ 17 $ 263 Prior service cost/credit 4 (42 ) — (38 ) Other expense: Net loss 13 — — 13 Prior service cost/credit 3 — — 3 Deferred income taxes (61 ) 4 (4 ) (61 ) $ 184 $ (17 ) $ 13 $ 180 Other movements during the year: Adoption of ASU 2018-02 (1) $ (330 ) $ (55 ) $ (12 ) $ (397 ) Net loss (336 ) 264 (2 ) (74 ) Prior service cost/credit (26 ) (45 ) (6 ) (77 ) Deferred income taxes 91 (54 ) 2 39 $ (601 ) $ 110 $ (18 ) $ (509 ) Total movements in other comprehensive earnings/losses $ (417 ) $ 93 $ (5 ) $ (329 ) (1) Reflects the reclassification of the stranded income tax effects of the Tax Reform Act. For further discussion, see Note 15 . Income Taxes . The movements in other comprehensive earnings/losses during the year ended December 31, 2017 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 197 $ 25 $ 17 $ 239 Prior service cost/credit 4 (38 ) — (34 ) Other expense: Net loss 86 — — 86 Deferred income taxes (113 ) 6 (6 ) (113 ) $ 174 $ (7 ) $ 11 $ 178 Other movements during the year: Net loss $ 81 $ (56 ) $ (11 ) $ 14 Prior service cost/credit — 38 — 38 Deferred income taxes (32 ) 7 4 (21 ) $ 49 $ (11 ) $ (7 ) $ 31 Total movements in other comprehensive earnings/losses $ 223 $ (18 ) $ 4 $ 209 The movements in other comprehensive earnings/losses during the year ended December 31, 2016 were as follows: (in millions) Pension Post- retirement Post- employment Total Amounts reclassified to net earnings as components of net periodic benefit cost: Amortization: Net loss $ 171 $ 25 $ 18 $ 214 Prior service cost/credit 5 (39 ) — (34 ) Other expense (income): Net loss 9 — — 9 Prior service cost/credit 2 (13 ) — (11 ) Deferred income taxes (69 ) 11 (7 ) (65 ) $ 118 $ (16 ) $ 11 $ 113 Other movements during the year: Net loss $ (232 ) $ (18 ) $ (9 ) $ (259 ) Prior service cost/credit (4 ) 16 — 12 Deferred income taxes 92 1 3 96 $ (144 ) $ (1 ) $ (6 ) $ (151 ) Total movements in other comprehensive earnings/losses $ (26 ) $ (17 ) $ 5 $ (38 )

Additional Information (Tables)

Additional Information (Tables)	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other Nonoperating Income (Expense)	For the Years Ended December 31, (in millions) 2018 2017 2016 Research and development expense $ 252 $ 241 $ 203 Advertising expense $ 37 $ 29 $ 27 Interest and other debt expense, net: Interest expense $ 697 $ 727 $ 754 Interest income (32 ) (31 ) (13 ) Interest related to NPM Adjustment Items — 9 6 $ 665 $ 705 $ 747 Rent expense $ 42 $ 43 $ 53
Schedule of Rental Commitments and Sublease Income Under Non-Cancelable Operating Leases	Minimum rental commitments and sublease income under non-cancelable operating leases in effect at December 31, 2018 were as follows: (in millions) Rental Commitments Sublease Income 2019 $ 41 $ 5 2020 35 5 2021 31 5 2022 24 5 2023 17 5 Thereafter 34 2 $ 182 $ 27
Schedule of Valuation and Qualifying Accounts	The activity in the allowance for discounts and allowance for returned goods for the years ended December 31, 2018 , 2017 and 2016 was as follows: (in millions) 2018 2017 2016 Discounts Returned Goods Discounts Returned Goods Discounts Returned Goods Balance at beginning of year $ — $ 40 $ — $ 49 $ — $ 68 Charged to costs and expenses 620 97 626 130 628 133 Deductions (1) (620 ) (105 ) (626 ) (139 ) (628 ) (152 ) Balance at end of year $ — $ 32 $ — $ 40 $ — $ 49 (1) Represents the recording of discounts and returns for which allowances were created. The activity in the allowance for losses on finance assets for the years ended December 31, 2018 , 2017 and 2016 was as follows: (in millions) 2018 2017 2016 Balance at beginning of year $ 23 $ 32 $ 42 Decrease to allowance (4 ) (9 ) (10 ) Balance at end of year $ 19 $ 23 $ 32

Contingencies (Tables)

Contingencies (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Schedule of Loss Contingencies By Contingency	The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows: (in millions) 2018 2017 2016 Accrued liability for tobacco and health litigation items at beginning of year (1) $ 106 $ 47 $ 132 Pre-tax charges for: Tobacco and health litigation 113 72 88 Related interest costs 18 8 17 Payments (1) (125 ) (21 ) (190 ) Accrued liability for tobacco and health litigation items at end of year (1) $ 112 $ 106 $ 47 (1) Includes amounts related to the costs of implementing the corrective communications remedy related to the Federal Government’s Lawsuit discussed below. The table below lists the number of certain tobacco-related cases pending in the United States against PM USA and, in some instances, Altria as of December 31, 2018, 2017 and 2016: 2018 2017 2016 Individual Smoking and Health Cases (1) 100 92 70 Smoking and Health Class Actions and Aggregated Claims Litigation (2) 2 4 5 Health Care Cost Recovery Actions (3) 1 1 1 “Lights/Ultra Lights” Class Actions 2 3 8 (1) Includes 30 cases filed in Massachusetts and 37 non- Engle cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the Engle case (these Engle progeny cases are discussed below in Smoking and Health Litigation - Engle Class Action ). Also does not include 1,490 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 ( Broin ). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, 923 of these cases were voluntarily dismissed without prejudice. (2) The 2016 and 2017 pending cases include as one case the 30 civil actions that were to be tried in six consolidated trials in West Virginia ( In re: Tobacco Litigation ). PM USA was a defendant in nine of the 30 cases. The parties resolved these cases for an immaterial amount, and in the second quarter of 2018, the court dismissed all 30 cases. (3) See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below. Currently Pending Engle Cases with Accrued Liabilities (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Compensatory Damages (All Defendants) Punitive Damages (PM USA) Appeal Status Accrual (1) Berger ( Cote ) September 2014 PM USA Federal Court - Middle District of Florida $6 million $21 million The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court. PM USA intends to challenge the punitive damages award. $6 million accrual in the fourth quarter of 2018 McKeever February 2015 PM USA Broward $6 million $12 million Fourth District Court of Appeal reduced compensatory damages; Florida Supreme Court remanded case to reinstate full compensatory damages award; PM USA’s petition for review by the U.S. Supreme Court is pending. $20 million accrual in fourth quarter of 2017 Pardue December 2016 PM USA and R.J. Reynolds Alachua $5 million $7 million First District Court of Appeal affirmed the judgment; defendants’ petition for review by the U.S. Supreme Court is pending. $10 million accrual ($9 million in second quarter of 2018 and $1 million in third quarter of 2018) Jordan August 2015 PM USA Duval $6 million $3 million First District Court of Appeal affirmed the judgment; PM USA’s petition for review by the U.S. Supreme Court is pending. $11 million accrual in second quarter of 2018 M. Brown May 2015 PM USA Duval $6 million $0 First District Court of Appeal affirmed the judgment; PM USA’s petition for review by the U.S. Supreme Court is pending. Trial court awarded plaintiff approximately $7 million in attorneys’ fees. PM USA filed a motion for rehearing. $7 million accrual in second quarter of 2018 Boatright November 2014 PM USA and Liggett Group LLC (“Liggett Group”) Polk $15 million $20 million Florida Supreme Court upheld the full amount of the trial court judgment without a reduction for plaintiff’s comparative fault and denied PM USA’s request for reconsideration; defendants’ petition for review by the U.S. Supreme Court is pending. $41 million accrual in second quarter of 2018 Searcy April 2013 PM USA and R.J. Reynolds Federal Court - Middle District of Florida <$1 million $2 million U.S. Court of Appeals for the Eleventh Circuit affirmed the judgment; defendants’ petition for review by the U.S. Supreme Court is pending. $2 million accrual in third quarter of 2018 (1) Accrual amounts include interest and associated costs if applicable. For cases with multiple defendants, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff’s favor after taking into account any portion potentially payable by the other defendant(s). Other Currently Pending Engle Cases with Verdicts Against PM USA (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Compensatory Damages (1) Punitive Damages Appeal Status Chadwell September 2018 PM USA Miami-Dade $2 million $0 Trial court denied post-trial motions. PM USA intends to appeal the trial court decision. Kaplan July 2018 PM USA and R.J. Reynolds Broward $2 million $2 million Appeals by plaintiff and defendants to Fourth District Court of Appeal pending. Landi June 2018 PM USA and R.J. Reynolds Broward $8 million $5 million Appeals by plaintiff and defendants to Fourth District Court of Appeal pending. Theis May 2018 PM USA and R.J. Reynolds Sarasota $7 million $10 million Defendants’ appeal to Second District Court of Appeal pending. Freeman March 2018 PM USA Alachua $4 million $0 Defendant’s appeal to First District Court of Appeal pending. Gloger February 2018 PM USA and R.J. Reynolds Miami-Dade $8 million $5 million Defendants’ appeal to Third District Court of Appeal pending. Bryant December 2017 PM USA Escambia <$1 million <$1 million Defendant’s appeal to First District Court of Appeal pending. R. Douglas November 2017 PM USA Duval <$1 million $0 Awaiting entry of final judgment by the trial court. Wallace October 2017 PM USA and R.J. Reynolds Brevard $12 million $16 million Appeals by plaintiff and defendants to Fifth District Court of Appeal pending. L. Martin May 2017 PM USA Miami-Dade $1 million $1 million Appeals by plaintiff and defendant to Third District Court of Appeal pending. Sommers April 2017 PM USA Miami-Dade $1 million $0 New trial ordered on punitive damages; appeals by plaintiff and defendant to Third District Court of Appeal pending. Santoro March 2017 PM USA, R.J. Reynolds and Liggett Group Broward $2 million $0 Trial court set aside punitive damages award; appeals by plaintiff and defendants to Fourth District Court of Appeal pending. J. Brown February 2017 PM USA and R.J. Reynolds Pinellas $5 million <$1 million Second District Court of Appeals issued a per curiam affirmance of the judgment; defendants’ motion for a written opinion pending. S. Martin November 2016 PM USA and R.J. Reynolds Broward $5 million $0 Fourth District Court of Appeal vacated the punitive damages and reinstated the entire compensatory damages award. Danielson November 2015 PM USA Escambia $3 million <$1 million Appeals by plaintiff and defendant to First District Court of Appeal pending. Cooper September 2015 PM USA and R.J. Reynolds Broward $5 million $0 Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages. McCoy July 2015 PM USA, Broward $2 million $3 million Fourth District Court of Appeal reversed judgment and ordered a new trial; plaintiff requested review by the Florida Supreme Court; case stayed pending decision in Pollari , discussed above. D. Brown January 2015 PM USA Federal Court - Middle District of Florida $8 million $9 million Appeal to U.S. Court of Appeals for the Eleventh Circuit stayed pending final disposition in the Searcy case, discussed below. Other Currently Pending Engle Cases with Verdicts Against PM USA (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Compensatory Damages (1) Punitive Damages Appeal Status Kerrivan October 2014 PM USA and R.J. Reynolds Federal Court - Middle District of Florida $16 million $16 million Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending. Harris July 2014 PM USA, Federal Court - Middle District of Florida $2 million $0 Post-trial motions pending. Skolnick June 2013 PM USA and R.J. Reynolds Palm Beach $0 $0 Fourth District Court of Appeal reversed compensatory damages award, ruled in favor of defendants on strict liability and negligence claims and remanded conspiracy and concealment claims for a new trial. Currently pending limited retrial. (1) PM USA’s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. Engle Cases Concluded Within Past 12 Months (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Accrual Date Payment Amount (if any) Payment Date Boulter December 2018 PM USA and Lee Fourth quarter of 2018 <$1 million January 2019 Simon September 2018 PM USA and Broward Fourth quarter of 2018 <$1 million October 2018 Perrotto November 2014 PM USA, Palm Beach Third quarter of 2018 $1 million September 2018 Gore March 2015 PM USA and Indian River First quarter of 2018 $1 million September 2018 Putney April 2010 PM USA, Broward Third quarter of 2018 $5 million September 2018 Sermons July 2016 PM USA and Duval Third quarter of 2018 <$1 million August 2018 Tognoli November 2015 PM USA Broward Fourth quarter of 2017 $1 million May 2018 Howles November 2016 PM USA and Broward First quarter of 2018 $6 million May 2018 Purdo April 2016 PM USA and Palm Beach First quarter of 2018 $10 million May 2018 Griffin June 2014 PM USA Federal Court - Middle District of Florida Second quarter of 2017 $1 million May 2018 Ledoux December 2015 PM USA and Miami-Dade Fourth quarter of 2017 $20 million May 2018 Burkhart May 2014 PM USA, Federal Court - Middle District of Florida Second quarter of 2018 $2 million May 2018 Barbose November 2015 PM USA and Pasco Fourth quarter of 2017 $12 million May 2018 Allen November 2014 PM USA and Duval First quarter of 2018 $10 million May 2018 Engle Cases Concluded Within Past 12 Months (rounded to nearest $ million) Plaintiff Verdict Date Defendant(s) Court Accrual Date Payment Amount (if any) Payment Date Ahrens February 2016 PM USA and Pinellas Fourth quarter of 2017 $7 million May 2018 Starr-Blundell June 2013 PM USA and Duval First quarters of 2016 and 2018 <$1 million March 2018 Zamboni February 2015 PM USA and Federal Court - Middle District of Florida First quarter of 2018 <$1 million March 2018 Graham May 2013 PM USA and Federal Court - Middle District of Florida Second quarter of 2017 $1 million January 2018 Naugle November 2009 PM USA Broward Second quarter of 2017 $14 million January 2018 Lourie October 2014 PM USA, Hillsborough Second quarter of 2017 $3 million January 2018 Marchese October 2015 PM USA and Broward Fourth quarter of 2017 $1 million January 2018

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information (Tables)	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Balance Sheet	Condensed Consolidating Balance Sheets (in millions of dollars) ____________________________ at December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Assets Cash and cash equivalents $ 1,277 $ — $ 56 $ — $ 1,333 Receivables — 18 124 — 142 Inventories: Leaf tobacco — 561 379 — 940 Other raw materials — 123 63 — 186 Work in process — 2 645 — 647 Finished product — 128 430 — 558 — 814 1,517 — 2,331 Due from Altria and subsidiaries 46 3,828 1,194 (5,068 ) — Income taxes 100 94 — (27 ) 167 Other current assets 41 167 118 — 326 Total current assets 1,464 4,921 3,009 (5,095 ) 4,299 Property, plant and equipment, at cost — 2,928 2,022 — 4,950 Less accumulated depreciation — 2,111 901 — 3,012 — 817 1,121 — 1,938 Goodwill — — 5,196 — 5,196 Other intangible assets, net — 2 12,277 — 12,279 Investment in AB InBev 17,696 — — — 17,696 Investment in JUUL — — 12,800 — 12,800 Investment in consolidated subsidiaries 25,996 2,825 — (28,821 ) — Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 193 955 952 (670 ) 1,430 Total Assets $ 50,139 $ 9,520 $ 35,355 $ (39,376 ) $ 55,638 Condensed Consolidating Balance Sheets (Continued) (in millions of dollars) ____________________________ at December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Liabilities Short-term borrowings $ 12,704 $ — $ — $ — $ 12,704 Current portion of long-term debt 1,144 — — — 1,144 Accounts payable 1 91 307 — 399 Accrued liabilities: Marketing — 483 103 — 586 Employment costs 16 11 162 — 189 Settlement charges — 3,448 6 — 3,454 Other 279 513 449 (27 ) 1,214 Dividends payable 1,503 — — — 1,503 Due to Altria and subsidiaries 4,499 407 162 (5,068 ) — Total current liabilities 20,146 4,953 1,189 (5,095 ) 21,193 Long-term debt 11,898 — — — 11,898 Deferred income taxes 3,010 — 2,832 (670 ) 5,172 Accrued pension costs 187 — 357 — 544 Accrued postretirement health care costs — 1,072 677 — 1,749 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 111 47 96 — 254 Total liabilities 35,352 6,072 9,941 (10,555 ) 40,810 Contingencies Redeemable noncontrolling interest — — 39 — 39 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,961 3,310 25,047 (28,357 ) 5,961 Earnings reinvested in the business 43,962 359 2,201 (2,560 ) 43,962 Accumulated other comprehensive losses (2,547 ) (221 ) (1,884 ) 2,105 (2,547 ) Cost of repurchased stock (33,524 ) — — — (33,524 ) Total stockholders’ equity attributable to Altria 14,787 3,448 25,373 (28,821 ) 14,787 Noncontrolling interests — — 2 — 2 Total stockholders’ equity 14,787 3,448 25,375 (28,821 ) 14,789 Total Liabilities and Stockholders’ Equity $ 50,139 $ 9,520 $ 35,355 $ (39,376 ) $ 55,638 Condensed Consolidating Balance Sheets (in millions of dollars) ____________________________ at December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Assets Cash and cash equivalents $ 1,203 $ 1 $ 49 $ — $ 1,253 Receivables 1 10 131 — 142 Inventories: Leaf tobacco — 579 362 — 941 Other raw materials — 111 59 — 170 Work in process — 5 555 — 560 Finished product — 128 426 — 554 — 823 1,402 — 2,225 Due from Altria and subsidiaries 2 2,413 1,022 (3,437 ) — Income taxes — 542 17 (98 ) 461 Other current assets 11 147 105 — 263 Total current assets 1,217 3,936 2,726 (3,535 ) 4,344 Property, plant and equipment, at cost — 2,930 1,949 — 4,879 Less accumulated depreciation — 2,086 879 — 2,965 — 844 1,070 — 1,914 Goodwill — — 5,307 — 5,307 Other intangible assets, net — 2 12,398 — 12,400 Investment in AB InBev 17,952 — — — 17,952 Investment in consolidated subsidiaries 13,111 2,818 — (15,929 ) — Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 34 671 1,056 (476 ) 1,285 Total Assets $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202 Condensed Consolidating Balance Sheets (Continued) (in millions of dollars) ____________________________ at December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Liabilities Current portion of long-term debt $ 864 $ — $ — $ — $ 864 Accounts payable 2 91 281 — 374 Accrued liabilities: Marketing — 578 117 — 695 Employment costs 21 14 153 — 188 Settlement charges — 2,437 5 — 2,442 Other 389 433 247 (98 ) 971 Dividends payable 1,258 — — — 1,258 Due to Altria and subsidiaries 3,040 317 80 (3,437 ) — Total current liabilities 5,574 3,870 883 (3,535 ) 6,792 Long-term debt 13,030 — — — 13,030 Deferred income taxes 2,809 — 2,914 (476 ) 5,247 Accrued pension costs 206 — 239 — 445 Accrued postretirement health care costs — 1,214 773 — 1,987 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 108 49 126 — 283 Total liabilities 21,727 5,133 9,725 (8,801 ) 27,784 Contingencies Redeemable noncontrolling interest — — 38 — 38 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,952 3,310 12,045 (15,355 ) 5,952 Earnings reinvested in the business 42,251 96 2,243 (2,339 ) 42,251 Accumulated other comprehensive losses (1,897 ) (268 ) (1,506 ) 1,774 (1,897 ) Cost of repurchased stock (31,864 ) — — — (31,864 ) Total stockholders’ equity attributable to Altria 15,377 3,138 12,791 (15,929 ) 15,377 Noncontrolling interests — — 3 — 3 Total stockholders’ equity 15,377 3,138 12,794 (15,929 ) 15,380 Total Liabilities and Stockholders’ Equity $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202
Condensed Consolidating of Earnings and Comprehensive Earnings Income Statement	Condensed Consolidating Statements of Earnings and Comprehensive Earnings (in millions of dollars) _____________________________ for the year ended December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 21,422 $ 3,980 $ (38 ) $ 25,364 Cost of sales — 6,153 1,258 (38 ) 7,373 Excise taxes on products — 5,517 220 — 5,737 Gross profit — 9,752 2,502 — 12,254 Marketing, administration and research costs 219 1,892 645 — 2,756 Asset impairment and exit costs — 81 302 — 383 Operating (expense) income (219 ) 7,779 1,555 — 9,115 Interest and other debt expense (income), net 511 (61 ) 215 — 665 Net periodic benefit cost (income), excluding service cost 16 (41 ) (9 ) — (34 ) Earnings from equity investment in AB InBev (890 ) — — — (890 ) Loss on AB InBev/SABMiller business combination 33 — — — 33 Earnings before income taxes and equity earnings of subsidiaries 111 7,881 1,349 — 9,341 Provision for income taxes 36 1,980 358 — 2,374 Equity earnings of subsidiaries 6,888 402 — (7,290 ) — Net earnings 6,963 6,303 991 (7,290 ) 6,967 Net earnings attributable to noncontrolling interests — — (4 ) — (4 ) Net earnings attributable to Altria $ 6,963 $ 6,303 $ 987 $ (7,290 ) $ 6,963 Net earnings $ 6,963 $ 6,303 $ 991 $ (7,290 ) $ 6,967 Other comprehensive (losses) earnings, net of deferred income taxes (242 ) 104 (54 ) (50 ) (242 ) Comprehensive earnings 6,721 6,407 937 (7,340 ) 6,725 Comprehensive earnings attributable to noncontrolling interests — — (4 ) — (4 ) Comprehensive earnings attributable to Altria $ 6,721 $ 6,407 $ 933 $ (7,340 ) $ 6,721 Condensed Consolidating Statements of Earnings and Comprehensive Earnings (in millions of dollars) _____________________________ for the year ended December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 21,826 $ 3,787 $ (37 ) $ 25,576 Cost of sales — 6,394 1,174 (37 ) 7,531 Excise taxes on products — 5,864 218 — 6,082 Gross profit — 9,568 2,395 — 11,963 Marketing, administration and research costs 161 1,713 464 — 2,338 Asset impairment and exit costs — — 32 — 32 Operating (expense) income (161 ) 7,855 1,899 — 9,593 Interest and other debt expense (income), net 510 (20 ) 215 — 705 Net periodic benefit cost, excluding service cost 12 18 7 — 37 Earnings from equity investment in AB InBev (532 ) — — — (532 ) Gain on AB InBev/SABMiller business combination (445 ) — — — (445 ) Earnings before income taxes and equity earnings of subsidiaries 294 7,857 1,677 — 9,828 (Benefit) provision for income taxes (2,624 ) 3,127 (902 ) — (399 ) Equity earnings of subsidiaries 7,304 558 — (7,862 ) — Net earnings 10,222 5,288 2,579 (7,862 ) 10,227 Net earnings attributable to noncontrolling interests — — (5 ) — (5 ) Net earnings attributable to Altria $ 10,222 $ 5,288 $ 2,574 $ (7,862 ) $ 10,222 Net earnings $ 10,222 $ 5,288 $ 2,579 $ (7,862 ) $ 10,227 Other comprehensive earnings, net of deferred income taxes 155 3 214 (217 ) 155 Comprehensive earnings 10,377 5,291 2,793 (8,079 ) 10,382 Comprehensive earnings attributable to noncontrolling interests — — (5 ) — (5 ) Comprehensive earnings attributable to Altria $ 10,377 $ 5,291 $ 2,788 $ (8,079 ) $ 10,377 Condensed Consolidating Statements of Earnings and Comprehensive Earnings (in millions of dollars) _____________________________ for the year ended December 31, 2016 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 22,146 $ 3,633 $ (35 ) $ 25,744 Cost of sales — 6,641 1,159 (35 ) 7,765 Excise taxes on products — 6,187 220 — 6,407 Gross profit — 9,318 2,254 — 11,572 Marketing, administration and research costs 160 2,009 493 — 2,662 Asset impairment and exit costs 5 77 67 — 149 Operating (expense) income (165 ) 7,232 1,694 — 8,761 Interest and other debt expense, net 519 10 218 — 747 Loss on early extinguishment of debt 823 — — — 823 Net periodic benefit cost (income), excluding service cost 5 (6 ) — — (1 ) Earnings from equity investment in SABMiller (795 ) — — — (795 ) Gain on AB InBev/SABMiller business combination (13,865 ) — — — (13,865 ) Earnings before income taxes and equity earnings of subsidiaries 13,148 7,228 1,476 — 21,852 Provision for income taxes 4,453 2,631 524 — 7,608 Equity earnings of subsidiaries 5,544 268 — (5,812 ) — Net earnings 14,239 4,865 952 (5,812 ) 14,244 Net earnings attributable to noncontrolling interests — — (5 ) — (5 ) Net earnings attributable to Altria $ 14,239 $ 4,865 $ 947 $ (5,812 ) $ 14,239 Net earnings $ 14,239 $ 4,865 $ 952 $ (5,812 ) $ 14,244 Other comprehensive earnings (losses), net of deferred income taxes 1,228 (16 ) (28 ) 44 1,228 Comprehensive earnings 15,467 4,849 924 (5,768 ) 15,472 Comprehensive earnings attributable to noncontrolling interests — — (5 ) — (5 ) Comprehensive earnings attributable to Altria $ 15,467 $ 4,849 $ 919 $ (5,768 ) $ 15,467
Condensed Consolidating Statement of Cash Flows	Condensed Consolidating Statements of Cash Flows (in millions of dollars) _____________________________ for the year ended December 31, 2018 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 6,907 $ 7,580 $ 1,354 $ (7,450 ) $ 8,391 Cash Provided by (Used in) Investing Activities Capital expenditures — (57 ) (181 ) — (238 ) Acquisitions of businesses and assets — — (15 ) — (15 ) Investment in JUUL — — (12,800 ) — (12,800 ) Proceeds from finance assets — — 37 — 37 Proceeds from derivative financial instruments 35 — — — 35 Investment in consolidated subsidiaries (13,003 ) — — 13,003 — Other, net — — (7 ) — (7 ) Net cash provided by (used in) investing activities (12,968 ) (57 ) (12,966 ) 13,003 (12,988 ) Cash Provided by (Used in) Financing Activities Proceeds from short-term borrowings 12,800 — — — 12,800 Long-term debt repaid (864 ) — — — (864 ) Repurchases of common stock (1,673 ) — — — (1,673 ) Dividends paid on common stock (5,415 ) — — — (5,415 ) Changes in amounts due to/from Altria and subsidiaries 1,415 (1,388 ) 12,976 (13,003 ) — Cash dividends paid to parent — (6,097 ) (1,353 ) 7,450 — Other (128 ) — (4 ) — (132 ) Net cash (used in) provided by financing activities 6,135 (7,485 ) 11,619 (5,553 ) 4,716 Cash, cash equivalents and restricted cash (1) : Increase 74 38 7 — 119 Balance at beginning of year 1,203 62 49 — 1,314 Balance at end of year $ 1,277 $ 100 $ 56 $ — $ 1,433 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 19 . Contingencies . Condensed Consolidating Statements of Cash Flows (in millions of dollars) _____________________________ for the year ended December 31, 2017 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 6,910 $ 4,028 $ 841 $ (6,878 ) $ 4,901 Cash Provided by (Used in) Investing Activities Capital expenditures — (34 ) (165 ) — (199 ) Acquisitions of businesses and assets — — (415 ) — (415 ) Proceeds from finance assets — — 133 — 133 Investment in consolidated subsidiaries (460 ) — — 460 — Other, net (5 ) 4 15 — 14 Net cash used in investing activities (465 ) (30 ) (432 ) 460 (467 ) Cash Provided by (Used in) Financing Activities Repurchases of common stock (2,917 ) — — — (2,917 ) Dividends paid on common stock (4,807 ) — — — (4,807 ) Changes in amounts due to/from Altria and subsidiaries (1,999 ) 1,410 1,049 (460 ) — Cash dividends paid to parent — (5,429 ) (1,449 ) 6,878 — Other (40 ) — (7 ) — (47 ) Net cash used in financing activities (9,763 ) (4,019 ) (407 ) 6,418 (7,771 ) Cash, cash equivalents and restricted cash (1) : (Decrease) increase (3,318 ) (21 ) 2 — (3,337 ) Balance at beginning of year 4,521 83 47 — 4,651 Balance at end of year $ 1,203 $ 62 $ 49 $ — $ 1,314 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 19 . Contingencies . Condensed Consolidating Statements of Cash Flows (in millions of dollars) _____________________________ for the year ended December 31, 2016 Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 4,356 $ 5,143 $ 319 $ (5,992 ) $ 3,826 Cash Provided by (Used in) Investing Activities Capital expenditures — (45 ) (144 ) — (189 ) Acquisition of assets — — (45 ) — (45 ) Proceeds from finance assets — — 231 — 231 Proceeds from AB InBev/SABMiller business combination 4,773 — — — 4,773 Purchase of AB InBev ordinary shares (1,578 ) — — — (1,578 ) Proceeds from derivative financial instruments 510 — — — 510 Investment in consolidated subsidiaries (138 ) — — 138 — Other, net (3 ) — 9 — 6 Net cash provided by (used in) investing activities 3,564 (45 ) 51 138 3,708 Cash Provided by (Used in) Financing Activities Long-term debt issued 1,976 — — — 1,976 Long-term debt repaid (933 ) — — — (933 ) Repurchases of common stock (1,030 ) — — — (1,030 ) Dividends paid on common stock (4,512 ) — — — (4,512 ) Changes in amounts due to/from Altria and subsidiaries (392 ) (28 ) 558 (138 ) — Premiums and fees related to early extinguishment of debt (809 ) — — — (809 ) Cash dividends paid to parent — (5,064 ) (928 ) 5,992 — Other, net (12 ) — (9 ) — (21 ) Net cash used in financing activities (5,712 ) (5,092 ) (379 ) 5,854 (5,329 ) Cash, cash equivalents and restricted cash (1) : Increase (decrease) 2,208 6 (9 ) — 2,205 Balance at beginning of year 2,313 77 56 — 2,446 Balance at end of year $ 4,521 $ 83 $ 47 $ — $ 4,651 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 19 . Contingencies .

Quarterly Financial Data (Una_2

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Data [Abstract]
Schedule of Quarterly Financial Data	2018 Quarters (in millions, except per share data) 1st 2nd 3rd 4th Net revenues $ 6,108 $ 6,305 $ 6,837 $ 6,114 Gross profit $ 2,936 $ 3,141 $ 3,255 $ 2,922 Net earnings $ 1,895 $ 1,877 $ 1,944 $ 1,251 Net earnings attributable to Altria $ 1,894 $ 1,876 $ 1,943 $ 1,250 Per share data: Basic EPS attributable to Altria $ 1.00 $ 0.99 $ 1.03 $ 0.67 Diluted EPS attributable to Altria $ 1.00 $ 0.99 $ 1.03 $ 0.66 2017 Quarters (in millions, except per share data) 1st 2nd 3rd 4th Net revenues $ 6,083 $ 6,663 $ 6,729 $ 6,101 Gross profit (1) $ 2,776 $ 3,114 $ 3,171 $ 2,902 Net earnings $ 1,402 $ 1,990 $ 1,867 $ 4,968 Net earnings attributable to Altria $ 1,401 $ 1,989 $ 1,866 $ 4,966 Per share data: Basic and diluted EPS attributable to Altria $ 0.72 $ 1.03 $ 0.97 $ 2.60 (1) Certain prior year amounts have been reclassified to conform with the current year’s presentation due to Altria’s adoption of ASU 2017-07. For further discussion, see Note 17 . Benefit Plans .
Schedule Of Pre-Tax Charges (Gains) Included In Net Earnings	During 2018 and 2017 , the following pre-tax (gains) or charges were included in net earnings attributable to Altria: 2018 Quarters (in millions) 1st 2nd 3rd 4th NPM Adjustment Items $ (68 ) $ (77 ) $ — $ — Tobacco and health litigation items, including accrued interest 28 70 21 12 Asset impairment, exit, implementation and acquisition-related costs 3 6 (3 ) 532 Loss on AB InBev/SABMiller business combination 33 — — — AB InBev special items (117 ) (72 ) 35 69 $ (121 ) $ (73 ) $ 53 $ 613 2017 Quarters (in millions) 1st 2nd 3rd 4th NPM Adjustment Items $ (1 ) $ — $ 5 $ — Tobacco and health litigation items, including accrued interest 1 17 — 62 Asset impairment, exit, implementation and acquisition-related costs 30 30 17 12 Settlement charge for lump sum pension payments — — — 81 Gain on AB InBev/SABMiller business combination — (408 ) (37 ) — AB InBev special items 73 2 34 51 $ 103 $ (359 ) $ 19 $ 206

Background and Basis of Prese_2

Background and Basis of Presentation (Details) $ / shares in Units, $ in Billions	6 Months Ended		12 Months Ended
	Jun. 30, 2019USD ($)directorboard_membershares	Jun. 30, 2019CAD ($)	Dec. 31, 2018USD ($)board_member	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)shares	Jun. 30, 2019CAD ($)directorboard_member$ / sharesshares	Jan. 31, 2019USD ($)	Jan. 31, 2019CAD ($)	Dec. 20, 2018USD ($)	Dec. 07, 2018shares	Sep. 30, 2018shares	Oct. 10, 2016shares	Oct. 09, 2016	Sep. 30, 2016
Schedule of Equity Method Investments [Line Items]
Earnings from equity investment in AB InBev/SABMiller			$ 890,000,000	$ 532,000,000	$ 795,000,000
SABMiller Plc [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage (approximately)													27.00%	27.00%
Ordinary shares owned/purchased (in shares) | shares												430,000,000
Earnings from equity investment in AB InBev/SABMiller					$ 795,000,000
AB InBev [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage (approximately)			10.10%		10.20%							9.60%
Ordinary shares owned/purchased (in shares) | shares					12,000,000						92,400,000
Earnings from equity investment in AB InBev/SABMiller			$ 890,000,000	532,000,000	$ 0
JUUL [Member]
Schedule of Equity Method Investments [Line Items]
Equity securities Fv Ni, ownership percentage									35.00%
Equity securities Fv-Ni, purchase price									$ 12,800,000,000
Cronos Group Inc. [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, number of shares eligible for purchase (in shares) | shares										146,200,000
Number of board of directors | board_member			5
Scenario, Forecast [Member] | Cronos Group Inc. [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage (approximately)	45.00%					45.00%
Equity method investment, number of shares eligible for purchase (in shares) | shares	72,200,000					72,200,000
Equity method investment, shares purchased, price per share (in CAD per share) | $ / shares						$ 19
Equity method investments, purchase price	$ 1,800,000,000					$ 2.4
Equity method investment, expiration period	4 years	4 years
Equity method investment, warrant exercised, ownership percentage	55.00%	55.00%
Equity method investment, warrant exercise price	$ 1,400,000,000	$ 1
Number of directors | director	4					4
Number of independent directors | director	1					1
Number of board of directors | board_member	7					7
Accounting Standards Update 2016-18 [Member]
Schedule of Equity Method Investments [Line Items]
Restricted cash and cash equivalents, current				$ 61,000,000	$ 82,000,000
Forward Contracts [Member] | Subsequent Event [Member]
Schedule of Equity Method Investments [Line Items]
Notional amount of option							$ 1,100,000,000	$ 1.5

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Revenue, contract duration	1 year
Revenue, performance obligation, description of timing	three days
Maximum [Member]
Property, Plant and Equipment [Line Items]
Definite-lived intangible assets useful life maximum, years	25 years
Maximum [Member] | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment	25 years
Maximum [Member] | Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment	50 years
USSTC [Member]
Property, Plant and Equipment [Line Items]
Revenue, performance obligation, description of timing	one business day
Ste. Michelle [Member]
Property, Plant and Equipment [Line Items]
Revenue, performance obligation, description of timing	45 days

Revenues from Contracts with _2

Revenues from Contracts with Customers (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenue from Contract with Customer [Abstract]
Allowance for cash discounts	$ 0	$ 0
Contract with customer, liability	$ 288,000,000	267,000,000
Revenue, performance obligation, description of timing	three days
Receivables	$ 142,000,000	$ 142,000,000

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Intangible Assets by Segment) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Line Items]
Goodwill	$ 5,196	$ 5,307	$ 5,285
Other Intangible Assets, net	12,279	12,400	$ 12,036
Smokeable Products [Member]
Goodwill [Line Items]
Goodwill	99	99
Other Intangible Assets, net	3,037	3,054
Smokeless Products [Member]
Goodwill [Line Items]
Goodwill	5,023	5,023
Other Intangible Assets, net	8,825	8,827
Wine [Member]
Goodwill [Line Items]
Goodwill	74	74
Other Intangible Assets, net	239	294
Other [Member]
Goodwill [Line Items]
Goodwill	0	111
Other Intangible Assets, net	$ 178	$ 225

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets, net (Other Intangible Assets Disclosure) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Indefinite-lived intangible assets	$ 11,846	$ 12,125
Definite-lived intangible assets	654	465
Total other intangible assets	12,500	12,590
Definite-lived intangible assets, accumulated amortization	$ 221	$ 190

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets, net (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 38,000,000	$ 21,000,000	$ 21,000,000
Estimated future amortization, year 1	30,000,000
Estimated future amortization, year 2	30,000,000
Estimated future amortization, year 3	30,000,000
Estimated future amortization, year 4	30,000,000
Estimated future amortization, year 5	30,000,000
Goodwill impairment charges	111,000,000
Impairment of Intangible Assets (Excluding Goodwill)	44,000,000
Impairment charges		0	$ 0
Accumulated impairment losses related to goodwill and other intangible assets, net		$ 0
UST [Member]
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived trademarks	9,000,000,000
Middleton [Member]
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived trademarks	$ 2,600,000,000
Definite-Lived Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Definite-lived intangible assets amortization period, maximum, in years	25 years
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment charges	$ 54,000,000
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Definite-lived intangible assets amortization period, maximum, in years	25 years

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Net Carrying Amount of Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Roll Forward]
Balance at beginning of period	$ 5,307	$ 5,285
Acquisitions	0	22
Asset impairment	(111)	0
Balance of end of period	5,196	5,307	$ 5,285
Intangible Assets [Roll Forward]
Balance beginning of period	12,400	12,036
Acquisitions	15	385
Asset Impairment	(98)	0
Amortization	(38)	(21)	(21)
Balance end of period	$ 12,279	$ 12,400	$ 12,036

Asset Impairment, Exit and Im_3

Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restructuring Cost and Reserve [Line Items]
Asset Impairment and Exit Costs	$ 383	$ 32	$ 149
Asset Impairment and Business Exit Costs, Net	386	33	179
Implementation Costs	67	45	24
Total	450	77	173
Less amounts included in net periodic benefit (income) cost, excluding service cost, asset impairment and exit costs	3	1	30
Less amounts included in net periodic benefit (income) cost, excluding service cost, implementation costs	0	0	0
Less amounts included in net periodic benefit (income) cost, excluding service cost, total	3	1	30
Other Restructuring Costs, Net	67	45	24
Restructuring Charges, Net	453	78	203
Operating Segments [Member] | Smokeable Products [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment and Business Exit Costs, Net	82	5	125
Other Restructuring Costs, Net	1	17	9
Restructuring Charges, Net	83	22	134
Operating Segments [Member] | Smokeless Products [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment and Business Exit Costs, Net	20	28	42
Other Restructuring Costs, Net	3	28	15
Restructuring Charges, Net	23	56	57
Operating Segments [Member] | Wine [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment and Business Exit Costs, Net	54	0	0
Other Restructuring Costs, Net	0	0	0
Restructuring Charges, Net	54	0	0
Operating Segments [Member] | All Other [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment and Business Exit Costs, Net	227	0	7
Other Restructuring Costs, Net	63	0	0
Restructuring Charges, Net	290	0	7
Corporate, Non-Segment [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment and Exit Costs	0	0	5
Asset Impairment and Business Exit Costs, Net	3	0	5
Other Restructuring Costs, Net	0	0	0
Restructuring Charges, Net	3	$ 0	$ 5
Cost of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs, Net	17
Marketing, Adminstration and Research Costs [Member]
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs, Net	$ 7

Asset Impairment, Exit and Im_4

Asset Impairment, Exit and Implementation Costs (Restructuring Liabilities) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 33	$ 79
Charges	154	25
Cash spent	(32)	(71)
Balance at end of period	$ 155	$ 33

Asset Impairment, Exit and Im_5

Asset Impairment, Exit and Implementation Costs (Narrative) (Details) - USD ($)	1 Months Ended	12 Months Ended			27 Months Ended	36 Months Ended
	Dec. 31, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2018	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		$ 450,000,000	$ 77,000,000	$ 173,000,000
Payments for restructuring		32,000,000	71,000,000
Refocus of Innovative Product Efforts [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		272,000,000
Refocus of Innovative Product Efforts [Member] | Asset Impairment and Exit Costs [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		209,000,000
Refocus of Innovative Product Efforts [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		63,000,000
Cost Reduction Program [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs	$ 121,000,000	121,000,000
Restructuring and related costs, expected savings	575,000,000
Expected restructuring related costs	210,000,000	210,000,000			$ 210,000,000	$ 210,000,000
Payments for restructuring		0
Cost Reduction Program [Member] | Corporate, Non-Segment [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		3,000,000
Cost Reduction Program [Member] | Smokeable Products [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		86,000,000
Cost Reduction Program [Member] | Smokeless Products [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		14,000,000
Cost Reduction Program [Member] | All Other [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		18,000,000
Cost Reduction Program [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring related costs	50,000,000	50,000,000			50,000,000	50,000,000
Cost Reduction Program [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring related costs	160,000,000	160,000,000			160,000,000	160,000,000
Facility Consolidation [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs		6,000,000	78,000,000	71,000,000
Restructuring and related cost, cost incurred to date	155,000,000	155,000,000			155,000,000	155,000,000
Payments for restructuring		34,000,000			97,000,000
Facility Consolidation [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring related costs	60,000,000	60,000,000			60,000,000	60,000,000
Facility Consolidation [Member] | Accelerated Depreciation And Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, cost incurred to date	55,000,000	55,000,000			55,000,000	55,000,000
Facility Consolidation [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring related costs	$ 40,000,000	$ 40,000,000			$ 40,000,000	40,000,000
Productivity Initiative [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs				132,000,000
Payments for restructuring			$ 32,000,000			$ 106,000,000
Productivity Initiative [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs				15,000,000
Productivity Initiative [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairment, exit costs and implementation costs				$ 117,000,000

Inventories (Details)

Inventories (Details) - USD ($) $ in Billions	Dec. 31, 2018	Dec. 31, 2017
Inventory Disclosure [Abstract]
Inventories determined using LIFO method	58.00%	59.00%
Current cost of inventories over LIFO amounts	$ 0.7	$ 0.7

Investment in AB InBev_SABMil_3

Investment in AB InBev/SABMiller (Narrative) (Details)	3 Months Ended								12 Months Ended
	Dec. 31, 2018USD ($)shares	Sep. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Sep. 30, 2017USD ($)	Jun. 30, 2017USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2018USD ($)shares	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)shares	Dec. 31, 2018€ / shares	Sep. 30, 2018€ / sharesshares	Oct. 10, 2016shares	Oct. 09, 2016	Sep. 30, 2016
Schedule of Equity Method Investments [Line Items]
Earnings from equity investment in AB InBev/SABMiller									$ 890,000,000	$ 532,000,000	$ 795,000,000
Investment in AB InBev	$ 17,696,000,000				$ 17,952,000,000				17,696,000,000	17,952,000,000
(Loss) gain on AB InBev/SABMiller business combination	$ 0	$ 0	$ 0	$ (33,000,000)	0	$ 37,000,000	$ 408,000,000	$ 0	$ (33,000,000)	445,000,000	$ 13,865,000,000
AB InBev [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage (approximately)	10.10%								10.10%		10.20%			9.60%
Equity method investment, number of shares owned, restricted (in shares) | shares	185,000,000								185,000,000
Equity method investment, number of shares owned, common (in shares) | shares	12,000,000								12,000,000
Earnings from equity investment in AB InBev/SABMiller									$ 890,000,000	532,000,000	$ 0
Ordinary shares owned/purchased (in shares) | shares											12,000,000		92,400,000
Share price (in EUR per share) | € / shares												€ 57.70	€ 75.22
Difference between carrying amount and underlying equity	$ 11,800,000,000								11,800,000,000
Fair value of investment	13,100,000,000				22,100,000,000				13,100,000,000	22,100,000,000
Investment in AB InBev	$ 17,700,000,000				$ 18,000,000,000				17,700,000,000	18,000,000,000
SABMiller Plc [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage (approximately)															27.00%	27.00%
Earnings from equity investment in AB InBev/SABMiller											$ 795,000,000
Ordinary shares owned/purchased (in shares) | shares														430,000,000
SABMiller Plc [Member] | The Coca-Cola Company and Gutsche Family Investments [Member]
Schedule of Equity Method Investments [Line Items]
Earnings from equity investment in AB InBev/SABMiller											309,000,000
AB InBev [Member]
Schedule of Equity Method Investments [Line Items]
(Loss) gain on AB InBev/SABMiller business combination									$ (33,000,000)	$ 445,000,000	13,900,000,000
After-tax accounting gain on AB InBev/SABMiller business combination (approximately)											$ 9,000,000,000

Investment in AB InBev_SABMil_4

Investment in AB InBev/SABMiller (Summary of Financial Data in AB InBev) (Details) - AB InBev [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Sep. 30, 2018	Sep. 30, 2017
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]
Net revenues	$ 55,500	$ 56,004
Gross profit	34,986	34,376
Earnings from continuing operations	9,020	6,769
Net earnings	9,020	6,845
Net earnings attributable to AB InBev	$ 7,641	$ 5,473
Current assets			$ 20,289	$ 30,920
Long-term assets			207,921	213,696
Current liabilities			32,019	37,765
Long-term liabilities			130,812	134,236
Noncontrolling interests			$ 7,251	$ 10,639

Investment in AB InBev_SABMil_5

Investment in AB InBev/SABMiller (Summary of Financial Data of SABMiller) (Details) - SABMiller Plc [Member] $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)
Schedule of Equity Method Investments [Line Items]
Net revenues	$ 14,543
Operating profit	2,099
Net earnings attributable to SABMiller	$ 1,803

Investment in AB InBev_SABMil_6

Investment in AB InBev/SABMiller (AB InBev and SABMiller Business Combination) (Details) $ in Millions	Oct. 10, 2016USD ($)	Oct. 31, 2016USD ($)	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)shares	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Sep. 30, 2017USD ($)	Jun. 30, 2017USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)shares	Oct. 10, 2016£ / sharesshares	Oct. 09, 2016	Sep. 30, 2016
Business Acquisition [Line Items]
Cash component of the partial share alternative											$ 0	$ 0	$ 4,773
Proceeds from derivative financial instruments		$ 500									35	0	510
Total pre-tax cash from AB InBev and derivative financial instruments	$ 5,300
Purchase of AB InBev ordinary shares											12,800		1,578
Gain on AB InBev/SABMiller business combination			$ 0	$ 0	$ 0	$ (33)	$ 0	$ 37	$ 408	$ 0	$ (33)	445	$ 13,865
AB InBev [Member]
Business Acquisition [Line Items]
Ordinary shares owned/purchased (in shares) | shares				92,400,000									12,000,000
Equity method investment, ownership percentage (approximately)			10.10%								10.10%		10.20%	9.60%
Cash component of the partial share alternative	$ 4,800
Purchase of AB InBev ordinary shares													$ 1,600
SABMiller Plc [Member]
Business Acquisition [Line Items]
Ordinary shares owned/purchased (in shares) | shares														430,000,000
Equity method investment, ownership percentage (approximately)															27.00%	27.00%
AB InBev [Member]
Business Acquisition [Line Items]
British pounds in cash for each SABMiller share, offered by AB InBev (GBP per share) | £ / shares														£ 45
Partial share alternative percentage available for SABMiller shares (approximately)														41.00%
Gain on AB InBev/SABMiller business combination											$ (33)	$ 445	13,900
After-tax accounting gain on AB InBev/SABMiller business combination (approximately)													$ 9,000
Restricted Shares [Member] | AB InBev [Member]
Business Acquisition [Line Items]
Restricted shares, lock-up period											5 years

Investment in AB InBev_SABMil_7

Investment in AB InBev/SABMiller (Derivative Financial Instruments) (Details) £ in Millions, $ in Millions	1 Months Ended	12 Months Ended
	Oct. 31, 2016USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Aug. 31, 2016GBP (£)	Aug. 31, 2016USD ($)	Nov. 30, 2015GBP (£)	Nov. 30, 2015USD ($)
Schedule of Equity Method Investments [Line Items]
Proceeds from derivative financial instruments	$ 500	$ 35	$ 0	$ 510
Foreign Exchange Option [Member]
Schedule of Equity Method Investments [Line Items]
Notional amount of option					£ 378	$ 480	£ 1,625	$ 2,467
Foreign Exchange Option [Member] | November 2015 Option [Member]
Schedule of Equity Method Investments [Line Items]
Derivative gain				330
Foreign Exchange Option [Member] | August 2015 Option [Member]
Schedule of Equity Method Investments [Line Items]
Derivative gain				$ 19

Investment in JUUL (Details)

Investment in JUUL (Details) - USD ($) $ in Millions	Dec. 20, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Debt and Equity Securities, FV-NI [Line Items]
Payments to acquire equity securities FV-NI		$ 12,800	$ 0	$ 0
JUUL [Member]
Debt and Equity Securities, FV-NI [Line Items]
Payments to acquire equity securities FV-NI	$ 12,800
Equity securities Fv Ni, ownership percentage	35.00%
Equity Securities Fv Ni, right to designate board members, percentage	33.33%
Equity Securities Fv Ni, eligible for sale or transfer, period	6 years
Equity Securities FV-NI, threshold for downward adjustment of board election	30.00%
Related party transaction, services agreement, term	6 years
Equity investments FV-NI, acquisition costs		$ 85

Short-Term Borrowings and Bor_2

Short-Term Borrowings and Borrowing Arrangements (Details)	Aug. 01, 2018USD ($)Extension	Dec. 31, 2018USD ($)	Dec. 20, 2018USD ($)	Dec. 31, 2017USD ($)
Short-term Debt [Line Items]
Short-term borrowings		$ 12,704,000,000		$ 0
Debt issuance costs		96,000,000
Accrued interest		15,000,000
Debt due by January 31, 2020, total		$ 14,900,000,000
Term Loan Agreement, JUUL [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 12,800,000,000
Term Loan Agreement, Cronos [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 1,800,000,000
Duration fee percentage			0.125%
Borrowings Agreement [Member]
Short-term Debt [Line Items]
Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum		4
Debt instrument, consolidated EBITDA to interest expense ratio		14.4
Line of Credit [Member] | Revolving Credit Facility Due August 2023 [Member] | Revolving Credit Facility [Member]
Short-term Debt [Line Items]
Debt instrument, face amount	$ 3,000,000,000
Debt instrument, number of extensions | Extension	2
Debt instrument, extension term	1 year
Term of debt	5 years
Line of Credit [Member] | Revolving Credit Facility Due August 2023 [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Short-term Debt [Line Items]
Credit line available under the credit agreement		$ 3,000,000,000
Interest rate for borrowing	1.00%
Line of Credit [Member] | Revolving Credit Facility Due August 2020 [Member] | Revolving Credit Facility [Member]
Short-term Debt [Line Items]
Debt instrument, face amount	$ 3,000,000,000
Term of debt	5 years
Short-term Debt [Member]
Short-term Debt [Line Items]
Debt due by December 31, 2019		13,900,000,000
Debt due by January 31, 2020		1,000,000,000
Notes Payable, Other Payables [Member] | Term Loan Agreement [Member]
Short-term Debt [Line Items]
Short-term borrowings		$ 12,800,000,000
Debt instrument, face amount			$ 14,600,000,000
Debt instrument, interest rate during period (approximately)		3.50%
Notes Payable, Other Payables [Member] | Term Loan Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member]
Short-term Debt [Line Items]
Interest rate for borrowing		1.00%

Long-Term Debt (Components of L

Long-Term Debt (Components of Long-Term Debt) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Long-term debt	$ 13,042	$ 13,894
Less current portion of long-term debt	1,144	864
Long-term debt excluding current portion	11,898	13,030
Notes 2.625% To 10.20% Due Through 2046 [Member] | Notes [Member]
Debt Instrument [Line Items]
Long-term debt	$ 13,000	$ 13,852
Notes 2.625% To 10.20% Due Through 2046 [Member] | Notes [Member] | Minimum [Member]
Debt Instrument [Line Items]
Stated interest rate	2.625%
Notes 2.625% To 10.20% Due Through 2046 [Member] | Notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Stated interest rate	10.20%
Notes 2.625% To 10.20% Due Through 2046 [Member] | Notes [Member] | Weighted Average [Member]
Debt Instrument [Line Items]
Weighted average interest rate	4.60%	4.90%
Debenture, 7.75% interest payable semi-annually, due 2027 [Member] | Debenture [Member]
Debt Instrument [Line Items]
Long-term debt	$ 42	$ 42
Stated interest rate	7.75%

Long-Term Debt (Aggregate Matur

Long-Term Debt (Aggregate Maturities of Long-Term Debt) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Debt Disclosure [Abstract]
2,019	$ 1,144
2,020	1,000
2,021	1,500
2,022	1,900
2,023	350
Thereafter	7,259
Long-term debt before debt issuance costs and debt discount	13,153
Less: debt issuance costs	60
Less: debt discounts	51
Long-term debt	$ 13,042	$ 13,894

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2016	Dec. 31, 2017
Debt Instrument [Line Items]
Interest Payable	$ 207		$ 219
Senior Notes [Member]
Debt Instrument [Line Items]
Extinguishment of debt		$ 933
Senior Notes [Member]
Debt Instrument [Line Items]
Repayments of debt	$ 864
Senior Notes [Member] | Change Of Control And Loss Of Investment Grade Rating [Member]
Debt Instrument [Line Items]
Required purchase price as percentage of aggregate principal amount	101.00%
Reported Value Measurement [Member]
Debt Instrument [Line Items]
Fair value of long term debt	$ 13,000		13,900
Level 2 [Member] | Estimate of Fair Value Measurement [Member]
Debt Instrument [Line Items]
Fair value of long term debt	$ 12,500		$ 15,300

Long-Term Debt (Debt Tender Off

Long-Term Debt (Debt Tender Offers and Redemption) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Extinguishment of Debt [Line Items]
Premiums and fees			$ 809
Write-off of unamortized debt discounts and debt issuance costs			14
Loss on early extinguishment of debt	$ 0	$ 0	823
Senior Notes [Member]
Extinguishment of Debt [Line Items]
Notes Purchased			933
9.95% Notes due 2038 [Member] | Senior Notes [Member]
Extinguishment of Debt [Line Items]
Notes Purchased			$ 441
Stated interest rate			9.95%
10.20% Note due 2039 [Member] | Senior Notes [Member]
Extinguishment of Debt [Line Items]
Notes Purchased			$ 492
Stated interest rate			10.20%

Capital Stock (Narrative) (Deta

Capital Stock (Narrative) (Details) - USD ($)	3 Months Ended			12 Months Ended			31 Months Ended
	Sep. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 31, 2018	May 31, 2018	Jul. 31, 2017	Oct. 31, 2016	Jul. 31, 2015
Class of Stock [Line Items]
Common stock, shares authorized (in shares)				12,000,000,000
Increase in quarterly dividend rate	14.30%	6.10%		21.20%
Cash dividends declared (USD per share)	$ 0.80	$ 0.7	$ 0.66	$ 3	$ 2.54	$ 2.35
Annualized dividend rate (USD per share)				$ 3.20
Repurchase of common stock (in shares)				27,878,324	41,604,141	16,221,001
Average price of repurchased shares (USD per share)				$ 60	$ 70.10	$ 63.48
Aggregate cost of shares repurchased				$ 1,673,000,000	$ 2,917,000,000	$ 1,030,000,000
July 2015 Share Repurchase Program [Member]
Class of Stock [Line Items]
Stock repurchase program, authorized amount									$ 4,000,000,000	$ 3,000,000,000	$ 1,000,000,000
Repurchase of common stock (in shares)				300,000	41,600,000	16,200,000	58,700,000
Average price of repurchased shares (USD per share)				$ 71.68	$ 70.10	$ 63.48	$ 68.15
Aggregate cost of shares repurchased				$ 18,000,000	$ 2,917,000,000	$ 1,030,000,000
January 2018 Share Repurchase Program [Member]
Class of Stock [Line Items]
Stock repurchase program, authorized amount							$ 1,000,000,000	$ 2,000,000,000
Repurchase of common stock (in shares)				27,600,000
Average price of repurchased shares (USD per share)				$ 59.89
Aggregate cost of shares repurchased				$ 1,655,000,000
Amount remaining in the share repurchased program				$ 345,000,000
Serial Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)				10,000,000
Preferred stock, par value (USD per share)				$ 1
Preferred stock, shares issued (in shares)				0
Stock Compensation Plan [Member]
Class of Stock [Line Items]
Shares of common stock reserved for stock-based awards (in shares)				40,400,278

Capital Stock (Schedule of Issu

Capital Stock (Schedule of Issued Repurchased and Outstanding Shares) (Details) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Common Stock, Shares Outstanding [Roll Forward]
Beginning balance, Shares Issued (in shares)	2,805,961,317	2,805,961,317	2,805,961,317
Beginning balance, Shares Repurchased (in shares)	(904,702,125)	(862,689,093)	(845,901,836)
Beginning balance, Shares Outstanding (in shares)	1,901,259,192	1,943,272,224	1,960,059,481
Stock award activity (in shares)	676,727	(408,891)	(566,256)
Repurchases of common stock (in shares)	(27,878,324)	(41,604,141)	(16,221,001)
Ending balance, Shares Issued (in shares)	2,805,961,317	2,805,961,317	2,805,961,317
Ending balance, Shares Repurchased (in shares)	(931,903,722)	(904,702,125)	(862,689,093)
Ending balance, Shares Outstanding (in shares)	1,874,057,595	1,901,259,192	1,943,272,224

Capital Stock (Schedule of Shar

Capital Stock (Schedule of Shares Repurchased) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Equity [Abstract]
Total number of shares repurchased (in shares)	27,878,324	41,604,141	16,221,001
Aggregate cost of shares repurchased	$ 1,673	$ 2,917	$ 1,030
Average price per share of shares repurchased (USD per share)	$ 60	$ 70.10	$ 63.48

Stock Plans (Narrative) (Detail

Stock Plans (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restricted Stock And Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period, in years	3 years
Pre-tax compensation expense	$ 39	$ 49	$ 44
Deferred tax benefit	9	18	17
Unamortized compensation expense	$ 62
Weighted-average period of recognition, in years	2 years
Weighted-average grant date fair value	$ 60	$ 46	$ 56
Weighted-average grant date fair value, per share (in USD per share)	$ 67.17	$ 71.05	$ 59.38
Total fair value vested	$ 65	$ 95	$ 78
Granted, number of shares (in shares)	896,962
Number of shares remaining (in shares)	2,129,626	2,384,501
Grant date fair value (in USD per share)	$ 64.94	$ 60.40
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, outstanding (in shares)		0
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period, in years	3 years
Pre-tax compensation expense	$ 7	$ 6
Unamortized compensation expense	$ 10
Granted, number of shares (in shares)	177,338	187,886	0
Number of shares remaining (in shares)	274,324
Grant date fair value (in USD per share)	$ 65.90
Common Stock [Member] | 2015 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares issuable under the stock compensation plan (in shares)	40,000,000
Shares available to be granted (in shares)	37,033,741
Common Stock [Member] | 2015 Directors Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares issuable under the stock compensation plan (in shares)	1,000,000
Shares available to be granted (in shares)	880,291

Stock Plans (Schedule of Restri

Stock Plans (Schedule of Restricted and Restricted Stock Units Activity) (Details) - Restricted Stock And Restricted Stock Units [Member] - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Number of Shares
Balance at beginning of year, Number of Shares	2,384,501
Granted, Number of Shares	896,962
Vested, Number Of Shares	(998,145)
Forfeited, Number of Shares	(153,692)
Balance at end of year, Number of Shares	2,129,626	2,384,501
Weighted-Average Grant Date Fair Value Per Share
Balance at beginning of year, Weighted-Average Grant Date Fair Value Per Share, in USD per share	$ 60.40
Granted, Weighted-Average Grant Date Fair Value Per Share, in USD per share	67.17	$ 71.05	$ 59.38
Vested, Weighted-Average Grant Date Fair Value Per Share, in USD per share	56.44
Forfeited, Weighted-Average Grant Date Fair Value Per Share, in USD per share	62.56
Balance at end of year, Weighted-Average Grant Date Fair Value Per Share, in USD per share	$ 64.94	$ 60.40

Earnings per Share (Details)

Earnings per Share (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Earnings Per Share [Abstract]
Net earnings attributable to Altria	$ 1,250	$ 1,943	$ 1,876	$ 1,894	$ 4,966	$ 1,866	$ 1,989	$ 1,401	$ 6,963	$ 10,222	$ 14,239
Less: Distributed and undistributed earnings attributable to share-based awards									(8)	(14)	(24)
Earnings for basic and diluted EPS									$ 6,955	$ 10,208	$ 14,215
Weighted-average shares for basic EPS (in shares)									1,887	1,921	1,952
Plus: contingently issuable PSUs (in shares)									1	0	0
Weighted-average shares for diluted EPS (in shares)									1,888	1,921	1,952

Other Comprehensive Earnings__3

Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Oct. 01, 2018	Jan. 01, 2018
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance		$ 15,377
Adoption of ASU No. 2018-02		(397)			$ 408	$ 0	[1]
Other comprehensive (losses) earnings before reclassifications		(475)	$ (39)	$ 541
Deferred income taxes		103	11	(180)
Other comprehensive losses before reclassifications, net of deferred income taxes		(372)	(28)	361
Amounts reclassified to net earnings		177	299	1,338
Deferred income taxes		(47)	(116)	(471)
Amounts reclassified to net earnings, net of deferred income taxes		130	183	867
Other comprehensive (losses) earnings, net of deferred income taxes		(242)	155	1,228
Ending balance		14,787	15,377
Accumulated other comprehensive losses		2,547	1,897
AB InBev and SABMiller [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Accumulated other comprehensive losses				414
Currency translations				97
SABMiller Plc [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Accumulated other comprehensive losses				737
Benefit Plans [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance		(1,839)	(2,048)	(2,010)
Other comprehensive (losses) earnings before reclassifications		(151)	52	(247)
Deferred income taxes		39	(21)	96
Other comprehensive losses before reclassifications, net of deferred income taxes		(112)	31	(151)
Amounts reclassified to net earnings		241	291	178
Deferred income taxes		(61)	(113)	(65)
Amounts reclassified to net earnings, net of deferred income taxes		180	178	113
Other comprehensive (losses) earnings, net of deferred income taxes		68	209	(38)
Ending balance		(2,168)	(1,839)	(2,048)
Accumulated Equity Method Investments Attributable To Parent [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance		(54)	0	(1,265)
Other comprehensive (losses) earnings before reclassifications		(323)	(91)	787
Deferred income taxes		64	32	(276)
Other comprehensive losses before reclassifications, net of deferred income taxes		(259)	(59)	511
Amounts reclassified to net earnings		(64)	8	1,160
Deferred income taxes		14	(3)	(406)
Amounts reclassified to net earnings, net of deferred income taxes		(50)	5	754
Other comprehensive (losses) earnings, net of deferred income taxes		(309)	(54)	1,265
Ending balance		(374)	(54)	0
Currency Translation Adjustments and Other [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance		(4)	(4)	(5)
Other comprehensive (losses) earnings before reclassifications		(1)	0	1
Deferred income taxes		0	0	0
Other comprehensive losses before reclassifications, net of deferred income taxes		(1)	0	1
Amounts reclassified to net earnings		0	0	0
Deferred income taxes		0	0	0
Amounts reclassified to net earnings, net of deferred income taxes		0	0	0
Other comprehensive (losses) earnings, net of deferred income taxes		(1)	0	1
Ending balance		(5)	(4)	(4)
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance		(1,897)	(2,052)	(3,280)
Adoption of ASU No. 2018-02	[1]					(408)
Other comprehensive (losses) earnings, net of deferred income taxes		(242)	155	1,228
Ending balance		$ (2,547)	$ (1,897)	$ (2,052)
Accounting Standards Update 2018-02 [Member] | Benefit Plans [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Adoption of ASU No. 2018-02						(397)
Accounting Standards Update 2018-02 [Member] | Accumulated Equity Method Investments Attributable To Parent [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Adoption of ASU No. 2018-02						(11)
Accounting Standards Update 2018-02 [Member] | Currency Translation Adjustments and Other [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Adoption of ASU No. 2018-02						0
Accounting Standards Update 2018-02 [Member] | AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Adoption of ASU No. 2018-02						$ (408)
[1]	For further discussion, see Note 15. Income Taxes.

Other Comprehensive Earnings__4

Other Comprehensive Earnings/Losses (Reclassifications) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net periodic benefit (income) cost, excluding service cost									$ (34)	$ 37	$ (1)
Earnings from equity investment in AB InBev									(890)	(532)	(795)
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings	$ (1,251)	$ (1,944)	$ (1,877)	$ (1,895)	$ (4,968)	$ (1,867)	$ (1,990)	$ (1,402)	(6,967)	(10,227)	(14,244)
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Earnings from equity investment in AB InBev									(64)	8	1,160
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings									177	299	1,338
Reclassification out of Accumulated Other Comprehensive Income [Member] | Net loss [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net periodic benefit (income) cost, excluding service cost									276	325	223
Reclassification out of Accumulated Other Comprehensive Income [Member] | Prior service costs/credit [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net periodic benefit (income) cost, excluding service cost									(35)	(34)	(45)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Benefit Plans [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net periodic benefit (income) cost, excluding service cost									$ 241	$ 291	$ 178

Income Taxes (Schedule of Earni

Income Taxes (Schedule of Earnings Before Income Taxes and Provision for Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
United States	$ 9,441	$ 9,809	$ 21,867
Outside United States	(100)	19	(15)
Earnings before income taxes	9,341	9,828	21,852
Current:
Federal	1,911	2,346	4,093
State and local	519	366	390
Outside United States	1	15	6
Total current provision for income taxes	2,431	2,727	4,489
Deferred:
Federal	(18)	(3,213)	3,102
State and local	(42)	86	20
Outside United States	3	1	(3)
Total deferred provision for income taxes	(57)	(3,126)	3,119
Total provision (benefit) for income taxes	$ 2,374	$ (399)	$ 7,608

Income Taxes (Reconciliation of

Income Taxes (Reconciliation of Beginning and Ending Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of Unrecognized Tax Benefits
Balance at beginning of year	$ 66	$ 169	$ 158
Additions based on tax positions related to the current year	0	0	15
Additions for tax positions of prior years	22	129	29
Reductions for tax positions due to lapse of statutes of limitations	0	(4)	(4)
Reductions for tax positions of prior years	(1)	(208)	(28)
Settlements	(2)	(20)	(1)
Balance at end of year	$ 85	$ 66	$ 169

Income Taxes (Schedule of Unrec

Income Taxes (Schedule of Unrecognized Tax Benefits and Consolidated Liability for Tax Contingencies) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 85	$ 66	$ 169	$ 158
Accrued interest and penalties	13	9
Tax credits and other indirect benefits	(1)	(1)
Liability for tax contingencies	$ 97	$ 74

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended			12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Oct. 01, 2018	Jan. 01, 2018	[1]
Income Taxes [Line Items]
Tax Cuts and Jobs Act of 2017, incomplete accounting, change in tax rate, provisional income tax expense (benefit)	$ (3,367)			$ 188
Unrecognized tax benefits if recognized would impact effective tax rate	43			59	$ 43
Unrecognized tax benefits if recognized would affect deferred taxes	23			26	23
Interest (income) expense associated with uncertain tax position				5	$ (13)	$ 9
Potential decrease in liability for uncertain tax positions				45
Effective income tax rate reconciliation, Tax Cuts and Jobs Act, transition tax on accumulated foreign earnings, amount				140
Effective income tax rate reconciliation, Tax Cuts and Jobs Act, tax credit, foreign				34
Tax Cuts and Jobs Act of 2017, transition tax for accumulated foreign earnings, income tax expense	413			14
Effective income tax rate reconciliation, change in enacted tax rate, amount	3,017
Tax Cuts and Jobs Act of 2017, measurement period adjustment, income tax benefit	$ 763
Tax (benefit) provision recorded		$ (232)
Foreign tax credits and other tax benefits, tax expense						$ 4,900
Foreign tax credits and other tax benefits, tax expense percentage						35.00%
Adoption of ASU No. 2018-02				(397)			$ 408	$ 0
Tax Year 2010 Through Tax Year 2013 [Member]
Income Taxes [Line Items]
Tax (benefit) provision recorded			$ (152)
Accruals no longer required [Member]
Income Taxes [Line Items]
Tax (benefit) provision recorded		$ 114
State and Local Jurisdiction [Member]
Income Taxes [Line Items]
Net operating losses carry forward				$ 658
[1]	For further discussion, see Note 15. Income Taxes.

Income Taxes (Reconciliation _2

Income Taxes (Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate) (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
U.S. federal statutory rate	21.00%	35.00%	35.00%
Increase (decrease) resulting from:
State and local income taxes, net of federal tax benefit	4.00%	3.50%	1.20%
Re-measurement of net deferred tax liabilities	0.00%	(31.20%)	0.00%
Tax basis in foreign investments	1.50%	(7.80%)	(0.00%)
Deemed repatriation tax	0.10%	4.20%	0.00%
Uncertain tax positions	0.10%	(0.90%)	0.00%
Investment in AB InBev/SABMiller	(1.10%)	(5.90%)	(0.60%)
Domestic manufacturing deduction	(0.00%)	(1.80%)	(0.80%)
Other	(0.20%)	0.80%	0.00%
Effective tax rate	25.40%	(4.10%)	34.80%

Income Taxes (Schedule of Defer

Income Taxes (Schedule of Deferred Income Tax Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Deferred income tax assets:
Accrued postretirement and postemployment benefits	$ 500	$ 539
Settlement charges	864	614
Accrued pension costs	155	136
Net operating losses and tax credit carryforwards	57	18
Total deferred income tax assets	1,576	1,307
Deferred income tax liabilities:
Property, plant and equipment	(251)	(261)
Intangible assets	(2,689)	(2,674)
Investment in AB InBev	(3,038)	(2,859)
Finance assets, net	(313)	(404)
Other	(115)	(121)
Total deferred income tax liabilities	(6,406)	(6,319)
Valuation allowances	(71)	0
Net deferred income tax liabilities	$ (4,901)	$ (5,012)

Segment Reporting (Segment Data

Segment Reporting (Segment Data Schedule) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Net revenues	$ 6,114	$ 6,837	$ 6,305	$ 6,108	$ 6,101	$ 6,729	$ 6,663	$ 6,083	$ 25,364	$ 25,576	$ 25,744
Operating income									9,115	9,593	8,761
Amortization of intangibles									(38)	(21)	(21)
Corporate asset impairment and exit costs									(383)	(32)	(149)
Interest and other debt expense, net									(665)	(705)	(747)
Loss on early extinguishment of debt									0	0	(823)
Net periodic benefit income (cost), excluding service cost									34	(37)	1
Earnings from equity investment in AB InBev/SABMiller									890	532	795
(Loss) gain on AB InBev/SABMiller business combination	$ 0	$ 0	$ 0	$ (33)	$ 0	$ 37	$ 408	$ 0	(33)	445	13,865
Earnings before income taxes									9,341	9,828	21,852
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Amortization of intangibles									(38)	(21)	(21)
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
General corporate expenses									(315)	(213)	(217)
Corporate asset impairment and exit costs									0	0	(5)
Smokeable Products [Member]
Segment Reporting Information [Line Items]
Net revenues									22,297	22,636	22,851
Smokeable Products [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income									8,408	8,426	7,766
Smokeless Products [Member]
Segment Reporting Information [Line Items]
Net revenues									2,262	2,155	2,051
Smokeless Products [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income									1,431	1,306	1,172
Wine [Member]
Segment Reporting Information [Line Items]
Net revenues									691	698	746
Wine [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income									50	146	164
All Other [Member]
Segment Reporting Information [Line Items]
Net revenues									114	87	96
All Other [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income									$ (421)	$ (51)	$ (98)

Segment Reporting (Narrative) (

Segment Reporting (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Net revenues	$ 6,114	$ 6,837	$ 6,305	$ 6,108	$ 6,101	$ 6,729	$ 6,663	$ 6,083	$ 25,364	$ 25,576	$ 25,744
Sales Revenue, Net [Member] | Credit Concentration Risk [Member] | McLane Company Inc [Member]
Segment Reporting Information [Line Items]
Contribution of net revenues by major customer percentage									27.00%	26.00%	25.00%
Sales Revenue, Net [Member] | Credit Concentration Risk [Member] | Core-Mark Holding Company, Inc. [Member]
Segment Reporting Information [Line Items]
Contribution of net revenues by major customer percentage									14.00%	14.00%	14.00%
Smokeable Products [Member]
Segment Reporting Information [Line Items]
Net revenues									$ 22,297	$ 22,636	$ 22,851
Smokeable Products [Member] | Cigarettes [Member]
Segment Reporting Information [Line Items]
Net revenues									21,506	21,900	22,199
Smokeable Products [Member] | Cigars [Member]
Segment Reporting Information [Line Items]
Net revenues									791	736	652
Wine [Member]
Segment Reporting Information [Line Items]
Net revenues									$ 691	$ 698	$ 746
Wine [Member] | Sales Revenue, Net [Member] | Credit Concentration Risk [Member] | Two Distributors [Member]
Segment Reporting Information [Line Items]
Contribution of net revenues by major customer percentage									64.00%
Wine [Member] | Sales Revenue, Net [Member] | Credit Concentration Risk [Member] | Three Distributors [Member]
Segment Reporting Information [Line Items]
Contribution of net revenues by major customer percentage										67.00%	69.00%
Smokeless Products [Member]
Segment Reporting Information [Line Items]
Net revenues									$ 2,262	$ 2,155	$ 2,051
Operating Segments [Member] | Smokeless Products [Member]
Segment Reporting Information [Line Items]
Inventory recall expense										$ 60

Segment Reporting (Schedule of

Segment Reporting (Schedule of Depreciation Expense and Capital Expenditures of Segments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Depreciation expense	$ 189	$ 188	$ 183
Capital expenditures	238	199	189
Operating Segments [Member] | Smokeable Products [Member]
Segment Reporting Information [Line Items]
Depreciation expense	90	93	93
Capital expenditures	81	39	55
Operating Segments [Member] | Smokeless Products [Member]
Segment Reporting Information [Line Items]
Depreciation expense	28	29	26
Capital expenditures	73	61	52
Operating Segments [Member] | Wine [Member]
Segment Reporting Information [Line Items]
Depreciation expense	40	40	36
Capital expenditures	40	53	59
General Corporate and Other [Member]
Segment Reporting Information [Line Items]
Depreciation expense	31	26	28
Capital expenditures	$ 44	$ 46	$ 23

Segment Reporting (Schedule o_2

Segment Reporting (Schedule of NPM Adjustment Items) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
NPM Adjustment Items [Line Items]
Loss (Gain) Related to Litigation Settlement	$ 0	$ 0	$ (77)	$ (68)	$ 0	$ 5	$ 0	$ (1)
Interest and other debt expense, net									$ 0	$ 9	$ 6
Non-Participating Manufacturer Arbitration Panel Decision [Member]
NPM Adjustment Items [Line Items]
Loss (Gain) Related to Litigation Settlement									(145)	4	18
Philip Morris USA [Member] | Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]
NPM Adjustment Items [Line Items]
Reduction to cost of sales					$ 39
Operating Income (Loss) [Member] | Smokeable Products [Member] | Philip Morris USA [Member] | NPM Adjustment to Cost Of Sales [Member] | Non-Participating Manufacturer Arbitration Panel Decision [Member]
NPM Adjustment Items [Line Items]
Loss (Gain) Related to Litigation Settlement									(145)	(5)	12
Interest And Other Debt Expense, Net [Member] | Philip Morris USA [Member] | Non-Participating Manufacturer Arbitration Panel Decision [Member]
NPM Adjustment Items [Line Items]
Interest and other debt expense, net									$ 0	$ 9	$ 6

Segment Reporting (Schedule o_3

Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Charges) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded	$ 12	$ 21	$ 70	$ 28	$ 62	$ 0	$ 17	$ 1
Philip Morris USA [Member] | Tobacco and Health Litigation Cases [Member]
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded									$ 131	$ 80	$ 105
Philip Morris USA [Member] | Tobacco and Health Litigation Cases [Member] | Operating Income (Loss) [Member] | Operating Segments [Member] | Smokeable Products [Member]
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded									103	72	88
Philip Morris USA [Member] | Tobacco and Health Litigation Cases [Member] | Operating Income (Loss) [Member] | Operating Segments [Member] | Smokeless Products [Member]
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded									10	0	0
Philip Morris USA [Member] | Tobacco and Health Litigation Cases [Member] | Interest And Other Debt Expense, Net [Member] | Segment Reconciling Items [Member]
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded									$ 18	$ 8	$ 17

Benefit Plans (Narrative) (Deta

Benefit Plans (Narrative) (Details) - USD ($)	1 Months Ended	3 Months Ended				12 Months Ended
	Dec. 31, 2017	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 270,000,000
Lump sum payment	277,000,000
One-time settlement charge relating to lump sum distributions		$ 81,000,000	$ 0	$ 0	$ 0		$ 81,000,000
Amounts charged to expense for defined contribution plans						$ 85,000,000	83,000,000	$ 93,000,000
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions						41,000,000	24,000,000
Net periodic benefit cost						17,000,000	49,000,000	14,000,000
Accumulated benefit obligation	8,200,000,000	8,200,000,000				7,400,000,000	8,200,000,000
Projected benefit obligation	413,000,000	413,000,000				7,598,000,000	413,000,000
Accumulated benefit obligation	364,000,000	364,000,000				7,239,000,000	364,000,000
Fair value of plan assets	124,000,000	124,000,000				7,012,000,000	124,000,000
Defined benefit plan, plan assets, amount	8,015,000,000	8,015,000,000				7,138,000,000	8,015,000,000	7,475,000,000
Pension [Member] | Minimum [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected future employer contributions						$ 50,000,000
Pension [Member] | Emerging Markets [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets						1.00%
Pension [Member] | Below grade investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets						7.00%
Pension [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Plan assets, target allocation percentage						55.00%
Pension [Member] | Equity Securities [Member] | Emerging Markets [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets						1.00%
Pension [Member] | Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Plan assets, target allocation percentage						45.00%
Pension [Member] | Fixed Income Securities [Member] | Below grade investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets						14.00%
Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions						$ 0	270,000,000
Net periodic benefit cost						48,000,000	79,000,000	78,000,000
Defined benefit plan, plan assets, amount	270,000,000	270,000,000				211,000,000	270,000,000	0
Expected future employer contributions						60,000,000
Postretirement Benefit Plan [Member] | Emerging Markets [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, plan assets, amount						$ 0
Postretirement Benefit Plan [Member] | Below grade investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets						6.00%
Postretirement Benefit Plan [Member] | Fixed Income Securities [Member] | Below grade investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets						13.00%
Postretirement Benefit Plan [Member] | Defined Benefit Plan, Common Collective Trust [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, plan assets, amount	148,000,000	148,000,000					148,000,000
Postretirement Benefit Plan [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, plan assets, amount	122,000,000	122,000,000					122,000,000
Fair Value, Inputs, Level 1, 2 and 3 [Member] | Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, plan assets, amount	0	0					0
Level 3 [Member] | Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, plan assets, amount	$ 0	$ 0				$ 0	0
Accounting Standards Update 2017-07 [Member] | Cost of Sales [Member]
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost							12,000,000	(19,000,000)
Accounting Standards Update 2017-07 [Member] | Marketing, Adminstration and Research Costs [Member]
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost							24,000,000	(12,000,000)
Accounting Standards Update 2017-07 [Member] | Asset Impairment and Exit Costs [Member]
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost							$ 1,000,000	$ (30,000,000)

Benefit Plans (Projected Benefi

Benefit Plans (Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans) (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Change in plan assets:
Employer contributions	$ 270
Accrued pension costs	(445)	$ (544)	$ (445)
Accrued postretirement health care costs	(1,987)	(1,749)	(1,987)
Pension [Member]
Change in benefit obligation:
Benefit obligation at beginning of year		8,510	8,312
Service cost		81	75	$ 76
Interest cost		276	288	281
Benefits paid		(488)	(703)
Actuarial (gains) losses		(660)	589
Termination, settlement and curtailment		(18)	(51)
Other		25	0
Benefit obligation at end of year	8,510	7,726	8,510	8,312
Change in plan assets:
Fair value of plan assets at beginning of year		8,015	7,475
Actual return on plan assets		(430)	1,219
Employer contributions		41	24
Benefits paid		(488)	(703)
Fair value of plan assets at end of year	8,015	7,138	8,015	7,475
Funded status at December 31	(495)	(588)	(495)
Other accrued liabilities	(51)	(44)	(51)
Accrued pension costs	(445)	(544)	(445)
Other assets	1	0	1
Accrued postretirement health care costs	0	0	0
Defined benefit plan, amounts for asset (liability) recognized in statement of financial position	(495)	(588)	(495)
Postretirement Benefit Plan [Member]
Change in benefit obligation:
Benefit obligation at beginning of year		2,335	2,364
Service cost		18	16	17
Interest cost		70	76	77
Benefits paid		(130)	(139)
Actuarial (gains) losses		(298)	56
Termination, settlement and curtailment		0	0
Other		45	(38)
Benefit obligation at end of year	2,335	2,040	2,335	2,364
Change in plan assets:
Fair value of plan assets at beginning of year		270	0
Actual return on plan assets		(14)	0
Employer contributions		0	270
Benefits paid		(45)	0
Fair value of plan assets at end of year	270	211	270	$ 0
Funded status at December 31	(2,065)	(1,829)	(2,065)
Other accrued liabilities	(78)	(80)	(78)
Accrued pension costs	0	0	0
Other assets	0	0	0
Accrued postretirement health care costs	(1,987)	(1,749)	(1,987)
Defined benefit plan, amounts for asset (liability) recognized in statement of financial position	$ (2,065)	$ (1,829)	$ (2,065)

Benefit Plans (Assumptions to D

Benefit Plans (Assumptions to Determine Postretirement Benefit Obligations) (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]
Health care cost trend rate assumed for next year	6.50%	7.00%
Ultimate trend rate	5.00%	5.00%
Year that the rate reaches the ultimate trend rate	2,025	2,022
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.40%	3.70%
Rate of compensation increase	4.00%	4.00%
Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.40%	3.70%
Rate of compensation increase	0.00%	0.00%

Benefit Plans (Schedule of Comp

Benefit Plans (Schedule of Components of Net Periodic Pension Cost) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 81	$ 75	$ 76
Interest cost	276	288	281
Expected return on plan assets	(585)	(601)	(553)
Amortization of net loss	225	197	171
Amortization of prior service cost (credit)	4	4	5
Termination, settlement and curtailment	16	86	34
Net periodic benefit cost	17	49	14
Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	18	16	17
Interest cost	70	76	77
Expected return on plan assets	(19)	0	0
Amortization of net loss	21	25	25
Amortization of prior service cost (credit)	(42)	(38)	(39)
Termination, settlement and curtailment	0	0	(2)
Net periodic benefit cost	$ 48	$ 79	$ 78

Benefit Plans (Termination, Set

Benefit Plans (Termination, Settlement and Curtailment Costs) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation	$ 0	$ 0	$ 23
Net loss	13	86	9
Prior service cost (credit)	3	0	2
Termination, settlement, and curtailment costs	16	86	34
Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation			11
Net loss			0
Prior service cost (credit)			(13)
Termination, settlement, and curtailment costs	$ 0	$ 0	$ (2)

Benefit Plans (Estimated Net Lo

Benefit Plans (Estimated Net Loss and Prior Service Cost (Credit) Expected to be Amortized in 2017) (Details) $ in Millions	Dec. 31, 2018USD ($)
Pension [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Estimated future net loss	$ 169
Estimated future prior service cost (credit)	6
Postretirement Benefit Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Estimated future net loss	12
Estimated future prior service cost (credit)	$ (32)

Benefit Plans (Assumptions used

Benefit Plans (Assumptions used to Determine Net Periodic Benefit Cost) (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate: Service cost	3.80%	4.30%	4.70%
Discount rate: Interest cost	3.30%	3.50%	3.60%
Expected rate of return on plan assets	7.80%	8.00%	8.00%
Rate of compensation increase	4.00%	4.00%	4.00%
Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate: Service cost	3.80%	4.30%	4.50%
Discount rate: Interest cost	3.30%	3.50%	3.40%
Expected rate of return on plan assets	7.80%	0.00%	0.00%
Health care cost trend rate	7.00%	7.00%	6.50%

Benefit Plans (Effects of One-P

Benefit Plans (Effects of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates) (Details)	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Defined benefit plan, effect of one percentage point increase on service and interest cost components, percent	7.50%
Defined benefit plan effect of one percentage point increase on accumulated postretirement benefit obligation percentage	5.60%
Defined benefit plan effect of one percentage point decrease on service and interest cost components percentage	(6.30%)
Defined benefit plan effect of one percentage point decrease on accumulated postretirement benefit obligation percentage	(4.80%)

Benefit Plans (Asset Allocation

Benefit Plans (Asset Allocations) (Details)	Dec. 31, 2018
Equity Securities [Member] | Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets	48.00%
Equity Securities [Member] | Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets	48.00%
Corporate Bonds [Member] | Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets	32.00%
Corporate Bonds [Member] | Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets	42.00%
US Treasury And Foreign Government Securities [Member] | Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets	20.00%
US Treasury And Foreign Government Securities [Member] | Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Composition of plan assets	10.00%

Benefit Plans (Fair Values of P

Benefit Plans (Fair Values of Pension and Postretirement Plan Assets) (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	$ 7,138,000,000	$ 8,015,000,000	$ 7,475,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	7,138,000,000	8,015,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Other Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	48,000,000	(1,000,000)
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	1,355,000,000	2,274,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Municipal Bonds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Debt Security, Government, Non-US [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Corporate Debt Security, Above Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Corporate Debt Security, Below Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Common stock: International equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	237,000,000	1,396,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Common stock: U.S. equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	1,082,000,000	831,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Other, Net [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	36,000,000	47,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	3,599,000,000	3,267,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	868,000,000	588,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Municipal Bonds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	73,000,000	81,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Debt Security, Government, Non-US [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	115,000,000	150,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Corporate Debt Security, Above Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	1,726,000,000	1,789,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Corporate Debt Security, Below Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	478,000,000	511,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Common stock: International equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Common stock: U.S. equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	303,000,000	106,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Other, Net [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	36,000,000	42,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Municipal Bonds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Debt Security, Government, Non-US [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Corporate Debt Security, Above Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Corporate Debt Security, Below Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Common stock: International equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Common stock: U.S. equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Other, Net [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	4,954,000,000	5,541,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	868,000,000	588,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Municipal Bonds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	73,000,000	81,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Debt Security, Government, Non-US [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	115,000,000	150,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Corporate Debt Security, Above Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	1,726,000,000	1,789,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Corporate Debt Security, Below Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	478,000,000	511,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Common stock: International equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	237,000,000	1,396,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Common stock: U.S. equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	1,082,000,000	831,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	303,000,000	106,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Other, Net [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	72,000,000	89,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | NAV [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	2,136,000,000	2,475,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | NAV [Member] | U S Large Cap [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	1,722,000,000	2,014,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | NAV [Member] | U S Small Cap [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	328,000,000	361,000,000
Pension [Member] | Fair Value, Measurements, Recurring [Member] | NAV [Member] | International Developed Markets [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	86,000,000	100,000,000
Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	211,000,000	270,000,000	$ 0
Postretirement Benefit Plan [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net		122,000,000
Postretirement Benefit Plan [Member] | Defined Benefit Plan, Common Collective Trust [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net		148,000,000
Postretirement Benefit Plan [Member] | Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0	0
Postretirement Benefit Plan [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net		$ 0
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	211,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Other Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	9,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	2,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Debt Security, Government, Non-US [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Corporate Debt Security, Above Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Corporate Debt Security, Below Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	0
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Other, Net [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	2,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	97,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	13,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Debt Security, Government, Non-US [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	3,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Corporate Debt Security, Above Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	71,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Corporate Debt Security, Below Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	8,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Other, Net [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	2,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	99,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	13,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Debt Security, Government, Non-US [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	3,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Corporate Debt Security, Above Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	71,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Corporate Debt Security, Below Investment Grade [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	8,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member] | Other, Net [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	4,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | NAV [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	103,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | NAV [Member] | U S Large Cap [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	77,000,000
Postretirement Benefit Plan [Member] | Fair Value, Measurements, Recurring [Member] | NAV [Member] | International Developed Markets [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, net	$ 26,000,000

Benefit Plans (Estimated Future

Benefit Plans (Estimated Future Benefit Payments) (Details) $ in Millions	Dec. 31, 2018USD ($)
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
2,019	$ 484
2,020	464
2,021	468
2,022	470
2,023	474
2024-2028	2,362
Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
2,019	132
2,020	130
2,021	129
2,022	129
2,023	125
2024-2028	$ 598

Benefit Plans (Amounts Recorded

Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Losses) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net loss	$ (2,996)	$ (3,198)
Prior service (cost) credit	68	180
Deferred income taxes	760	1,179
Amounts recorded in accumulated other comprehensive losses	(2,168)	(1,839)
Pension [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net loss	(2,591)	(2,493)
Prior service (cost) credit	(34)	(15)
Deferred income taxes	679	979
Amounts recorded in accumulated other comprehensive losses	(1,946)	(1,529)
Postretirement Benefit Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net loss	(327)	(612)
Prior service (cost) credit	108	195
Deferred income taxes	61	166
Amounts recorded in accumulated other comprehensive losses	(158)	(251)
Postemployment Retirement Benefits [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net loss	(78)	(93)
Prior service (cost) credit	(6)	0
Deferred income taxes	20	34
Amounts recorded in accumulated other comprehensive losses	$ (64)	$ (59)

Benefit Plans (Movements in Oth

Benefit Plans (Movements in Other Comprehensive Earnings/Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Oct. 01, 2018	Jan. 01, 2018	[1]
Amortization:
Net loss	$ 263	$ 239	$ 214
Prior service cost/credit	(38)	(34)	(34)
Other expense:
Net loss	13	86	9
Prior service cost/credit	3		(11)
Deferred income taxes	(61)	(113)	(65)
Amounts reclassified to net earnings as components of net periodic benefit cost	180	178	113
Other movements during the year:
Adoption of ASU No. 2018-02	(397)			$ 408	$ 0
Net loss	(74)	14	(259)
Prior service cost/credit	(77)	38	12
Deferred income taxes	39	(21)	96
Other movements	(509)	31	(151)
Total movements in other comprehensive earnings/losses, including cumulative effect adjustment	(329)
Total movements in other comprehensive earnings/losses	68	209	(38)
Pension [Member]
Amortization:
Net loss	225	197	171
Prior service cost/credit	4	4	5
Other expense:
Net loss	13	86	9
Prior service cost/credit	3		2
Deferred income taxes	(61)	(113)	(69)
Amounts reclassified to net earnings as components of net periodic benefit cost	184	174	118
Other movements during the year:
Adoption of ASU No. 2018-02	(330)
Net loss	(336)	81	(232)
Prior service cost/credit	(26)	0	(4)
Deferred income taxes	91	(32)	92
Other movements	(601)	49	(144)
Total movements in other comprehensive earnings/losses, including cumulative effect adjustment	(417)
Total movements in other comprehensive earnings/losses		223	(26)
Postretirement Benefit Plan [Member]
Amortization:
Net loss	21	25	25
Prior service cost/credit	(42)	(38)	(39)
Other expense:
Net loss	0	0	0
Prior service cost/credit	0		(13)
Deferred income taxes	4	6	11
Amounts reclassified to net earnings as components of net periodic benefit cost	(17)	(7)	(16)
Other movements during the year:
Adoption of ASU No. 2018-02	(55)
Net loss	264	(56)	(18)
Prior service cost/credit	(45)	38	16
Deferred income taxes	(54)	7	1
Other movements	110	(11)	(1)
Total movements in other comprehensive earnings/losses, including cumulative effect adjustment	93
Total movements in other comprehensive earnings/losses		(18)	(17)
Postemployment Retirement Benefits [Member]
Amortization:
Net loss	17	17	18
Prior service cost/credit	0	0	0
Other expense:
Net loss	0	0	0
Prior service cost/credit	0		0
Deferred income taxes	(4)	(6)	(7)
Amounts reclassified to net earnings as components of net periodic benefit cost	13	11	11
Other movements during the year:
Adoption of ASU No. 2018-02	(12)
Net loss	(2)	(11)	(9)
Prior service cost/credit	(6)	0	0
Deferred income taxes	2	4	3
Other movements	(18)	(7)	(6)
Total movements in other comprehensive earnings/losses, including cumulative effect adjustment	$ (5)
Total movements in other comprehensive earnings/losses		$ 4	$ 5
[1]	For further discussion, see Note 15. Income Taxes.

Additional Information (Schedul

Additional Information (Schedule of Additional Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Research and development expense	$ 252	$ 241	$ 203
Advertising expense	37	29	27
Interest expense	697	727	754
Interest income	(32)	(31)	(13)
Interest related to NPM Adjustment Items	0	9	6
Interest and other debt expense, net	665	705	747
Rent expense	$ 42	$ 43	$ 53

Additional Information (Sched_2

Additional Information (Schedule of Rental Commitments and Sublease Income Under Non-Cancelable Operating Leases) (Details) $ in Millions	Dec. 31, 2018USD ($)
Rental Commitments
2,019	$ 41
2,020	35
2,021	31
2,022	24
2,023	17
Thereafter	34
Total	182
Sublease Income
2,019	5
2,020	5
2,021	5
2,022	5
2,023	5
Thereafter	2
Total	$ 27

Additional Information (Sched_3

Additional Information (Schedule of Valuation and Qualifying Accounts) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Allowance, Discounts [Member]
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year	$ 0	$ 0	$ 0
Charged to costs and expenses	620	626	628
Deductions	(620)	(626)	(628)
Balance at end of year	0	0	0
Allowance, Returned Goods [Member]
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year	40	49	68
Charged to costs and expenses	97	130	133
Deductions	(105)	(139)	(152)
Balance at end of year	32	40	49
Allowance for losses on finance assets [Member]
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year	23	32	42
Decrease to allowance	(4)	(9)	(10)
Balance at end of year	$ 19	$ 23	$ 32

Contingencies (General Informat

Contingencies (General Information Narrative) (Details)	Dec. 31, 2018state
Commitments and Contingencies Disclosure [Abstract]
Number of states that cap or do not require bond	47

Contingencies (Overview of Altr

Contingencies (Overview of Altria Group, Inc. and/or PM USA Tobacco-Related Litigation - Schedule Of Pending Cases) (Details)	1 Months Ended	12 Months Ended	24 Months Ended	272 Months Ended
	Mar. 31, 2018case	Dec. 31, 2018case	Dec. 31, 2017casetrialplantiff	Dec. 31, 2018case	Dec. 31, 2016case
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of unfavorable verdicts partially or entirely reversed on		100	92	100	70
Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of unfavorable verdicts partially or entirely reversed on		2	4	2	5
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of unfavorable verdicts partially or entirely reversed on		1	1	1	1
Lights Ultra Lights Class Actions [Member]
Loss Contingencies [Line Items]
Number of unfavorable verdicts partially or entirely reversed on		2	3	2	8
Pending Litigation [Member] | ETS Smoking and Health Case, Flight Attendants [Member]
Loss Contingencies [Line Items]
Number of cases		1,490
Number of claims dismissed	923
Philip Morris USA [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of claims dismissed				61
Massachusetts [Member] | Pending Litigation [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of unfavorable verdicts partially or entirely reversed on		30		30
Florida [Member] | Pending Litigation [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of unfavorable verdicts partially or entirely reversed on		37		37
Florida [Member] | Philip Morris USA [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of claims dismissed				2
West Virginia [Member] | Pending Litigation [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases			30
Number of plaintiffs | plantiff			30
Number of consolidated trials | trial			6
West Virginia [Member] | Philip Morris USA [Member] | Pending Litigation [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases			9

Contingencies (Overview of Al_2

Contingencies (Overview of Altria Group, Inc. and/or PM USA Tobacco-Related Litigation - Narrative) (Details) $ in Millions	Jan. 29, 2019case	Dec. 31, 2018USD ($)case	Dec. 31, 2017USD ($)case	Dec. 31, 2016USD ($)case	Dec. 31, 2015case	Dec. 31, 2018USD ($)case	Jan. 29, 2019case
Loss Contingencies [Line Items]
Litigation settlement interest expense (income) | $		$ 0	$ 9	$ 6
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending		1	1	1		1
Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending		2	4	5		2
Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Judgments paid | $						$ 186
Litigation settlement interest expense (income) | $						$ 33
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases pending		100	92	70		100
Tobacco and Health Judgment [Member]
Loss Contingencies [Line Items]
Judgments paid | $						$ 578
Litigation settlement interest expense (income) | $						$ 195
Philip Morris USA [Member] | Engle Progeny Cases, Federal [Member]
Loss Contingencies [Line Items]
Number of claims resolved					415
Subsequent Event [Member] | Philip Morris USA [Member] | Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of cases set for trial	10						10
Number of verdicts returned	126
Number of favorable verdicts	47
Number of unfavorable verdicts	69
Subsequent Event [Member] | Philip Morris USA [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases set for trial	0						0
Subsequent Event [Member] | Philip Morris USA [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of verdicts returned							65
Number of favorable verdicts							43
Number of unfavorable verdicts							22
Number of claims resolved							19
Subsequent Event [Member] | Philip Morris USA [Member] | Engle Progeny Cases, Federal [Member]
Loss Contingencies [Line Items]
Number of cases pending	7						7
Subsequent Event [Member] | Philip Morris USA [Member] | Alaska [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | California [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							7
Subsequent Event [Member] | Philip Morris USA [Member] | Connecticut [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | Florida [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							10
Number cases with granted new trial	1						1
Subsequent Event [Member] | Philip Morris USA [Member] | Louisiana [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | Massachusetts [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							3
Subsequent Event [Member] | Philip Morris USA [Member] | Mississippi [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | Missouri [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							4
Subsequent Event [Member] | Philip Morris USA [Member] | New Hampshire [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | New Jersey [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | New York [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							5
Subsequent Event [Member] | Philip Morris USA [Member] | Ohio [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							2
Subsequent Event [Member] | Philip Morris USA [Member] | Pennsylvania [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | Rhode Island [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							1
Subsequent Event [Member] | Philip Morris USA [Member] | Tennessee [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							2
Subsequent Event [Member] | Philip Morris USA [Member] | West Virginia [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts							2
Subsequent Event [Member] | Philip Morris USA [Member] | Canada [Member] | Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending	10						10
Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Canada [Member] | Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending	8						8
Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Canada [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending	7						7
Pending Litigation [Member] | Florida [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases pending		37				37
Pending Litigation [Member] | Massachusetts [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases pending		30				30
Pending Litigation [Member] | Philip Morris USA [Member] | Assets [Member]
Loss Contingencies [Line Items]
Security posted for appeal of judgments | $		$ 100				$ 100

Contingencies (Overview of Al_3

Contingencies (Overview of Altria Group, Inc. and/or PM USA Tobacco-Related Litigation - Schedule of Judgments Recorded and Paid) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended			168 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2018
Loss Contingency Accrual [Roll Forward]
Accrued liability for tobacco and health litigation items at beginning of period				$ 106				$ 47	$ 106	$ 47	$ 132
Provision related to litigation recorded	$ 12	$ 21	$ 70	$ 28	$ 62	$ 0	$ 17	$ 1
Payments									(125)	(21)	(190)
Accrued liability for tobacco and health litigation items at end of period	$ 112				$ 106				112	106	47
Interest Expense Related To Litigation [Member]
Loss Contingency Accrual [Roll Forward]
Provision related to litigation recorded									18	8	17
Tobacco and Health Judgment [Member] | Litigation Cases Results [Member]
Loss Contingency Accrual [Roll Forward]
Provision related to litigation recorded									$ 113	$ 72	$ 88
Philip Morris USA [Member] | Engle Progeny Cases, Federal [Member]
Loss Contingency Accrual [Roll Forward]
Increase (decrease) in deposit assets												$ 43

Contingencies (Smoking and Heal

Contingencies (Smoking and Health Litigation - Non-Engle Progeny Litigation Narrative) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Apr. 30, 2018	Oct. 31, 2017	Dec. 31, 2015
Loss Contingencies [Line Items]
Provision related to litigation recorded	$ 12,000,000	$ 21,000,000	$ 70,000,000	$ 28,000,000	$ 62,000,000	$ 0	$ 17,000,000	$ 1,000,000
Non-Engle Progeny Smoking and Health Case, Gentile [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded	$ 225,000									$ 7,100,000
Non-Engle Progeny Smoking and Health Case, Gentile [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded										$ 5,300,000
Compensatory damages award, allocation percentage										75.00%
Appeal bond posted									$ 8,000,000
Non-Engle Progeny Smoking and Health Case, Bullock [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded											$ 900,000
Non-Engle Progeny Smoking and Health Case, Bullock [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Provision related to litigation recorded					$ 1,000,000

Contingencies (Smoking and He_2

Contingencies (Smoking and Health Litigation - Engle Class Action, Engle Progeny Appellate Issues, Florida Bond Statute Narrative) (Details)	Jan. 29, 2019USD ($)caseplantiff	Jun. 30, 2009USD ($)case	Jul. 31, 2006	Dec. 31, 2015case	Jul. 31, 2000USD ($)
Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Punitive damages awarded | $					$ 145,000,000,000
Engle Progeny Cases [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Punitive damages awarded | $					$ 74,000,000,000
Period for members of decertified class to file individual actions against defendants			1 year
Engle Progeny Cases [Member] | Philip Morris USA [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of verdicts returned	126
Number of unfavorable verdicts	69
Unfavorable verdicts pending/reversed	7
Number of favorable verdicts	47
Engle Progeny Cases, State [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of cases pending	2,100
Number of plaintiffs | plantiff	3,000
Engle Progeny Cases, State [Member] | Philip Morris USA [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts	39
Engle Progeny Cases, D Cohen, Collar, Chacon [Member] | Philip Morris USA [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Verdict reversed, number	3
Engle Progeny Cases, Federal [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims resolved				415
Engle Progeny Cases, Federal [Member] | Philip Morris USA [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of cases pending	7
Engle Progeny Cases, Reider and Banks [Member] | Philip Morris USA [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Damages awarded, value | $	$ 0
Engle Progeny Cases, Weingart and Hancock [Member] | Philip Morris USA [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Damages awarded, value | $	$ 0
Florida [Member] | Engle Progeny Cases, State [Member]
Loss Contingencies [Line Items]
Maximum bond required by all defendants | $		$ 200,000,000
Alachua County, Florida [Member] | Engle Progeny Cases, State [Member]
Loss Contingencies [Line Items]
Number of cases in which plaintiffs that challenged constitutionality of bond cap statute		3
Escambia County, Florida [Member] | Engle Progeny Cases, State [Member]
Loss Contingencies [Line Items]
Number of cases in which plaintiffs that challenged constitutionality of bond cap statute		1

Contingencies (Smoking and He_3

Contingencies (Smoking and Health Litigation - Engle Progeny Cases Trial Results - Pending and Concluded Narrative) (Details) - USD ($) $ in Millions

3 Months Ended

12 Months Ended

27 Months Ended

Dec. 31, 2018

Sep. 30, 2018

Jun. 30, 2018

Mar. 31, 2018

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2018

Mar. 31, 2018

Jul. 31, 2018

May 31, 2018

Feb. 28, 2018

Nov. 30, 2017

Oct. 31, 2017

May 31, 2017

Apr. 30, 2017

Feb. 28, 2017

Dec. 31, 2016

Nov. 30, 2016

Nov. 30, 2015

Sep. 30, 2015

Aug. 31, 2015

Jul. 31, 2015

May 31, 2015

Feb. 28, 2015

Jan. 31, 2015

Nov. 30, 2014

Oct. 31, 2014

Sep. 30, 2014

Jul. 31, 2014

Jun. 30, 2013

Apr. 30, 2013

Loss Contingencies [Line Items]

Provision related to litigation recorded

$ 12

$ 21

$ 70

$ 28

$ 62

$ 0

$ 17

$ 1

Pending Litigation [Member] | Engle Progeny Cases, Berger [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 6

Provision related to litigation recorded

6

Pending Litigation [Member] | Engle Progeny Cases, Berger [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 21

Pending Litigation [Member] | Engle Progeny Cases, McKeever [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 6

Provision related to litigation recorded

20

Pending Litigation [Member] | Engle Progeny Cases, McKeever [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 12

Pending Litigation [Member] | Engle Progeny Cases, Pardue [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 5

Provision related to litigation recorded

1

9

$ 10

Pending Litigation [Member] | Engle Progeny Cases, Pardue [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 7

Pending Litigation [Member] | Engle Progeny Cases, Jordan [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 6

Provision related to litigation recorded

11

Pending Litigation [Member] | Engle Progeny Cases, Jordan [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 3

Pending Litigation [Member] | Engle Progeny Cases, M. Brown [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 6

Provision related to litigation recorded

7

Pending Litigation [Member] | Engle Progeny Cases, M. Brown [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

0

Attorneys fees

$ 7

Pending Litigation [Member] | Engle Progeny Cases, Boatright [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 15

Provision related to litigation recorded

41

Pending Litigation [Member] | Engle Progeny Cases, Boatright [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 20

Pending Litigation [Member] | Engle Progeny Cases, Searcy [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 1

Provision related to litigation recorded

2

Pending Litigation [Member] | Engle Progeny Cases, Searcy [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 2

Pending Litigation [Member] | Engle Progeny Cases, Chadwell [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

2

Pending Litigation [Member] | Engle Progeny Cases, Chadwell [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

0

Pending Litigation [Member] | Engle Progeny Cases, Kaplan [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 2

Pending Litigation [Member] | Engle Progeny Cases, Kaplan [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 2

Pending Litigation [Member] | Engle Progeny Cases, Landi [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

8

Pending Litigation [Member] | Engle Progeny Cases, Landi [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

5

Pending Litigation [Member] | Engle Progeny Cases, Theis [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 7

Pending Litigation [Member] | Engle Progeny Cases, Theis [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 10

Pending Litigation [Member] | Engle Progeny Cases, Freeman [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

4

$ 4

Pending Litigation [Member] | Engle Progeny Cases, Freeman [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

0

0

Pending Litigation [Member] | Engle Progeny Cases, Gloger [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 8

Pending Litigation [Member] | Engle Progeny Cases, Gloger [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 5

Pending Litigation [Member] | Engle Progeny Cases, Bryant [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

1

Pending Litigation [Member] | Engle Progeny Cases, Bryant [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

1

Pending Litigation [Member] | Engle Progeny Cases, R. Douglas [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 1

Pending Litigation [Member] | Engle Progeny Cases, R. Douglas [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 0

Pending Litigation [Member] | Engle Progeny Cases, Wallace [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 12

Pending Litigation [Member] | Engle Progeny Cases, Wallace [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 16

Pending Litigation [Member] | Engle Progeny Cases, L. Martin [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 1

Pending Litigation [Member] | Engle Progeny Cases, L. Martin [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

1

Punitive damages awarded

$ 1

Pending Litigation [Member] | Engle Progeny Cases, Sommers [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 1

Pending Litigation [Member] | Engle Progeny Cases, Sommers [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 0

Pending Litigation [Member] | Engle Progeny Cases, Santoro [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

2

Pending Litigation [Member] | Engle Progeny Cases, Santoro [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 0

Pending Litigation [Member] | Engle Progeny Cases, J. Brown [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 5

Pending Litigation [Member] | Engle Progeny Cases, J. Brown [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 1

Pending Litigation [Member] | Engle Progeny Cases, Martin [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 5

Pending Litigation [Member] | Engle Progeny Cases, Martin [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 0

Pending Litigation [Member] | Engle Progeny Cases, Danielson [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 3

Pending Litigation [Member] | Engle Progeny Cases, Danielson [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 1

Pending Litigation [Member] | Engle Progeny Cases, Cooper [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 5

Pending Litigation [Member] | Engle Progeny Cases, Cooper [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

1

Punitive damages awarded

$ 0

Pending Litigation [Member] | Engle Progeny Cases, McCoy [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 2

Pending Litigation [Member] | Engle Progeny Cases, McCoy [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

1

Punitive damages awarded

$ 3

Pending Litigation [Member] | Engle Progeny Cases, D. Brown [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 8

Pending Litigation [Member] | Engle Progeny Cases, D. Brown [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 9

Pending Litigation [Member] | Engle Progeny Cases, Kerrivan [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 16

Pending Litigation [Member] | Engle Progeny Cases, Kerrivan [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 16

Pending Litigation [Member] | Engle Progeny Cases, Harris [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 2

Pending Litigation [Member] | Engle Progeny Cases, Harris [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 0

Pending Litigation [Member] | Engle Progeny Cases, Skolnick [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded (less than)

$ 0

Pending Litigation [Member] | Engle Progeny Cases, Skolnick [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 0

Settled Litigation [Member] | Engle Progeny Cases, Perrotto [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

$ 1

1

Settled Litigation [Member] | Engle Progeny Cases, Gore [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

1

Settled Litigation [Member] | Engle Progeny Cases, Putney [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

5

Settled Litigation [Member] | Engle Progeny Cases, Sermons [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

$ 1

Settled Litigation [Member] | Engle Progeny Cases, Tognoli [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

1

Settled Litigation [Member] | Engle Progeny Cases, Howles [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

6

Settled Litigation [Member] | Engle Progeny Cases, Purdo [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

10

Settled Litigation [Member] | Engle Progeny Cases, Griffin [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

1

Settled Litigation [Member] | Engle Progeny Cases, Ledoux [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

20

Settled Litigation [Member] | Engle Progeny Cases, Burkhart [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

$ 2

Settled Litigation [Member] | Engle Progeny Cases, Barbose [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

12

Settled Litigation [Member] | Engle Progeny Cases, Allen [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

10

Settled Litigation [Member] | Engle Progeny Cases, Ahrens [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

7

Settled Litigation [Member] | Engle Progeny Cases, Starr-Blundell [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

$ 1

Settled Litigation [Member] | Engle Progeny Cases, Zamboni [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

$ 1

Settled Litigation [Member] | Engle Progeny Cases, Graham [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

1

Settled Litigation [Member] | Engle Progeny Cases, Naugle [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

14

Settled Litigation [Member] | Engle Progeny Cases, Lourie [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

$ 3

Settled Litigation [Member] | Engle Progeny Cases, Marchese [Member] | Philip Morris USA [Member]

Loss Contingencies [Line Items]

Damages awarded, value (less than)

$ 1

Contingencies (Other Smoking an

Contingencies (Other Smoking and Health Class Actions Narrative) (Details) - Smoking And Health Class Actions And Aggregated Claims Litigation [Member] - case	272 Months Ended
	Dec. 31, 2018	Jan. 29, 2019	Dec. 31, 2017	Dec. 31, 2016
Loss Contingencies [Line Items]
Number of cases pending	2		4	5
Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	61
Arkansas [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
California [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Delaware [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
District Of Columbia [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	2
Florida [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	2
Illinois [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	3
Iowa [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Kansas [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Louisiana [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Maryland [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Michigan [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Minnesota [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Nevada [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	29
New Jersey [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	6
New York [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	2
Ohio [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Oklahoma [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Oregon [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Pennsylvania [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Puerto Rico [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
South Carolina [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Texas [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Wisconsin [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Canada [Member] | Philip Morris USA and Altria Group [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of cases pending		7
British Columbia [Member] | Philip Morris USA and Altria Group [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of cases pending		2

Contingencies (Health Care Cost

Contingencies (Health Care Cost Recovery Litigation Narrative) (Details)	1 Months Ended	12 Months Ended
	Nov. 30, 1998USD ($)state	Dec. 31, 2018USD ($)case	Dec. 31, 2017USD ($)case	Dec. 31, 2016USD ($)case
Cost of Sales [Member]
Loss Contingencies [Line Items]
State settlement agreements		$ 4,200,000,000	$ 4,500,000,000	$ 4,600,000,000
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending | case		1	1	1
Number of states with settled litigation | state	46
State Settlement Agreements annual payments	$ 9,400,000,000
State settlement agreements attorney fees annual cap	$ 500,000,000
Health Care Cost Recovery Actions [Member] | Canada [Member] | Threatened Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending | case		10

Contingencies (Health Care Co_2

Contingencies (Health Care Cost Recovery Litigation - NPM Adjustment Disputes - Settlement with 36 States and Territories and Settlement with New York) (Details) $ in Millions	1 Months Ended			3 Months Ended			12 Months Ended
	Apr. 30, 2018USD ($)	Oct. 31, 2017USD ($)state	Nov. 30, 1998state	Jun. 30, 2018USD ($)state	Mar. 31, 2018USD ($)state	Dec. 31, 2017USD ($)	Dec. 31, 2018stateclaim	Dec. 31, 2015USD ($)	Dec. 31, 2012state
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of states with settled litigation | state			46
Health Care Cost Recovery Actions [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Loss contingency, number of states | state							52
Reduction to cost of sales				$ 90
Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Reduction to cost of sales						$ 39
Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Reduction to cost of sales				38
Settled Litigation [Member] | Health Care Cost Recovery Actions [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of states with settled litigation, first settlement | state							36
Number of claims resolved | claim							2
Number of states with settled litigation | state							37
Loss contingency number of states with settled litigation including new york | state									19
Litigation settlement amount								$ 217
Settled Litigation [Member] | Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of states with settled litigation, first settlement | state		26
Litigation settlement amount		$ 740
Settled Litigation [Member] | Health Care Cost Recovery Actions, 2004-2017 [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Litigation settlement amount				90	$ 81
Number of additional states with settled litigation | state					9
Proceeds from legal settlements	$ 68
Settled Litigation [Member] | Health Care Cost Recovery Actions, 2015-2017 Transition Years [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Litigation settlement amount				$ 13	$ 13
Settled Litigation [Member] | Health Care Cost Recovery Actions, 2016 and 2017 NPM Adjustments [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of states with settled litigation, first settlement | state				26
Litigation settlement amount				$ 77

Contingencies (Health Care Co_3

Contingencies (Health Care Cost Recovery - 2003 and subsequent NPM Adjustment Disputes - Continuing Disputes with Non-Signatory States that Have Not Setteled) (Details) - Philip Morris USA [Member] $ in Millions	1 Months Ended		12 Months Ended
	Aug. 31, 2018USD ($)	Sep. 30, 2013USD ($)state	Dec. 31, 2018USD ($)
Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Loss contingency, number of states | state		15
Loss contingency, number of states that did not enforce escrow statutes | state		6
Loss contingency, number of disputes outstanding | state		2
Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member] | Maryland, Missouri, New Mexico and Pennsylvania [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of States Remaining | state		4
Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Settled Litigation [Member]
Loss Contingencies [Line Items]
Number of states with settled litigation | state		2
Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			$ 388
Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			181
Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			154
Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			185
Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			250
Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			211
Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			218
Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			166
Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			214
Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			224
Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			253
Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			300
Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			295
Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]
Loss Contingencies [Line Items]
Estimate of possible gain			$ 288
Other Disputes Under the State Settlement Agreements [Member]
Loss Contingencies [Line Items]
Amount awarded from other party	$ 9.8
Cost of Sales [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Litigation settlement amount		$ 74

Contingencies (Health Care Co_4

Contingencies (Health Care Cost Recovery - Federal Government's Lawsuit Narrative) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended								12 Months Ended
	Aug. 31, 2006	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2014
Loss Contingencies [Line Items]
Provision related to litigation recorded		$ 12	$ 21	$ 70	$ 28	$ 62	$ 0	$ 17	$ 1
Federal Governments Lawsuit [Member]
Loss Contingencies [Line Items]
Federal trade commission, disclosure period	10 years
Implementation of Corrective Communications [Member] | Federal Governments Lawsuit [Member]
Loss Contingencies [Line Items]
Provision related to litigation recorded										$ 31

Contingencies (Health Care Co_5

Contingencies (Health Care Cost Recovery - Lights/Ultra Lights Cases) (Details)	Jan. 29, 2019casecourt	Dec. 31, 2018case	Dec. 31, 2017case	Dec. 31, 2016case
Lights Ultra Lights Class Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending		2	3	8
Subsequent Event [Member] | Lights [Member]
Loss Contingencies [Line Items]
Claims not certified, number	23
Subsequent Event [Member] | Lights [Member] | Philip Morris USA [Member]
Loss Contingencies [Line Items]
Number of state courts | court	21
Subsequent Event [Member] | Lights Ultra Lights Class Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending	2

Contingencies (Health Care Co_6

Contingencies (Health Care Cost Recovery - Certain Other Tobacco-Related Litigation, Guarantees and Other Similar Matters) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Loss Contingencies [Line Items]
Contingent liability related to performance surety bonds	$ 30
Redeemable noncontrolling interest	39	$ 38
Letter of Credit [Member]
Loss Contingencies [Line Items]
Maximum borrowing capacity	$ 57

Contingencies (Redeemable Nonco

Contingencies (Redeemable Noncontrolling Interest) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Sep. 30, 2007
Loss Contingencies [Line Items]
Redeemable noncontrolling interest	$ 39	$ 38
Ste. Michelle [Member]
Loss Contingencies [Line Items]
Noncontrolling interest, ownership percentage by parent			85.00%
Antinori California [Member]
Loss Contingencies [Line Items]
Noncontrolling interest, ownership percentage by noncontrolling owners			15.00%
Redeemable noncontrolling interest			$ 27

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 1,333,000,000	$ 1,253,000,000	$ 4,569,000,000
Receivables	142,000,000	142,000,000
Inventories:
Leaf tobacco	940,000,000	941,000,000
Other raw materials	186,000,000	170,000,000
Work in process	647,000,000	560,000,000
Finished product	558,000,000	554,000,000
Inventory, net	2,331,000,000	2,225,000,000
Due from Altria and subsidiaries	0	0
Income taxes	167,000,000	461,000,000
Other current assets	326,000,000	263,000,000
Total current assets	4,299,000,000	4,344,000,000
Property, plant and equipment, at cost	4,950,000,000	4,879,000,000
Less accumulated depreciation	3,012,000,000	2,965,000,000
Property, plant and equipment, net	1,938,000,000	1,914,000,000
Goodwill	5,196,000,000	5,307,000,000	5,285,000,000
Other intangible assets, net	12,279,000,000	12,400,000,000	12,036,000,000
Investment in AB InBev	17,696,000,000	17,952,000,000
Investment in JUUL	12,800,000,000	0
Investment in consolidated subsidiaries	0	0
Due from Altria and subsidiaries	0	0
Other assets	1,430,000,000	1,285,000,000
Total Assets	55,638,000,000	43,202,000,000
Liabilities
Short-term borrowings	12,704,000,000	0
Current portion of long-term debt	1,144,000,000	864,000,000
Accounts payable	399,000,000	374,000,000
Accrued liabilities:
Marketing	586,000,000	695,000,000
Employment costs	189,000,000	188,000,000
Settlement charges	3,454,000,000	2,442,000,000
Other	1,214,000,000	971,000,000
Dividends payable	1,503,000,000	1,258,000,000
Due to Altria and subsidiaries	0	0
Total current liabilities	21,193,000,000	6,792,000,000
Long-term debt	11,898,000,000	13,030,000,000
Deferred income taxes	5,172,000,000	5,247,000,000
Accrued pension costs	544,000,000	445,000,000
Accrued postretirement health care costs	1,749,000,000	1,987,000,000
Due to Altria and subsidiaries	0	0
Other liabilities	254,000,000	283,000,000
Total liabilities	40,810,000,000	27,784,000,000
Contingencies
Redeemable noncontrolling interest	39,000,000	38,000,000
Stockholders' Equity
Common stock	935,000,000	935,000,000
Additional paid-in capital	5,961,000,000	5,952,000,000
Earnings reinvested in the business	43,962,000,000	42,251,000,000
Accumulated other comprehensive losses	(2,547,000,000)	(1,897,000,000)
Cost of repurchased stock	(33,524,000,000)	(31,864,000,000)
Total stockholders’ equity attributable to Altria	14,787,000,000	15,377,000,000
Noncontrolling interests	2,000,000	3,000,000
Total stockholders’ equity	14,789,000,000	15,380,000,000	$ 12,773,000,000	$ 2,873,000,000
Total Liabilities and Stockholders’ Equity	55,638,000,000	43,202,000,000
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	1,277,000,000	1,203,000,000
Receivables	0	1,000,000
Inventories:
Leaf tobacco	0	0
Other raw materials	0	0
Work in process	0	0
Finished product	0	0
Inventory, net	0	0
Due from Altria and subsidiaries	46,000,000	2,000,000
Income taxes	100,000,000	0
Other current assets	41,000,000	11,000,000
Total current assets	1,464,000,000	1,217,000,000
Property, plant and equipment, at cost	0	0
Less accumulated depreciation	0	0
Property, plant and equipment, net	0	0
Goodwill	0	0
Other intangible assets, net	0	0
Investment in AB InBev	17,696,000,000	17,952,000,000
Investment in JUUL	0
Investment in consolidated subsidiaries	25,996,000,000	13,111,000,000
Due from Altria and subsidiaries	4,790,000,000	4,790,000,000
Other assets	193,000,000	34,000,000
Total Assets	50,139,000,000	37,104,000,000
Liabilities
Short-term borrowings	12,704,000,000
Current portion of long-term debt	1,144,000,000	864,000,000
Accounts payable	1,000,000	2,000,000
Accrued liabilities:
Marketing	0	0
Employment costs	16,000,000	21,000,000
Settlement charges	0	0
Other	279,000,000	389,000,000
Dividends payable	1,503,000,000	1,258,000,000
Due to Altria and subsidiaries	4,499,000,000	3,040,000,000
Total current liabilities	20,146,000,000	5,574,000,000
Long-term debt	11,898,000,000	13,030,000,000
Deferred income taxes	3,010,000,000	2,809,000,000
Accrued pension costs	187,000,000	206,000,000
Accrued postretirement health care costs	0	0
Due to Altria and subsidiaries	0	0
Other liabilities	111,000,000	108,000,000
Total liabilities	35,352,000,000	21,727,000,000
Contingencies
Redeemable noncontrolling interest	0	0
Stockholders' Equity
Common stock	935,000,000	935,000,000
Additional paid-in capital	5,961,000,000	5,952,000,000
Earnings reinvested in the business	43,962,000,000	42,251,000,000
Accumulated other comprehensive losses	(2,547,000,000)	(1,897,000,000)
Cost of repurchased stock	(33,524,000,000)	(31,864,000,000)
Total stockholders’ equity attributable to Altria	14,787,000,000	15,377,000,000
Noncontrolling interests	0	0
Total stockholders’ equity	14,787,000,000	15,377,000,000
Total Liabilities and Stockholders’ Equity	50,139,000,000	37,104,000,000
Reportable Legal Entities [Member] | PM USA [Member]
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	0	1,000,000
Receivables	18,000,000	10,000,000
Inventories:
Leaf tobacco	561,000,000	579,000,000
Other raw materials	123,000,000	111,000,000
Work in process	2,000,000	5,000,000
Finished product	128,000,000	128,000,000
Inventory, net	814,000,000	823,000,000
Due from Altria and subsidiaries	3,828,000,000	2,413,000,000
Income taxes	94,000,000	542,000,000
Other current assets	167,000,000	147,000,000
Total current assets	4,921,000,000	3,936,000,000
Property, plant and equipment, at cost	2,928,000,000	2,930,000,000
Less accumulated depreciation	2,111,000,000	2,086,000,000
Property, plant and equipment, net	817,000,000	844,000,000
Goodwill	0	0
Other intangible assets, net	2,000,000	2,000,000
Investment in AB InBev	0	0
Investment in JUUL	0
Investment in consolidated subsidiaries	2,825,000,000	2,818,000,000
Due from Altria and subsidiaries	0	0
Other assets	955,000,000	671,000,000
Total Assets	9,520,000,000	8,271,000,000
Liabilities
Short-term borrowings	0
Current portion of long-term debt	0	0
Accounts payable	91,000,000	91,000,000
Accrued liabilities:
Marketing	483,000,000	578,000,000
Employment costs	11,000,000	14,000,000
Settlement charges	3,448,000,000	2,437,000,000
Other	513,000,000	433,000,000
Dividends payable	0	0
Due to Altria and subsidiaries	407,000,000	317,000,000
Total current liabilities	4,953,000,000	3,870,000,000
Long-term debt	0	0
Deferred income taxes	0	0
Accrued pension costs	0	0
Accrued postretirement health care costs	1,072,000,000	1,214,000,000
Due to Altria and subsidiaries	0	0
Other liabilities	47,000,000	49,000,000
Total liabilities	6,072,000,000	5,133,000,000
Contingencies
Redeemable noncontrolling interest	0	0
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	3,310,000,000	3,310,000,000
Earnings reinvested in the business	359,000,000	96,000,000
Accumulated other comprehensive losses	(221,000,000)	(268,000,000)
Cost of repurchased stock	0	0
Total stockholders’ equity attributable to Altria	3,448,000,000	3,138,000,000
Noncontrolling interests	0	0
Total stockholders’ equity	3,448,000,000	3,138,000,000
Total Liabilities and Stockholders’ Equity	9,520,000,000	8,271,000,000
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	56,000,000	49,000,000
Receivables	124,000,000	131,000,000
Inventories:
Leaf tobacco	379,000,000	362,000,000
Other raw materials	63,000,000	59,000,000
Work in process	645,000,000	555,000,000
Finished product	430,000,000	426,000,000
Inventory, net	1,517,000,000	1,402,000,000
Due from Altria and subsidiaries	1,194,000,000	1,022,000,000
Income taxes	0	17,000,000
Other current assets	118,000,000	105,000,000
Total current assets	3,009,000,000	2,726,000,000
Property, plant and equipment, at cost	2,022,000,000	1,949,000,000
Less accumulated depreciation	901,000,000	879,000,000
Property, plant and equipment, net	1,121,000,000	1,070,000,000
Goodwill	5,196,000,000	5,307,000,000
Other intangible assets, net	12,277,000,000	12,398,000,000
Investment in AB InBev	0	0
Investment in JUUL	12,800,000,000
Investment in consolidated subsidiaries	0	0
Due from Altria and subsidiaries	0	0
Other assets	952,000,000	1,056,000,000
Total Assets	35,355,000,000	22,557,000,000
Liabilities
Short-term borrowings	0
Current portion of long-term debt	0	0
Accounts payable	307,000,000	281,000,000
Accrued liabilities:
Marketing	103,000,000	117,000,000
Employment costs	162,000,000	153,000,000
Settlement charges	6,000,000	5,000,000
Other	449,000,000	247,000,000
Dividends payable	0	0
Due to Altria and subsidiaries	162,000,000	80,000,000
Total current liabilities	1,189,000,000	883,000,000
Long-term debt	0	0
Deferred income taxes	2,832,000,000	2,914,000,000
Accrued pension costs	357,000,000	239,000,000
Accrued postretirement health care costs	677,000,000	773,000,000
Due to Altria and subsidiaries	4,790,000,000	4,790,000,000
Other liabilities	96,000,000	126,000,000
Total liabilities	9,941,000,000	9,725,000,000
Contingencies
Redeemable noncontrolling interest	39,000,000	38,000,000
Stockholders' Equity
Common stock	9,000,000	9,000,000
Additional paid-in capital	25,047,000,000	12,045,000,000
Earnings reinvested in the business	2,201,000,000	2,243,000,000
Accumulated other comprehensive losses	(1,884,000,000)	(1,506,000,000)
Cost of repurchased stock	0	0
Total stockholders’ equity attributable to Altria	25,373,000,000	12,791,000,000
Noncontrolling interests	2,000,000	3,000,000
Total stockholders’ equity	25,375,000,000	12,794,000,000
Total Liabilities and Stockholders’ Equity	35,355,000,000	22,557,000,000
Total Consolidating Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	0	0
Receivables	0	0
Inventories:
Leaf tobacco	0	0
Other raw materials	0	0
Work in process	0	0
Finished product	0	0
Inventory, net	0	0
Due from Altria and subsidiaries	(5,068,000,000)	(3,437,000,000)
Income taxes	(27,000,000)	(98,000,000)
Other current assets	0	0
Total current assets	(5,095,000,000)	(3,535,000,000)
Property, plant and equipment, at cost	0	0
Less accumulated depreciation	0	0
Property, plant and equipment, net	0	0
Goodwill	0	0
Other intangible assets, net	0	0
Investment in AB InBev	0	0
Investment in JUUL	0
Investment in consolidated subsidiaries	(28,821,000,000)	(15,929,000,000)
Due from Altria and subsidiaries	(4,790,000,000)	(4,790,000,000)
Other assets	(670,000,000)	(476,000,000)
Total Assets	(39,376,000,000)	(24,730,000,000)
Liabilities
Short-term borrowings	0
Current portion of long-term debt	0	0
Accounts payable	0	0
Accrued liabilities:
Marketing	0	0
Employment costs	0	0
Settlement charges	0	0
Other	(27,000,000)	(98,000,000)
Dividends payable	0	0
Due to Altria and subsidiaries	(5,068,000,000)	(3,437,000,000)
Total current liabilities	(5,095,000,000)	(3,535,000,000)
Long-term debt	0	0
Deferred income taxes	(670,000,000)	(476,000,000)
Accrued pension costs	0	0
Accrued postretirement health care costs	0	0
Due to Altria and subsidiaries	(4,790,000,000)	(4,790,000,000)
Other liabilities	0	0
Total liabilities	(10,555,000,000)	(8,801,000,000)
Contingencies
Redeemable noncontrolling interest	0	0
Stockholders' Equity
Common stock	(9,000,000)	(9,000,000)
Additional paid-in capital	(28,357,000,000)	(15,355,000,000)
Earnings reinvested in the business	(2,560,000,000)	(2,339,000,000)
Accumulated other comprehensive losses	2,105,000,000	1,774,000,000
Cost of repurchased stock	0	0
Total stockholders’ equity attributable to Altria	(28,821,000,000)	(15,929,000,000)
Noncontrolling interests	0	0
Total stockholders’ equity	(28,821,000,000)	(15,929,000,000)
Total Liabilities and Stockholders’ Equity	$ (39,376,000,000)	$ (24,730,000,000)

Condensed Consolidating Finan_4

Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Net revenues	$ 6,114	$ 6,837	$ 6,305	$ 6,108	$ 6,101	$ 6,729	$ 6,663	$ 6,083	$ 25,364	$ 25,576	$ 25,744
Cost of sales									7,373	7,531	7,765
Excise taxes on products									5,737	6,082	6,407
Gross profit	2,922	3,255	3,141	2,936	2,902	3,171	3,114	2,776	12,254	11,963	11,572
Marketing, administration and research costs									2,756	2,338	2,662
Asset impairment and exit costs									383	32	149
Operating (expense) income									9,115	9,593	8,761
Interest and other debt expense, net									665	705	747
Loss on early extinguishment of debt									0	0	823
Net periodic benefit (income) cost, excluding service cost									(34)	37	(1)
Earnings from equity investment in AB InBev/SABMiller									(890)	(532)	(795)
Loss (gain) on AB InBev/SABMiller business combination	0	0	0	33	0	(37)	(408)	0	33	(445)	(13,865)
Earnings before income taxes									9,341	9,828	21,852
(Benefit) provision for income taxes									2,374	(399)	7,608
Equity earnings of subsidiaries									0	0	0
Net earnings	1,251	1,944	1,877	1,895	4,968	1,867	1,990	1,402	6,967	10,227	14,244
Net earnings attributable to noncontrolling interests									(4)	(5)	(5)
Net earnings attributable to Altria	$ 1,250	$ 1,943	$ 1,876	$ 1,894	$ 4,966	$ 1,866	$ 1,989	$ 1,401	6,963	10,222	14,239
Other comprehensive earnings (losses), net of deferred income taxes									(242)	155	1,228
Comprehensive earnings									6,725	10,382	15,472
Comprehensive earnings attributable to noncontrolling interests									(4)	(5)	(5)
Comprehensive earnings attributable to Altria									6,721	10,377	15,467
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]
Condensed Financial Statements, Captions [Line Items]
Net revenues									0	0	0
Cost of sales									0	0	0
Excise taxes on products									0	0	0
Gross profit									0	0	0
Marketing, administration and research costs									219	161	160
Asset impairment and exit costs									0	0	5
Operating (expense) income									(219)	(161)	(165)
Interest and other debt expense, net									511	510	519
Loss on early extinguishment of debt											823
Net periodic benefit (income) cost, excluding service cost									16	12	5
Earnings from equity investment in AB InBev/SABMiller									(890)	(532)	(795)
Loss (gain) on AB InBev/SABMiller business combination									33	(445)	(13,865)
Earnings before income taxes									111	294	13,148
(Benefit) provision for income taxes									36	(2,624)	4,453
Equity earnings of subsidiaries									6,888	7,304	5,544
Net earnings									6,963	10,222	14,239
Net earnings attributable to noncontrolling interests									0	0	0
Net earnings attributable to Altria									6,963	10,222	14,239
Other comprehensive earnings (losses), net of deferred income taxes									(242)	155	1,228
Comprehensive earnings									6,721	10,377	15,467
Comprehensive earnings attributable to noncontrolling interests									0	0	0
Comprehensive earnings attributable to Altria									6,721	10,377	15,467
Reportable Legal Entities [Member] | PM USA [Member]
Condensed Financial Statements, Captions [Line Items]
Net revenues									21,422	21,826	22,146
Cost of sales									6,153	6,394	6,641
Excise taxes on products									5,517	5,864	6,187
Gross profit									9,752	9,568	9,318
Marketing, administration and research costs									1,892	1,713	2,009
Asset impairment and exit costs									81	0	77
Operating (expense) income									7,779	7,855	7,232
Interest and other debt expense, net									(61)	(20)	10
Loss on early extinguishment of debt											0
Net periodic benefit (income) cost, excluding service cost									(41)	18	(6)
Earnings from equity investment in AB InBev/SABMiller									0	0	0
Loss (gain) on AB InBev/SABMiller business combination									0	0	0
Earnings before income taxes									7,881	7,857	7,228
(Benefit) provision for income taxes									1,980	3,127	2,631
Equity earnings of subsidiaries									402	558	268
Net earnings									6,303	5,288	4,865
Net earnings attributable to noncontrolling interests									0	0	0
Net earnings attributable to Altria									6,303	5,288	4,865
Other comprehensive earnings (losses), net of deferred income taxes									104	3	(16)
Comprehensive earnings									6,407	5,291	4,849
Comprehensive earnings attributable to noncontrolling interests									0	0	0
Comprehensive earnings attributable to Altria									6,407	5,291	4,849
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net revenues									3,980	3,787	3,633
Cost of sales									1,258	1,174	1,159
Excise taxes on products									220	218	220
Gross profit									2,502	2,395	2,254
Marketing, administration and research costs									645	464	493
Asset impairment and exit costs									302	32	67
Operating (expense) income									1,555	1,899	1,694
Interest and other debt expense, net									215	215	218
Loss on early extinguishment of debt											0
Net periodic benefit (income) cost, excluding service cost									(9)	7	0
Earnings from equity investment in AB InBev/SABMiller									0	0	0
Loss (gain) on AB InBev/SABMiller business combination									0	0	0
Earnings before income taxes									1,349	1,677	1,476
(Benefit) provision for income taxes									358	(902)	524
Equity earnings of subsidiaries									0	0	0
Net earnings									991	2,579	952
Net earnings attributable to noncontrolling interests									(4)	(5)	(5)
Net earnings attributable to Altria									987	2,574	947
Other comprehensive earnings (losses), net of deferred income taxes									(54)	214	(28)
Comprehensive earnings									937	2,793	924
Comprehensive earnings attributable to noncontrolling interests									(4)	(5)	(5)
Comprehensive earnings attributable to Altria									933	2,788	919
Total Consolidating Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Net revenues									(38)	(37)	(35)
Cost of sales									(38)	(37)	(35)
Excise taxes on products									0	0	0
Gross profit									0	0	0
Marketing, administration and research costs									0	0	0
Asset impairment and exit costs									0	0	0
Operating (expense) income									0	0	0
Interest and other debt expense, net									0	0	0
Loss on early extinguishment of debt											0
Net periodic benefit (income) cost, excluding service cost									0	0	0
Earnings from equity investment in AB InBev/SABMiller									0	0	0
Loss (gain) on AB InBev/SABMiller business combination									0	0	0
Earnings before income taxes									0	0	0
(Benefit) provision for income taxes									0	0	0
Equity earnings of subsidiaries									(7,290)	(7,862)	(5,812)
Net earnings									(7,290)	(7,862)	(5,812)
Net earnings attributable to noncontrolling interests									0	0	0
Net earnings attributable to Altria									(7,290)	(7,862)	(5,812)
Other comprehensive earnings (losses), net of deferred income taxes									(50)	(217)	44
Comprehensive earnings									(7,340)	(8,079)	(5,768)
Comprehensive earnings attributable to noncontrolling interests									0	0	0
Comprehensive earnings attributable to Altria									$ (7,340)	$ (8,079)	$ (5,768)

Condensed Consolidating Finan_5

Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Oct. 31, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities		$ 8,391	$ 4,901	$ 3,826
Cash Provided by (Used in) Investing Activities
Capital expenditures		(238)	(199)	(189)
Acquisitions of businesses and assets		(15)	(415)	(45)
Payments to acquire investments		(12,800)		(1,578)
Proceeds from finance assets		37	133	231
Proceeds from AB InBev/SABMiller business combination		0	0	4,773
Proceeds from derivative financial instruments	$ 500	35	0	510
Investment in consolidated subsidiaries		0	0	0
Other, net		(7)	14	6
Net cash (used in) provided by investing activities		(12,988)	(467)	3,708
Cash Provided by (Used in) Financing Activities
Proceeds from short-term borrowings		12,800	0	0
Long-term debt issued		0	0	1,976
Long-term debt repaid		(864)	0	(933)
Repurchases of common stock		(1,673)	(2,917)	(1,030)
Dividends paid on common stock		(5,415)	(4,807)	(4,512)
Changes in amounts due to/from Altria and subsidiaries		0	0	0
Premiums and fees related to early extinguishment of debt		0	0	(809)
Cash dividends paid to parent		0	0	0
Other		(132)	(47)	(21)
Net cash used in financing activities		4,716	(7,771)	(5,329)
Increase (decrease)		119	(3,337)	2,205
Balance at beginning of year		1,314	4,651	2,446
Balance at end of year		1,433	1,314	4,651
Reportable Legal Entities [Member]
Cash Provided by (Used in) Financing Activities
Cash dividends paid to parent				0
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities		6,907	6,910	4,356
Cash Provided by (Used in) Investing Activities
Capital expenditures		0	0	0
Acquisitions of businesses and assets		0	0	0
Payments to acquire investments		0		(1,578)
Proceeds from finance assets		0	0	0
Proceeds from AB InBev/SABMiller business combination				4,773
Proceeds from derivative financial instruments		35		510
Investment in consolidated subsidiaries		(13,003)	(460)	(138)
Other, net		0	(5)	(3)
Net cash (used in) provided by investing activities		(12,968)	(465)	3,564
Cash Provided by (Used in) Financing Activities
Proceeds from short-term borrowings		12,800
Long-term debt issued				1,976
Long-term debt repaid		(864)		(933)
Repurchases of common stock		(1,673)	(2,917)	(1,030)
Dividends paid on common stock		(5,415)	(4,807)	(4,512)
Changes in amounts due to/from Altria and subsidiaries		1,415	(1,999)	(392)
Premiums and fees related to early extinguishment of debt				(809)
Cash dividends paid to parent		0	0
Other		(128)	(40)	(12)
Net cash used in financing activities		6,135	(9,763)	(5,712)
Increase (decrease)		74	(3,318)	2,208
Balance at beginning of year		1,203	4,521	2,313
Balance at end of year		1,277	1,203	4,521
Reportable Legal Entities [Member] | PM USA [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities		7,580	4,028	5,143
Cash Provided by (Used in) Investing Activities
Capital expenditures		(57)	(34)	(45)
Acquisitions of businesses and assets		0	0	0
Payments to acquire investments		0		0
Proceeds from finance assets		0	0	0
Proceeds from AB InBev/SABMiller business combination				0
Proceeds from derivative financial instruments		0		0
Investment in consolidated subsidiaries		0	0	0
Other, net		0	4	0
Net cash (used in) provided by investing activities		(57)	(30)	(45)
Cash Provided by (Used in) Financing Activities
Proceeds from short-term borrowings		0
Long-term debt issued				0
Long-term debt repaid		0		0
Repurchases of common stock		0	0	0
Dividends paid on common stock		0	0	0
Changes in amounts due to/from Altria and subsidiaries		(1,388)	1,410	(28)
Premiums and fees related to early extinguishment of debt				0
Cash dividends paid to parent		(6,097)	(5,429)	(5,064)
Other		0	0	0
Net cash used in financing activities		(7,485)	(4,019)	(5,092)
Increase (decrease)		38	(21)	6
Balance at beginning of year		62	83	77
Balance at end of year		100	62	83
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities		1,354	841	319
Cash Provided by (Used in) Investing Activities
Capital expenditures		(181)	(165)	(144)
Acquisitions of businesses and assets		(15)	(415)	(45)
Payments to acquire investments		(12,800)		0
Proceeds from finance assets		37	133	231
Proceeds from AB InBev/SABMiller business combination				0
Proceeds from derivative financial instruments		0		0
Investment in consolidated subsidiaries		0	0	0
Other, net		(7)	15	9
Net cash (used in) provided by investing activities		(12,966)	(432)	51
Cash Provided by (Used in) Financing Activities
Proceeds from short-term borrowings		0
Long-term debt issued				0
Long-term debt repaid		0		0
Repurchases of common stock		0	0	0
Dividends paid on common stock		0	0	0
Changes in amounts due to/from Altria and subsidiaries		12,976	1,049	558
Premiums and fees related to early extinguishment of debt				0
Cash dividends paid to parent		(1,353)	(1,449)	(928)
Other		(4)	(7)	(9)
Net cash used in financing activities		11,619	(407)	(379)
Increase (decrease)		7	2	(9)
Balance at beginning of year		49	47	56
Balance at end of year		56	49	47
Total Consolidating Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities		(7,450)	(6,878)	(5,992)
Cash Provided by (Used in) Investing Activities
Capital expenditures		0	0	0
Acquisitions of businesses and assets		0	0	0
Payments to acquire investments		0		0
Proceeds from finance assets		0	0	0
Proceeds from AB InBev/SABMiller business combination				0
Proceeds from derivative financial instruments		0		0
Investment in consolidated subsidiaries		13,003	460	138
Other, net		0	0	0
Net cash (used in) provided by investing activities		13,003	460	138
Cash Provided by (Used in) Financing Activities
Proceeds from short-term borrowings		0
Long-term debt issued				0
Long-term debt repaid		0		0
Repurchases of common stock		0	0	0
Dividends paid on common stock		0	0	0
Changes in amounts due to/from Altria and subsidiaries		(13,003)	(460)	(138)
Premiums and fees related to early extinguishment of debt				0
Cash dividends paid to parent		7,450	6,878	5,992
Other		0	0	0
Net cash used in financing activities		(5,553)	6,418	5,854
Increase (decrease)		0	0	0
Balance at beginning of year		0	0	0
Balance at end of year		$ 0	$ 0	$ 0

Quarterly Financial Data (Una_3

Quarterly Financial Data (Unaudited) (EPS attributable to Altria Group, Inc.) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly Financial Data [Abstract]
Net revenues	$ 6,114	$ 6,837	$ 6,305	$ 6,108	$ 6,101	$ 6,729	$ 6,663	$ 6,083	$ 25,364	$ 25,576	$ 25,744
Gross profit	2,922	3,255	3,141	2,936	2,902	3,171	3,114	2,776	12,254	11,963	11,572
Net earnings	1,251	1,944	1,877	1,895	4,968	1,867	1,990	1,402	6,967	10,227	14,244
Net earnings attributable to Altria	$ 1,250	$ 1,943	$ 1,876	$ 1,894	$ 4,966	$ 1,866	$ 1,989	$ 1,401	$ 6,963	$ 10,222	$ 14,239
Basic EPS attributable to Altria (in usd per share)	$ 0.67	$ 1.03	$ 0.99	$ 1					$ 3.69	$ 5.31	$ 7.28
Diluted EPS attributable to Altria (in usd per share)	$ 0.66	$ 1.03	$ 0.99	$ 1					$ 3.68	$ 5.31	$ 7.28
Basic and diluted EPS attributable to Altria (usd per share)					$ 2.60	$ 0.97	$ 1.03	$ 0.72

Quarterly Financial Data (Una_4

Quarterly Financial Data (Unaudited) (Schedule of Pre-tax Charges or (Gains) Included in Net Earnings Attributable to Altria Group, Inc.) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly Financial Data [Abstract]
NPM Adjustment Items	$ 0	$ 0	$ (77)	$ (68)	$ 0	$ 5	$ 0	$ (1)
Tobacco and health litigation items, including accrued interest	12	21	70	28	62	0	17	1
Asset impairment, exit, implementation and acquisition-related costs	532	(3)	6	3	12	17	30	30
Settlement charge for lump sum pension payments					81	0	0	0		$ 81
Loss (gain) on AB InBev/SABMiller business combination	0	0	0	33	0	(37)	(408)	0	$ 33	$ (445)	$ (13,865)
AB InBev special items	69	35	(72)	(117)	51	34	2	73
Pre-tax charges (gains) included in net earnings	$ 613	$ 53	$ (73)	$ (121)	$ 206	$ 19	$ (359)	$ 103

Uncategorized Items - mo-201812

Label	Element	Value
Restricted Cash, Noncurrent	us-gaap_RestrictedCashNoncurrent	$ 82,000,000	[1]
Restricted Cash, Noncurrent	us-gaap_RestrictedCashNoncurrent	36,000,000	[1]
Restricted Cash, Noncurrent	us-gaap_RestrictedCashNoncurrent	43,000,000	[1]
Restricted Cash, Current	us-gaap_RestrictedCashCurrent	0	[1]
Restricted Cash, Current	us-gaap_RestrictedCashCurrent	25,000,000	[1]
Restricted Cash, Current	us-gaap_RestrictedCashCurrent	57,000,000	[1]
Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 408,000,000	[2]
[1]	Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 19. Contingencies.
[2]	For further discussion, see Note 15. Income Taxes.